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Psychometrics of Pediatric Heart Rate Variability: Reliability and Stability 
Oren Weiner 
Measures of heart rate variability (HRV) are commonly used in longitudinal 
studies among infants, children, and adolescents as an indicator of autonomic 
cardiovascular control. However, the psychometric properties of pediatric HRV measures 
have yet to be established. This thesis examined the psychometrics of time- and 
frequency-domain HRV measures among infants and youth through two complementary 
studies. The first study was a systematic review and meta-analysis of 46 studies that 
evaluated how study methodology (study protocol, sample characteristics, ECG signal 
acquisition and pre-processing, HRV analyses) affects HRV test-retest reliability. HRV 
displayed moderate reliability overall across infant/toddler (Mage <5 yrs; Fisher’s Z = 
0.42) and child/adolescent groups (Mage 5–18 yrs; Z = 0.64); reliability among 
infant/toddler studies was relatively more sensitive to examined a priori moderator 
variables. The second study examined temporal stability of HRV measures obtained from 
children (Mage 9 yrs) participating in a large, longitudinal cohort study (N = 632) within 
Quebec. Results indicated that HRV is a moderately stable individual difference in 
children (ICCrange = 0.74–0.85; rrange = 0.67–0.75), and stability was robust to initial 
differences in, and developmental changes among demographic (age, puberty), 
cardiovascular (blood pressure), anthropometric (height, adiposity indices), and physical 
activity (e.g., weekday/end screen time) covariates. However, stability of HRV measures 
reflecting parasympathetic (rMSSD, pNN50, HF) activity was augmented following 
statistical control of time-varying heart rate measures. Together, this thesis contributes 
original knowledge regarding the psychometrics of pediatric HRV measures. Pertinent 
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methodological and intra-individual factors recommended for consideration by future 
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 Heart rate variability (HRV) is an established measure of autonomic 
cardiovascular control. Although HRV is commonly reported in studies of health with 
adult and pediatric samples, the psychometric properties of pediatric HRV measures are 
not well-established. The overarching goal of this thesis was to conduct a comprehensive 
examination of test-retest reliability and temporal stability of HRV measures from 
pediatric samples. A thorough background introduction will first describe physiological 
and methodological factors pertinent to HRV measurement and interpretation; following 
this, key research findings relevant to the reliability and stability of HRV will be 
highlighted and discussed.  
Autonomic and Cardiovascular Physiology 
The autonomic nervous system is a highly interconnected physiological network. 
The autonomic nervous system contains a sympathetic and a parasympathetic branch, 
both of which innervate multiple bodily systems (e.g., heart, lungs, kidney; Guyton & 
Hall, 2006; Johnson, 2003). Sympathetic nerves originate from thoracic and lumbar 
spinal regions; these nerves release epinephrine and norepinepherine to target organs 
(Guyton & Hall, 2006) and activate the “fight or flight” response. “Fight or flight” 
mobilizes the body for action upon detection of a real or perceived stressor by stimulating 
certain physiological processes (e.g., cardiovascular activity, respiration) and suppressing 
others (e.g., digestion; Johnson, 2003; Rogers, 2011). Parasympathetic nerves originate 
from cranial (e.g., vagus nerve) and sacral spinal regions; these nerves release 
acetylcholine to target organs (Guyton & Hall, 2006) and activate the “rest and digest” 
response. “Rest and digest” promotes recovery throughout the body upon removal of a 
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stressor by suppressing certain physiological processes (e.g., cardiovascular activity, 
respiration) and stimulating others (e.g., digestion; Johnson, 2003; Rogers, 2011).  
Early theories of autonomic nervous system functioning posited that sympathetic 
and parasympathetic branches act reciprocally, wherein activation of one autonomic 
branch inhibited the other; this was referred to as “autonomic reciprocity” (Berntson, 
Cacioppo, & Quigley, 1991). Contemporary research suggests that autonomic functioning 
is more complex and can exist in states of reciprocal, coactive, or independent 
functioning, such that sympathetic and parasympathetic activity can be negatively 
correlated, positively correlated, or uncorrelated; this is referred to as “autonomic 
determinism” or “autonomic space” (Berntson et al., 1991; Berntson, Quigley, & Lozano, 
2007; Reyes Del Paso, Langewitz, Mulder, van Roon, & Duscheck, 2013).  
Activity of the sympathetic and parasympathetic autonomic branches on the heart 
produces quantifiable modulations to cardiovascular activity. This modulation reflects 
autonomic regulation of homeostasis across bodily systems (Berntson et al., 2007; 
Guyton & Hall, 2006), and can be captured with measures of heart rate variability 
(HRV). Measures of HRV can be non-invasively quantified through continuous 
recordings of the heart’s electrical activity using an electrocardiogram (ECG). While 
HRV can also be derived using photoplethysmography (Lu, Yang, Taylor, & Stein, 
2009), blood pressure waveforms (McKinley, Shapiro, Bagiella, Myers, De Meersman, 
Grant, & Sloan, 2003), or Doppler ultrasound techniques (Jezewski, Kupka, & Horoba, 
2008), electrocardiogram methodology is often preferred because it produces a clear and 
well-defined visual signal of cardiovascular activity from which HRV can be derived 
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(Task Force of The European Society of Cardiology and The North American Society of 
Pacing and Electrophysiology, 1996).  
The electrocardiogram produces a characteristic visual signal that represents 
distinct phases of each heartbeat, or cardiac cycle. A cardiac cycle begins in the right 
atrium, where electrical discharges from the sino-atrial node are transmitted to the atrio-
ventricular node (Johnson, 2003); this is represented on an electrocardiogram as the P-
wave. Signals from the atrio-ventricular node propagate through Purkinje fibres, located 
in the septum wall between the heart’s left and right ventricles, and stimulate contraction 
of the ventricles, which is referred to as ventricular depolarization (Johnson, 2003). This 
ventricular depolarization is represented on an electrocardiogram as the QRS-complex, 
with the R-wave typically the most visually prominent signal in the waveform. Finally, 
the ventricles become repolarised in preparation for the next contraction (Johnson, 2003); 
this is represented on an electrocardiogram as the T-wave.  
While the sino-atrial node has an internal pacemaker that generates its own 
electrical activity (Cacioppo, Berntson, Binkley, Quigley, Uchino, & Fieldstone, 1994), 
sympathetic and parasympathetic mechanisms regulate this activity, which results in 
continuous adjustments to the timing of each heartbeat (Berntson, Cacioppo, & Quigley, 
1993; Berntson et al., 2007). As such, HRV reflects variance in the time between 
successive heartbeats (i.e., R-waves; Berntson, Bigger, Jr., Eckberg, Grossman, 
Kaufmann, Malik, et al., 1997; Ernst, 2014). This time between beats is commonly 
referred to as an NN-interval (representing a “normal-to-normal” cardiac cycle), but also 
called an RR-interval, inter-beat interval (IBI), or heart period (HP). NN-interval data is 
processed by specialized algorithms, which derive measures of HRV. Several NN-
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interval processing techniques are available, each of which provides a slightly unique 
perspective of autonomic cardiovascular control. Linear-based time- and frequency-
domain measures are the most commonly reported in contemporary HRV literature 
(Ernst, 2014; Kleiger, Stein, & Bigger, Jr., 2005). Other non-linear HRV measures can 
also be derived using Poincare plot, geometric (e.g., triangular), entropy-based, and 
wavelet-based analyses.  
Frequency-Domain HRV 
Frequency-domain analyses examine HRV using specialized algorithms that 
decompose the NN-interval signal into distinct sinusoidal waveforms (Ernst, 2014). More 
specifically, spectral analyses determine the frequency amplitude of each sinusoidal 
waveform as a function of a pre-set bandwidth that dictates the minimum and maximum 
frequency range to be detected (Berntson et al., 1997). Frequency-domain bandwidths are 
classified as high-frequency (HF), low-frequency (LF), very-low-frequency (VLF), or 
ultra-low-frequency (ULF) range. LF:HF ratio and total spectral power can also be 
derived (Berntson et. al., 2007; Sztajzel, 2004). In the pediatric HRV literature, HF is 
commonly expressed using indices of vagal tone or respiratory sinus arrhythmia; these 
are typically defined as reflecting the rhythmic oscillations in heart rate activity occurring 
at the frequency of respiration mediated by neural projections of the vagus nerve, or tenth 
cranial nerve, to the sino-atrial node (El-Sheikh, 2005; Porges, Doussard-Roosevelt, 
Portales, & Suess, 1994). Notedly, measures of HF, vagal tone, and respiratory sinus 
arrhythmia all reflect the same underlying construct.  
Frequency-domain analyses are thought to provide valid estimates of autonomic 
factors that regulate HRV (Karim, Hasan, & Ali, 2011; Sztajzel, 2004). Frequency-
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domain methods isolate variance (i.e., power) within a series of NN intervals into distinct 
spectral components associated with different frequency bandwidths. Power within a 
frequency-domain bandwidth reflects the extent to which faster (e.g., HF) or slower (e.g., 
VLF) physiological mechanisms contribute to variance in heart rate. Mechanisms 
underlying each frequency-domain HRV measure have been examined using 
pharmacological blockade studies with chemical agents to partially or totally inhibit 
activity of one or both autonomic branches. Changes within an HRV measure following 
blockade provides insight into the extent to which each autonomic branch contributes to 
that index (Cacioppo et al. 1994). Notedly, when both autonomic branches are 
completely blocked, there is no variability between heartbeats; thus, HRV is abolished, 
resulting in a metronome-like heartbeat with equal NN intervals (Akselrod, Gordon, 
Ubel, Shannon, Barger, & Cohen, 1981).  
Physiological mechanisms underlying high-frequency (HF) spectral components 
are generally well-established. Parasympathetic blockade, using muscarinic receptor 
antagonists (e.g., atropine), consistently reduces or abolishes power (i.e., variance) in the 
HF spectrum by dampening vagal and respiratory influences (Berntson et al., 1993; 
Yasuma & Hayano, 2004) on heart rate. Conversely, sympathetic blockade shows little or 
no effects on HF (Akselrod et al, 1981; Akselrod, Gordon, Madwed, Snidman, Shannon, 
& Cohen, 1985; Cacioppo et al., 1994; Chen & Mukkamala, 2008; Martinmaki, Rusko, 
Kooistra, Kettunen, & Saalasti, 2005). Together these blockade studies demonstrate that 
HF is chiefly mediated by parasympathetic and respiratory mechanisms.  
Physiological mechanisms underlying low-frequency (LF) spectral components 
are less well-established and are assumed to include activity of both autonomic branches 
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as well as baroreceptor reflex mechanisms that regulate blood pressure homeostasis 
(Berntson et al., 2007; Kleiger et al., 2005). Sympathetic blockade using adrenergic 
receptor antagonists (e.g., propranolol, metoprolol) reduces LF power (Akselrod, 1981; 
Chen & Mukkamala, 2008), particularly when changing postures (e.g., sitting to standing; 
head-tilt) where sympathetic activity normally increases to maintain blood circulation in 
the upper limbs and brain (Cacioppo et al., 1994; Kleiger et al., 2005). However, results 
are not uniform across studies. Akselrod and colleagues (1985) found that LF increased 
by ~50% following sympathetic blockade, and decreased by ~90% following 
parasympathetic blockade; decreases in LF following parasympathetic blockade have 
also been reported elsewhere (Akselrod, 1981; Cacioppo et al., 1994; Chen & 
Mukkamala, 2008). These blockade studies provide mixed results about the relative 
contributions of each autonomic nervous system branch on LF. Current thinking 
speculates that LF is mediated by a combination of sympathetic, parasympathetic, and 
baroreceptor reflex activity.   
Physiological mechanisms underlying LF:HF ratio are also not well understood. 
Pharmacological studies demonstrate that blockade of one or both autonomic branches 
decrease (Cacioppo et al., 1994; Chen & Mukkamala, 2008) or increase LF:HF ratio 
(Reyes Del Paso et al., 2013). LF:HF ratio is often reported as an index of autonomic 
balance; however, this interpretation is actively debated because first, LF has both 
sympathetic and parasympathetic influences, and second, autonomic nervous system 
activity is not exclusively reciprocal (Reyes Del Paso et al., 2013). As LF and HF each 
reflect tonic influences of the autonomic nervous system on cardiovascular activity, the 
LF:HF ratio is more likely an index of autonomic modulation rather than of autonomic 
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balance. Nevertheless, despite uncertainties in its interpretation, a reduced LF:HF ratio is 
frequently reported as being associated with poorer health outcomes (Ernst, 2014; 
Heathers, 2014).  
Physiological mechanisms underlying very-low (VLF) and ultra-low-frequency 
(ULF) spectral components are poorly understood. Blockade studies suggest VLF is 
mediated by sympathetic and parasympathetic mechanisms, the angiotensin system 
(which regulates blood pressure and water balance), and mechanisms underlying 
regulation of temperature and inflammatory markers (e.g., C-reactive protein, white 
blood cell count; Akselrod et al., 1985; Ernst, 2014; Taylor, Carr, Myers, & Eckberg, 
1998). Similar mechanisms may underlie both VLF and ULF (Berntson et al., 2007); 
however, underlying mechanisms potentially unique to ULF also include physical 
activity (Serrador, Finlayson, & Hughson, 1999) and circadian rhythmicity, as indicated 
by long-term ECG studies (e.g., 24 hr; Bigger, Jr., Fleiss, Rolnitzky, & Steinman , 1993; 
Ernst, 2014; Karim et al., 2011). While underlying mechanisms of VLF and ULF are not 
fully elucidated, both measures of HRV have clinical utility as predictors of 
cardiovascular mortality (Bigger, Fleiss, Steinman, Rolnitzky, Kleiger, & Rottman, 1992; 
Kleiger et al., 2005; Sztajzel, 2004).   
Time-Domain HRV 
Time-domain measures of HRV are also commonly reported. Time-domain 
measures are mathematically derived from NN-intervals. The standard deviation of NN 
intervals (SDNN) is derived from the entire NN-interval series and reflects overall heart 
rate variability (Malik, 1997; Sztajzel, 2004). Physiological mechanisms underlying 
SDNN include both sympathetic and parasympathetic inputs. Further, 30–40% of the 
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variance in SDNN is thought to be attributable to circadian components of HRV (Kleiger 
et al., 2005). The root mean square of successive NN-interval differences (rMSSD) and 
the proportion of successive NN-intervals that differ by more than 50 msec (pNN50) are 
two time-domain methods derived using the differences between adjacent NN intervals. 
Physiological mechanisms underlying rMSSD and pNN50 chiefly reflect 
parasympathetic components of HRV (Kleiger et al., 2005; Malik, 1997; Sztajzel, 2004). 
While other time-domain measures can be derived (e.g., SDNNi, SDANN) to reflect 
short- and longer-term (e.g., circadian) components of HRV, they are rarely reported in 
the pediatric literature.  
Time- and frequency-domain HRV measures are complementary in that they 
capture the same underlying autonomic nervous system phenomenon in different ways, 
and are thus, highly correlated. SDNN is correlated with total spectral power, while 
rMSSD and pNN50 are correlated with HF (Ernst, 2014; Kleiger et al., 2005; Sztajzel, 
2004). The decision to use either time-domain or frequency-domain HRV is often 
influenced by personal preference, study aims, and the type and quality of NN interval 
data available (e.g., short- vs. long-term). Examination of HRV yields an indication of 
important mechanisms associated with autonomic cardiovascular control, and thus, 
autonomic nervous system functioning; as such, time- and frequency-domain HRV 
measures provide a useful means of quantifying autonomic dysfunction.    
Autonomic Dysfunction, Health, and HRV 
Autonomic dysfunction (i.e., sympathetic hyperactivity and/or parasympathetic 
hypoactivity) is associated with poor health. Autonomic dysfunction occurs when one 
autonomic nervous system branch persistently dominates over the other (Janig, 2006), 
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causing a prolonged state of physiological arousal that places excessive demands on the 
body. This demand results in “wear and tear” of the body, referred to as allostatic load 
(e.g., Thayer & Sternberg, 2006), which can result in many acute and chronic illnesses. 
As such, autonomic dysfunction, indicated by reduced HRV, is commonly studied as an 
index of health in both adults and children. In studies with adults, autonomic dysfunction 
is evident following a myocardial infarction and in those with cardiac arrhythmias, 
hyper/hypotension, Type 1 and Type 2 diabetes, and obesity (Boer-Martins, Figueiredo, 
Demacq, Martins, Consolin-Colombo, et al., 2011; Kleiger et al., 2005; Schmid, 
Schonlebe, Drexler, & Mueck-Weymann, 2010; Singh, Larson, Tsuji, Evans, O’Donnell, 
& Levy, 1998; Sztajzel, 2004; Thayer & Sternberg, 2006). Among these studies, 
autonomic dysfunction is typically indicated by reduced time-domain measures and HF 
spectral power, as well as increased LF, LF:HF ratio, and heart rate. Autonomic 
dysfunction is also evident among adults diagnosed with depression, bipolar disorder, 
schizophrenia, and sleep problems (e.g., insomnia, sleep apnea), relative to controls 
(Bonnet & Arand, 1998; Bylsma, Salomon, Taylor-Clift, Morris, & Rottenberg, 2014; 
Henry, Minassian, & Paulus, 2010; Roche et al., 2003). In studies with children, 
autonomic dysfunction is evident among children with hypertension, obesity, and Type 1 
and Type 2 diabetes (Akinci, Celiker, Bayka, & Tezic, 1993; Faulkner, Hathaway, & 
Tolley, 2005; Gui-Ling et al., 2013; Latchman, Mathur, Bartels, Axtell, & De Meersman, 
2011; Martini et al., 2001; Oliveira et al., 2010; Rodriguez-Colon, Bixler, Li, Vgontzas, 
& Liao, 2011). Among these pediatric studies, and similar to adult studies, autonomic 
dysfunction is typically indicated by reduced time-domain measures and HF spectral 
power, as well as increased LF, LF:HF ratio, and heart rate. Autonomic dysfunction is 
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also evident among children diagnosed with depression, anxiety, sleep problems (e.g., 
sleep apnea), and internalizing and externalizing behaviour disorders (Baharav, Kotagal, 
Rubin, Pratt, & Akselrod, 1999; El-Sheikh & Hinnant, 2011; El-Sheikh & Whitson, 
2006; Sampei, Murata, Dakeishi, & Wood, 2006). 
HRV has been demonstrated as a useful physiological marker of autonomic 
dysfunction associated with poor or declining health (e.g., risk stratification for mortality 
in adults following myocardial infarction; Ernst, 2014). However, it currently remains to 
be established whether autonomic dysfunction is merely reflective of, or is mechanistic 
to, chronic illnesses such as obesity, diabetes, and cardiovascular disease. Considering 
the implications of HRV to the study of health, it is pertinent that HRV be accurately 
measured, analyzed, and interpreted to minimize the probability of erroneous conclusions 
about health status or treatment effectiveness (i.e., clinical utility) from being made.  
HRV Measurement, Analysis, and Reporting 
The Task Force of the European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology (Task Force, 1996) previously established 
guidelines for the measurement, analysis, and interpretation of HRV for adults, which 
were extended in a subsequent committee report (Berntson et al., 1997). While these 
available guidelines are frequently cited in the HRV literature, wide variability in study 
methodology remains. Further, theoretical and methodological advances in HRV 
measurement within the last two decades are not reflected in these guidelines. Moreover, 
there remains a paucity of research establishing HRV measurement guidelines for infants, 
children, and adolescents. Some researchers have attempted to refine existing adult 
guidelines to reflect more recent findings (e.g., Cerutti, Goldberger, & Yamamoto, 2006; 
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Denver, Reed, & Porges, 2007), and others have aimed to extend these guidelines to 
pediatric samples (Bar-Haim, Marshall, & Fox, 2000).  
Published measurement guidelines detail several methodological conditions 
which are key to obtaining HRV data that is of suitable psychometric quality for 
psychophysiological research. One way to conceptually organize these methodological 
conditions (reviewed below) is by using four overarching categories: study protocol (e.g., 
methodological protocol), sample characteristics (e.g., exclusion criteria, participant sex), 
ECG signal acquisition and pre-processing (e.g., time of ECG recording, data editing and 
filtering), and HRV analyses (e.g., ECG recording duration, frequency bandwidth 
selection).    
Study Protocol 
The methodological protocol in which ECG data is obtained must be controlled to 
minimize internal and external sources of measurement error. There are at least two ways 
in which the methodological protocol can be controlled to ensure HRV is measured under 
similar experimental conditions across each study visit. First, instructing participants to 
refrain from behaviours (e.g., strenuous exercise, alcohol use, eating) that affect 
autonomic and/or cardiovascular function, allowing all participants to acclimatize or 
habituate to the experimental situation prior to data collection, and ensuring that each 
participant maintains a consistent recording posture (to account for established 
moderating effects of posture on autonomic functioning; e.g., Cacioppo et al., 1994; 
Kleiger et al., 2005) will each help promote standardized ECG recording conditions. 
Second, HRV is often higher during rest compared to challenge (e.g., tasks, stressors) and 
recovery conditions (McNarry & Lewis, 2012; Winsley, Armstrong, Bywater, & Fawkner, 
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2003), warranting consideration of the ECG recording protocol. Ensuring a standardized 
ECG recording protocol (e.g., rest, task, recovery conditions) for all participants and 
across each study assessment can improve reliability in both cross-sectional and 
longitudinal designs. Taken together, increased methodological control will likely 
augment data reproducibility by improving the replicability of study conditions, and 
further help to promote HRV psychometrics.  
Sample Characteristics  
The homogeneity of a study sample is a key factor in obtaining reliable HRV data. 
Selection of specific a priori inclusion and exclusion criteria permit the researcher to 
optimize the homogeneity of the sample, while controlling for variables known to 
influence HRV. For example, medications, and acute (e.g., infection) or chronic (e.g., 
diabetes) illnesses known to alter cardiovascular functioning can affect resulting HRV 
measures and should be considered when recruiting participants. Among adults, studies 
often report stringent exclusion criteria (e.g., medication use; food, caffeine, alcohol; 
cardiovascular abnormalities; acute/chronic illness; smoking; Cipryan & Litschmannova, 
2013; La Fountaine, Wecht, Spungen, & Bauman, 2010; Pinna et al., 2007). Among 
infants and youth, sample selection criteria are less rigorous or often unspecified (e.g., 
Kennedy, Rubin, Hastings, & Maisel, 2004; Liew et al., 2011; Nepal & Paudel, 2012; 
Rigterink, Fainsilber Katz, & Hessler, 2010). A minority of pediatric studies have 
excluded participants taking prescription medications, or who have cardiovascular 
conditions (e.g., arrhythmia, hypertension) or chronic illnesses (e.g., metabolic syndrome, 
obesity; Bar-Haim et al., 2000; Galland, Taylor, Bolton, & Sayers, 2006; Nepal & Paudel, 
2012). Further considerations for ensuring a homogenous sample include recruiting 
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participants with a narrow versus wide age range (e.g., 8–10 yrs vs. 5–18 yrs), and 
recruiting a balanced ratio of male to female participants to account for possible sex 
differences in autonomic cardiovascular control. Thus, greater sample homogeneity may 
help to promote the psychometric quality of HRV.  
ECG Signal Acquisition and Pre-Processing 
Circadian factors in autonomic activity warrant consideration for the time of day 
when ECG is recorded. Circadian variations in HRV have been established in adults (e.g., 
Armstrong, Kenny, Green, & Seely, 2011) and in children (e.g., Massin, Maeyns, 
Withofs, Ravet, & Gerard, 2000). Sympathetic dominance is normally observed just after 
awakening, and becomes withdrawn throughout the day, allowing for a progressive 
increase in resting parasympathetic dominance that is higher at night and peaks just 
before awakening (Guo & Stein, 2003; Huikruri, Kessler, Terracall, Castellanos, 
Linnaluoto, & Myerburg, 1990). Considering this, HRV measures obtained at different 
times of the day, either within or across study assessments, would be more difficult to 
compare because resulting data may reflect considerably different patterns of autonomic 
cardiovascular control. Ensuring that the ECG recording time is standardized across each 
study assessment will minimize confounding effects of circadian variations in HRV and 
improve data reproducibility in both cross-sectional and longitudinal studies. HRV 
measurement guidelines do not specify an ideal time for ECG recording, making this a 
predominantly researcher-based decision.  
Reliable and clean HRV data requires reliable and clean ECG signals. Optimal 
electrode positioning and adherence is required (Jennings, Berg, Hutcheson, Obrist, 
Porges, & Turpin, 1981; Mulder, 1992), which involves proper skin preparation (i.e., 
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abrasive cleaning to remove dirt and dead skin cells) at a site that will be minimally 
influenced by movement but will also be comfortable for the participant (Shaffer & 
Combatalade, 2013). Electrode placement reporting should include sufficient anatomical 
details to facilitate study replication (Jennings et al., 1981). ECG recording hardware 
should be routinely calibrated and assessed for precision (Berntson et al., 1997). ECG 
sampling rate is another factor that promotes reliable cardiovascular measurement. 
Sampling rate (measured in Hertz, Hz) refers to the number of physiological “snapshots” 
or samples recorded per second and defines the minimal R-wave oscillation amplitude 
that can be detected (Berntson et al., 1997; Hejjel & Roth, 2004; Riniolo & Porges, 
1997). Measurement guidelines recommend 500–1000 Hz or greater as an optimal 
sampling rate for HRV measurement, although 250 Hz can also be used when additional 
processing techniques are applied (Berntson et al., 1997; Riniolo & Porges, 1997; Task 
Force, 1996). Sampling rates that are too slow (e.g., < 100 Hz) or too fast (e.g., > 2500 
Hz) are thought to limit the precision of R-wave identification and can contribute 
unwanted variance, overestimate HRV, or limit reproducibility (Ernst, 2014; Hejjel & 
Roth, 2004; Riniolo & Porges, 1997).  
Following data collection, application of proper editing and pre-processing 
techniques is essential for data integrity. Artifacts and recording errors are often 
unavoidable in cardiovascular research and can result from poor electrode adhesion, 
movement during ECG recording, or aberrant heart beats (e.g., premature ventricular 
contractions; Shaffer & Combatalade, 2013). Correction of artifacts and recording errors 
is a necessary prerequisite to HRV measurement, as even a single artifact can disturb the 
continuity of a recording, violate statistical assumptions of HRV analysis, or falsely 
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increase the variance in an ECG signal (Berntson & Quigley, 1990; Berntson & Stowell, 
1998; Kim, Lim, Kim, & Park, 2007; Kim, Kim, Lim, & Park, 2009; Salo, Huikuri, & 
Seppanen, 2001). A systematic and reproducible artifact editing procedure should be 
performed using visual inspection of ECG data by trained technicians. Software-based 
editing methods are also recommended and include pattern detection algorithms as well 
as linear, non-linear, and cubic spline interpolations (Berntson et al., 1990; Berntson et 
al., 1997; Jarrin, McGrath, Giovanniello, Poirier, & Lambert, 2012; Kim et al., 2007, 
2009; Salo, Huikuri, & Seppanen, 2001; Porges & Byrne, 1992). Measurement guidelines 
recommend using both manual and software-based editing procedures and reporting the 
proportion of data excluded due to artifacts (Berntson et al., 1997; Jennings et al., 1981; 
Task Force, 1996). Despite these recommendations, few authors report the proportion of 
data excluded due to artifacts, which precludes knowledge of the integrity and quality, 
and thus, interpretability of the HRV data. Following artifact correction, the ECG signal 
must be filtered using digital smoothing procedures. Additional “noise” and overlapping 
frequency components (i.e., spectral leakage) can magnify the apparent HRV power 
spectrum and lead to erroneous conclusions regarding autonomic cardiovascular control 
(Singh, Vinod, & Saxena, 2004). These smoothing algorithms (e.g., triangular or Hanning 
windows) crop ECG recording segments and remove unwanted sources of variance 
(Berntson & Quigley , 1990; Jarrin et al., 2012; Kim et al., 2007, 2009; Salo et al., 2001). 
One software filter commonly used in pediatric HRV studies is Porges’ (1985) moving 
polynomial window. The moving polynomial algorithm filters out additional variance in 
cardiovascular patterns from an ECG recording and produces a residual time-series that is 
corrected for the confounding effects of baseline heart rate; application of this filter 
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potentially eliminates the need to include heart rate as a covariate in HRV analysis 
(Porges, 1985).  
HRV Analyses  
Data reduction and analyses decisions can also influence HRV reliability. 
Measures of HRV are commonly derived using algorithms in commercially available 
software programs. These programs often permit user-adjusted default settings. Four 
pertinent user-defined decisions are outlined below; such adjustments must be chosen 
carefully, as each modification can impact the resulting measures (Berntson et al., 1997).  
One important user-defined analysis decision is choosing the ECG recording 
duration to be analyzed for HRV. ECG recordings must be long enough to sample short-
and long-term heart rate variations. Published guidelines recommend that ECG be 
recorded for a minimum of 1 min to assess HF, 2 min for LF, and ~50 min for VLF 
(Berntson et al., 1997; Sztajzel, 2004). A 5-min recording duration is a generally accepted 
standard in short-term studies, while 24-hr recordings are often standard in long-term 
studies (Kim et al., 2007, 2009; Task Force, 1996). ECG recording duration determines 
the extent of variability that can be captured within the signal, and thus influences 
resulting measures of HRV. For instance, a researcher that obtains a 2-min ECG recording 
may only have enough data available to derive reliable estimates of HF activity. Further, 
because very-low-frequency oscillations occur in intervals greater than 5 min, short-term 
HRV recordings are likely unsuitable to adequately capture very-low-frequency sources 
of variability (Berntson et al., 1997; Heathers, 2014; Kleiger et al., 2005). VLF, which in 
part reflects longer circadian patterns, is less reliable if the ECG recording duration is too 
short to adequately capture variability in this frequency range (Heathers, 2014; Kleiger et 
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al., 2005); a signal occurring at 0.04 cycles per second (Hz) may occur less than 3 times 
per min (Heathers, 2014). Thus, an ECG recording duration that is appropriate for the 
variable of interest must be considered a priori to improve both the precision and the 
reproducibility of HRV.  
A second important user-defined analysis decision is the selection of ECG data to 
be analysed for HRV. Following data collection, selection of the ECG recording duration 
to be analyzed (i.e., data reduction) is pertinent for reliable measures of HRV. An “epoch” 
is a segment of the ECG recording submitted for analyses. HRV can be derived using the 
mean of a single analytical epoch, or by analyzing multiple (i.e., ≥ 2) short analytical 
epochs. For example, a 5-min recording of ECG can be used to derive HRV measures 
from the mean value of the entire 5-min epoch, the mean value of five 1-min epochs, or 
the mean value of six 30-sec epochs. Certain HRV measures may be less impacted by the 
use of short epochs than others (e.g., HF vs. LF) that require more ECG data to properly 
capture sources of variability, which oscillate at periods longer than the analyzed 
recording duration (Berntson et al., 2007; McNames & Aboy, 2006; Porges & Byrne, 
1992). Some researchers suggest deriving HRV from the mean of several short epochs 
can reduce the impact of missed or uncorrected artifacts or slower heart rate trends (often 
more present in longer recordings) that were not accounted for in the data cleaning phase 
(Izard et al., 1991; Karim et al., 2011; Malik, 1997; Salo et al., 2001). However, exclusive 
use of shorter, artifact-free recording epochs may introduce a selection bias that would 
limit the reliability and generalizability of results (Berntson et al., 1997, 2007; Porges & 
Byrne, 1992). Similar to artifact editing, the decision to derive HRV using a full or 
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segmented recording epoch should be explicitly reported to enhance the interpretability 
of results.  
A third important user-defined analysis decision is the selection of spectral 
frequency bands, which dictate the measurement boundaries between spectral variables. 
Among adults, standard frequency bands are defined as: HF 0.15–0.40 Hz; LF 0.04–0.15 
Hz; VLF 0.003–0.04 Hz; ULF <0.003 Hz (Berntson et al., 1997; Ernst, 2014; Task Force, 
1996). Importantly, available guidelines for frequency bands among infants and young 
children are limited to HF (0.2–1.20 Hz or 0.3–1.30 Hz for infants; 0.24–1.04 Hz for 
young children; Bar-Haim et al., 2000; Fox & Porges, 1985); no guidelines exist for LF 
or VLF, with adult frequency bands typically applied. If adult HF frequency bands are 
erroneously applied to pediatric samples, which is not uncommon, resulting HRV data 
will be an inaccurate estimate of parasympathetic modulation of autonomic 
cardiovascular control; this would distort interpretations of HF among subsequent 
analyses. Thus, selection and explicit reporting of frequency bandwidths is also pertinent 
to the interpretability of results. 
A fourth important user-defined analysis decision is the selection of measurement 
units used to present HRV data. Time-domain HRV is commonly expressed in 
milliseconds (e.g., SDNN, RSA) or as a percentage (e.g., pNN50). Frequency-domain 
HRV can be expressed in absolute (ms
2
/Hz) units, which reduce dependency on ECG 
recording length; normalized units (n.u.), which minimize within- and between-subjects 
variability across the total HRV spectrum and reduce difficulties with comparing HRV 
between studies or analytical methods by quantifying a measure of proportional change; 
or, natural log (ln) transformation units, which reduce the effects of skewed distributional 
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characteristics (Berntson et al., 1997; Healthers, 2014; Sztajzel, 2004). Interpretations can 
differ based on their respective metrics. For example, HRV in normalized units is 
expressed in a ratio metric and is derived using data from HRV that has already been 
expressed in absolute units (Burr, 2007). Thus, HRV in normalized units supplement, 
rather than substitute, HRV in absolute units. Guidelines suggest that spectral HRV can be 
more precisely interpreted if both absolute and normalized units are presented together 
(Task Force, 1996); however, journal space limitations mean few authors in the pediatric 
HRV literature comply with this guideline, which further contributes to methodological 
variability across HRV studies and makes results difficult to compare.  
As outlined above, obtaining accurate measures of HRV requires careful 
consideration of multiple methodological factors by the researcher, ranging from 
participant selection to the metric in which HRV is reported. Guidelines for HRV 
measurement and analysis were established to promote methodological standardization. 
Despite these guidelines being widely cited in the cardiovascular literature, there is 
considerable variability across studies. It remains unknown to what extent these 
methodological differences may impact HRV’s psychometric properties. Few studies to 
date have thoroughly examined the psychometric properties of HRV, especially in 
children and adolescents. Given that HRV is commonly utilized as a predictor of future 
health outcomes, it is important to elucidate factors that can influence the psychometrics 
of longitudinal HRV measures. Test-retest reliability and temporal stability of HRV are 
psychometric properties that both relate to the reproducibility of HRV data. There are 
multiple methodological conditions and user-defined measurement decisions that are 
likely pertinent to obtaining reliable HRV measures. Further, there are multiple biological 
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and intra-individual characteristics that may also affect the stability of HRV. An 
examination of these constructs is pertinent to understanding the extent to which HRV 
measures change across time.  
HRV Reliability 
To meaningfully measure HRV, it must be psychometrically reliable and reflect a 
stable individual difference. Reliability refers to the level of agreement or concordance 
between results obtained on at least two occasions and/or between two or more 
measurement contexts (Field, 2009; Weir, 2005; Thompson & Vacha-Haase, 2000; See 
Appendix A). Classical test theory explains that measured data is comprised of a “true 
score” and “measurement error”; increased true score variance increases a measure’s 
reliability, whereas increased measurement error decreases reliability (Thompson & 
Vacha-Haase, 2000). Stability refers to the consistency of a score obtained over time for a 
given individual (Bornstein & Suess, 2000). Stability is conceptually distinct from 
reliability as it indicates the extent to which a phenomenon is a stable individual 
difference.  
Study protocol. The reliability of a measure typically decreases as the time 
between assessments (i.e., study follow-up length) increases (Cohen & Swerdlik, 2002). 
This observation is consistent with examinations of HRV reliability in both adults and 
children. Among young adults (Mage = 22 yrs), test-retest reliability of HF and LF 
measured within a single day was higher than reliability measured after a 9-day period 
(ICCLF = 0.72 vs. 0.48, ICCHF = 0.93 vs. 0.78; Cipryan & Litschmannova, 2013) and 
higher within a single day than reliability measured across a 24-month period (ICCLF = 
0.85 vs. 0.79, ICCHF = 0.89 vs. 0.79; Kowalewski & Urban, 2004). Among infants and 
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youth, a similar pattern has been observed, but less consistently. For example, Fracasso 
and colleagues (1994) observed generally decreasing test-retest reliability of HF over 
time in infants across 2-month (r = 0.50), 3-month (r = 0.55), 5-month (r = 0.60), 6-
month (r = 0.15) and 7-month periods (r = 0.10). Perry and colleagues (2012) observed 
higher test-retest reliability of HF in toddlers across 1 year (4–5 yrs; r = 0.52) compared 
to 2 years (3–5 yrs; r = 0.34). Finally, El-Sheikh and Hinnant (2011) observed 
progressively declining test-retest reliability of HF in children across 1-year (r = 0.63), 2-
year (r = 0.54), and 3-year follow-ups (r = 0.32). All of these pediatric studies used 
similar HRV acquisition protocols across their study visits. It is plausible that 
methodological details not described (e.g., sample heterogeneity, differences in the time 
of ECG recording) may have also contributed to these declines in reliability over time. 
These findings suggest HRV reliability decreases with longer test-retest intervals. 
Sample characteristics. Reliability of HRV is also sensitive to sample 
heterogeneity. Sample heterogeneity can result from researchers not excluding 
participants who consume prescription medication or who are suffering from an illness 
that may impact cardiovascular functioning. Consumption of several prescription 
medications or the presence of an acute or chronic illness can each alter sympathovagal 
balance (e.g., sympathetic-mediated inflammatory responses; Lin et al., 2006). Recruiting 
a mixed sample of participants, wherein only some take prescription medication or have a 
medical illness, may augment individual differences in autonomic activity and reduce 
HRV test-retest reliability. Medications prescribed to adults, including beta-blocker, 
anticholinergic, and antiarrhythmic drugs, have been associated with mean-level 
decreases to LF, HF, LF:HF ratio, and SDNN (Penttila, Kuusela, & Scheinin, 2005; 
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Shaffer & Combatalade, 2013; Task Force, 1996). Buchhorn and colleagues (2012) 
demonstrated that methylphenidate, a stimulant medication commonly prescribed for 
children with ADHD, was associated with mean-level decreases in 24-hr HR and higher 
rMSSD and pNN50. Few studies have directly examined the effects of other medications 
on HRV or HRV reliability in children. Exposure to certain medications has been 
associated with changes in sympathovagal balance; thus, it is plausible that studies that 
measure HRV from a sample wherein only some participants consume prescription 
medications would yield less reliable measures of HRV. Several acute and chronic 
illnesses (e.g., infections, hypertension, diabetes) have also been associated with changes 
in sympathovagal balance (i.e., sympathetic hyperactivity/parasympathetic hypoactivity) 
and reduced HRV among adults (e.g., Boer-Martins et al., 2011; Ernst, 2014; Henry et 
al., 2010; Schmid et al., 2010) and children (e.g., El-Sheikh & Whitson, 2006; Latchman 
et al., 2011; Oliveira et al., 2010; Rodriguez-Colon et al., 2011; Shroff et al., 2013). 
Indeed, HRV reliability is typically lower among clinical, relative to non-clinical, 
samples of adults and children (Kochiadakis, Orfanakis, Rombola, Chrysostomakis, 
Chlouverakis, & Vardas, 1997; Sandercock, Bromley, & Brodie, 2005). Taken together, 
specifying study exclusion criteria, accounting for medication use, and ensuring that 
participants are free of acute and chronic illnesses or cardiovascular risk factors will 
improve sample homogeneity, reduce individual differences in sympathovagal balance, 
and in turn, promote greater reliability.   
Sex differences in HRV have been observed in adults and children, although 
results are often inconsistent. Among adults, males typically display greater sympathetic 
dominance (e.g., higher LF, LF:HF ratio), whereas females typically display greater 
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parasympathetic dominance (e.g., higher HF, rMSSD; Antelmi et al., 2004). Ramaekers 
and colleagues (1998) demonstrated that adult males have significantly higher mean-level 
SDNN, SDANN, LF, HF, and LF:HF ratio, even after controlling for basal heart rate. 
Adult females have also demonstrated greater stress-related decreases in HF and rMSSD, 
relative to males (Li et al., 2009). In a sample of young adults (N = 44; Mage = 20.43 yrs), 
Sookan and McKune (2012) indicated good to excellent reliability (ICCrange 0.77–0.92) 
for all time- and frequency-domain variables among females, but only weak to good 
reliability (ICCrange = 0.36–0.90) among males. It is plausible that sex differences in HRV 
reliability also exist among children; evidence for mean-level sex differences in HRV 
measures among children is scarce. Boys typically display increased mean-level NN and 
SDNN relative to girls (Faulkner et al., 2003; Silvetti, Drago, & Ragonese, 2001), and 
male sex has also been associated with increased HF among 9- and 11-year-old children, 
before and after controlling for differences in weight (El-Sheikh, 2005). However, sex 
differences between other HRV measures remain to be examined. Sex-specific shifts in 
sympathovagal balance across childhood may relate to developmental changes in sex 
hormone concentrations (e.g., testosterone, estrogen), which have been shown to exert 
unique effects on blood pressure and heart rate between boys and girls (Spear, 2000).  
ECG signal acquisition and pre-processing. A 24-hr circadian rhythm of HRV 
has been observed in infants as early as 7 to12 weeks old (Hoppenbrouwers, Oliveira, 
Sandarupa, Khoo, Neuman, & Ramanathan, 2012). Studies with adults (e.g., Burges, 
Trinder, Kim, Luke, & Helen, 1997) and children (e.g., Massin et al., 2000) provide 
compelling evidence for diurnal variations in HRV; however, few studies have 
specifically examined HRV reliability in relation to the time of day data were collected. 
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Hurikuri and colleagues (1990) observed reproducible circadian variations in SDNN 
using data from repeated 24-hr recordings analyzed in consecutive 1-hr epochs. While 
similar studies are not available in the pediatric literature, mean-level changes in HRV 
across day, night, and 24-hr recordings suggest circadian factors impact HRV reliability. 
Rabbia and colleagues (2003) demonstrated that measures of HF and VLF in 12 non-
clinical adolescents were higher at night compared to the day, while the opposite result 
was observed for heart rate and LF:HF ratio and no differences were observed for LF. 
The notion that circadian factors can influence HRV psychometrics is supported by 
observations that suggest HRV measures differ depending on the time of data collection. 
Considering this, consistency in the timing of HRV recordings across test-retest 
observations may be pertinent to HRV reliability.  
Allowing participants to acclimatize (or habituate) to their surroundings prior to 
ECG recording is recommended by HRV measurement guidelines (Berntson et al., 1997; 
Task Force, 1996); however, few studies report including a designated pre-recording 
acclimatization period. Resting measures of HRV provide insight into baseline autonomic 
cardiovascular control, and are also a staple from which to compare change. However, 
even if participants are instructed to rest quietly during baseline recordings, they may not 
actually be fully at rest (i.e., anxious, humming quietly, ruminating). Unfamiliarity and/or 
discomfort with psychophysiological research protocols may be stressful and alter 
sympathovagal balance and respiration, which would hinder the collection of a stable 
baseline recording; this may be especially true among infants and young children. 
Ensuring an adequate resting baseline or “vanilla” baseline recording (wherein 
participants complete a standardized, minimally-demanding comparison task; Jennings et 
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al., 1992) may not be enough to neutralize inter-individual differences in reactivity to the 
testing situation (e.g., Ottaviani, Shapiro, Davydov, & Goldstein, 2008; Ottaviani & 
Shapiro, 2011; Salomon, Matthews, & Allen, 2000; Sharpley, 1993). A pre-recording 
acclimatization period helps participants to familiarize with their surroundings and to 
habituate to the physiological sensors prior to data collection; as familiarity with study 
conditions increases, sympathetic influences on heart rate will progressively decline and 
reduce cardiovascular reactivity to the unfamiliar (e.g., study environment, awareness of 
ECG sensors). Using adult ECG data, Sharpley (1993) noted that fifteen minutes may be 
a sufficient duration for reducing heart rate activity to resting levels; however, he argued 
that a standardized acclimatization duration may be less useful than a duration unique to 
each participant’s distinctive cardiovascular profile. Data collection that follows a 
sufficient acclimatization period may yield more accurate and reproducible estimates of 
HRV because of decreased inter-individual variability in heart rate activity within and 
across study assessments. Thus, it is plausible that including a pre-recording 
acclimatization period is relevant to producing reliable measures of HRV.  
HRV is influenced by postural position (e.g., supine, seated, standing). 
Parasympathetic dominance is often observed in seated or supine positions, while 
sympathetic dominance is often observed in standing or head-up-tilt positions (Cacioppo 
et al, 1994; Kleiger et al., 2005). Among adults (Mage = 22 yrs) measured across 24 
months, HF reliability, but not LF reliability, was notably higher in supine versus 
standing postures (ICCHF = 0.89 vs. 0.79; ICCLF = 0.81 vs. 0.79; Kowalewski & Urban, 
2004). Among children (Mage = 9.5 yrs), mean-level increases in NN, SDNN, rMSSD, 
and pNN50 have been observed in supine relative to standing postures (Nepal & Paudel, 
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2012), suggesting that posture may affect HRV reliability in pediatric samples. Indeed, 
among children (Mage = 11 yrs) measured across 2 weeks, HR and SDNN reliability was 
higher in supine versus standing postures (ICCHR = 0.78 vs. 0.65; ICCSDNN = 0.79 vs. 
0.69), whereas HF and LF reliability were minimally affected by posture (ICCHF = 0.77 
vs. 0.73; ICCLF = 0.66 vs. 0.63; Dietrich et al., 2010). Conversely, among adolescent 
males measured across 1 year, HF reliability, but not LF reliability, was higher in supine 
versus standing postures (rHF = 0.37 vs. 0.25; rLF = 0.37 vs. 0.31; Mezzacappa et al., 
1997). Sympathetic modulation may exhibit greater consistency across recording 
postures, whereas parasympathetic modulation may be more sensitive to postural 
changes. Considering the above results for HF and LF between children (Dietrich et al., 
2010) and adolescents (Mezzacappa et al., 1997), developmental differences in 
sympathovagal balance may be relevant to the study of recording posture and HRV 
reliability. Taken together, HRV reliability (except for LF) appears to be influenced by 
posture.  
ECG sampling rate defines the minimal R-wave oscillation amplitude that can be 
detected within a heart rate recording (Berntson et al., 1997; Hejjel & Roth, 2004). 
Sampling rates that are too slow (e.g., < 100 Hz) or too fast (e.g., > 2500 Hz) may have 
increasingly negative effects on the precision of HRV estimation (e.g., increased error 
variance, limited R-wave detection accuracy; Berntson et al., 1997). With decreasing 
sampling rates, a dose-response inflation in VLF, LF, HF, LF:HF ratio, SDNN, and 
rMSSD has been demonstrated using adult (Ernst, 2014) and preterm infant data (Riniolo 
& Porges, 1997). Selection of an appropriate ECG sampling rate for HRV may be age- 
and sample-dependent (Merri, Farden, Mottley, & Titlebaum, 1990; Singh, Vinod, & 
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Saxena, 2004); it is possible that a threshold in ECG sampling rate exists among 
differently-aged samples, such that obtaining reliable and accurate HRV measures may 
require sampling rates to be adjusted based on the characteristics specific to a study 
population, and based on changes among these characteristics over time. Considering 
this, it is plausible that ensuring an adequate sampling rate for detection of cardiovascular 
activity contributes to HRV reliability.   
Artifact editing should be performed carefully, and by using both manual visual 
inspection and software-based filtering algorithms. Guidelines for HRV measurement 
convey the importance of editing artifacts and recording errors prior to analysis (e.g., 
poor electrode adherence, participant movement, background physiological activity; 
Berntson et al., 1997; Task Force, 1996). Disturbances in the continuity and variance of 
an ECG recording caused by artifacts are known, and their effects on HRV have been 
widely discussed and examined using real and simulated data (Berntson et al., 1990; Kim 
et al., 2007, 2009; Mulder, 1992; Porges & Byrne, 1992; Salo et al., 2001). Berntson and 
Stowell (1998) demonstrated that HF becomes inflated by almost three natural log units 
in the presence of a single ECG artifact. Salo and colleagues (2001) demonstrated that 
SDNN, LF, and HF had different sensitivities to the amount (0–50%) and type (deletion 
vs. interpolation) of editing, and that these editing procedures had different effects 
between recordings from non-clinical and clinical (myocardial infarction) participants. 
Among samples of adults (Kroll, Freed, & Stein, 1996) and children (Batten, Urbina, & 
Berenson, 2000), HRV reproducibility has been demonstrated despite inter-rater 
variability in the manual editing process. Following manual editing, NN-intervals must 
be digitally filtered and smoothed to correct for problems with stationarity and spectral 
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leakage (Task Force, 1996). Random “noise” (e.g., slow non-stationary trends) and 
overlapping frequency components (i.e., spectral leakage) contribute unwanted variance 
to ECG recordings, which could compromise estimation of HRV and further reduce 
reliability of the measure. Common filtering techniques include triangular, 
Hanning/Hamming, or moving polynomial windows (Berntson et al., 1997; Porges, 
1985). Improved accuracy and reliability of HRV have been demonstrated using adult 
data following digital filtering (Lee & Yu, 2010; Singh et al., 2005). Studies examining 
HRV reliability in the context of different (or absent) software-based filtering algorithms 
among children remain to be completed; however, it is plausible that HRV reliability will 
be reduced if NN-interval data is not properly filtered.  
HRV analyses. HRV measures are sensitive to the duration of ECG data from 
which they are derived (e.g., SDNN, VLF; see above section on HRV measurement). In 
turn, reliability of HRV is also influenced by ECG recording duration. Among adults, 
Hurikuri and colleagues (1990) demonstrated that SDNN can be reliably measured when 
using the mean of repeated 24-hr ECG recordings (coefficient of variation [CV] = 7 ± 
6%). Further, Marks and Lightfoot (1999) demonstrated that LF was more reliable when 
derived from the mean of repeated 5-min, compared to 2.5-min recordings (ICC = 0.82 
vs. 0.78). Among infants, Richards (1995) demonstrated a positive association between 
HF reliability and ECG recording duration, with durations of 3 min or longer showing the 
highest reliabilities (>0.8). Taken together, studies suggest that HRV reliability is 
influenced by the ECG recording duration; it is plausible that reliability of some 
measures (e.g., mean NN interval) would decrease with longer recordings, whereas 
reliability of other measures (e.g., VLF) would increase or remain unaffected (e.g., 
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LF:HF ratio). The consistency of ECG recording duration within and across study 
assessments is another important consideration for HRV reliability. Dalla Pozza and 
colleagues (2006) reported higher correlations between pediatric HRV measures derived 
from two 10-min ECG recordings compared to measures derived from a 10-min and 24-
hr recording (rNN = 0.81 vs. 0.65; rHF = 0.69 vs. 0.48; rLF = 0.88 vs. 0.54). Thus, HRV 
reliability may also depend on whether identical ECG recording durations were analyzed 
across study follow-up assessments. Finally, ECG data reduction methods (i.e., selection 
of an ECG analysis epoch) are pertinent. Among adults, McNames and Aboy (2006) 
demonstrated that HF was reproducible across ECG epochs ranging from 10 sec to 10 
min, while measures reflecting LF activity displayed poor reproducibility with epochs 
less than 10 min. Among infants, Richards (1995) analyzed HF using 75-sec recording 
samples and observed higher HF reliability when measures were derived using fifteen 5-
sec samples compared to five 15-sec samples. Thus, it is plausible that ECG data 
reduction techniques (i.e., selection of single or multiple analytical epochs) are pertinent 
to obtaining reliable HRV measures.  
Spectral frequency bandwidths dictate the measurement boundaries between 
spectral variables and are intended to capture specific physiological underpinnings of 
HRV. Recommended frequency bandwidths for common HRV variables are available for 
adults (Ernst, 2014), whereas a recommended bandwidth for HF is available only for 
samples of young children (Bar-Haim et al., 2000; Fox & Porges, 1985). The selection of 
an appropriate frequency band is pertinent and should be carefully considered prior to 
analysis. Erroneous application of frequency bandwidths (i.e., using adult frequency band 
cutoffs with pediatric samples), results in data that will not constitute a reliable measure 
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of HRV because NN-interval oscillations occurring at higher or lower frequencies than 
the selected frequency band can detect would distort the data and produce inaccurate 
estimates of variability. Thus, it is plausible that selection of appropriate frequency 
bandwidths is pertinent to HRV reliability, although this has yet to be examined.  
Taken together, evidence suggests that HRV is a moderately reliable measure of 
cardiac autonomic control; however, as the majority of this evidence comes from studies 
with adults, relatively less is understood about HRV reliability in children. Considerable 
variability within and between study protocols exists, which makes it difficult to 
determine which methodological factors are most salient for HRV reliability. Given the 
available data from adult and pediatric HRV studies, it is plausible that study follow-up 
length; extent of sample homogeneity and standardization of study protocol; ECG 
recording posture, sampling rate, and recording duration; collection of stable baseline 
data; and, selection of appropriate frequency bandwidths are each methodological 
considerations that are pertinent for promoting HRV reliability. 
HRV Stability 
Stability examines the extent to which changes in HRV over time may be 
attributed to developmental differences within individuals; understanding stability is 
important when considering trajectories of individual differences in psychophysiological 
development (El Sheikh, 2005; See Appendix A). Several researchers have examined 
HRV stability in children due to its developmental relevance for the prediction of future 
health outcomes, including hypertension, obesity, and Type 1 and Type 2 diabetes 
(Faulkner et al., 2005; Kleiger et al., 2005; Latchman et al., 2011; Martini et al., 2001; 
Thayer & Sternberg, 2006). Multiple, developmentally-relevant factors have been 
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previously associated with HRV in children, including age, heart rate, blood pressure, 
pubertal status, anthropometric characteristics (e.g., height, weight), and physical activity. 
Consideration of these factors may be pertinent to understanding HRV stability. 
Age. Parasympathetic-mediated measures of HRV increase across infancy and 
early childhood, and subsequently decline across adolescence into adulthood (Longin et 
al., 2009; Lenard, Studinger, Mersich, Kocsis, & Kollai, 2004; Silvetti et al., 2001). 
Considering these mean-level changes in HRV across development, several studies have 
examined stability of measures reflecting the mean NN-interval and HF across infancy 
and childhood; relatively less data is available across adolescence. Measures of the mean 
NN-interval (“NN”) do not appear consistently stable in young children. For example, 
NN stability was weak when measured from 2-months-old to 5-years-old (r = 0.08; 
Bornstein & Suess, 2000), but moderate when measured from 4-months-old to 4-years-
old (r = 0.38; Bar-Haim et al., 2000). Among younger children, stability of HF has been 
examined across 1- to 3-months-old (r = 0.12–0.24; Hsu & Porter, 2004; Porter, Bryan, & 
Hsu, 1995), 3- to 6-months-old (r = 0.36), 6- to 12-months-old (r = 0.62; Propper et al., 
2008), 2- to 4.5-years-old (r = 0.57; Calkins & Keane, 2004), 5- to 6-years-old (r = 0.53), 
and 6- to 7-years-old (r = 0.62; Heathers, Fink, Kuhnert, & de Rosnay, 2012). Among 
older children, HF stability has been examined in samples aged 8- to 10-years-old (r = 
0.79; Hinnant & El-Sheikh, 2009), 8- to 11-years-old (r = 0.56; Hinnant, Elmore-Staton, 
& El-Sheikh, 2011), 9- to 11-years-old (r = 0.49; El-Sheikh, 2005), and among 
adolescents aged 15 to 17 years across 6 months (rHF = 0.66; rLF = 0.65; rSDNN = 0.66; 
Henje Blom, Olsson, Serlachius, Ericson, & Ingvar, 2009). Notedly, most of these studies 
contained small sample sizes (N < 71), analyzed less than 5 min of ECG, did not report 
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several methodological details (e.g., time of ECG recording, sampling rate), and only two 
(El-Sheikh, 2005; Henje Blom et al., 2009) included developmentally-relevant covariates 
in their analyses. Taken together, moderate HRV stability is typically observed among 
pediatric samples despite the mixed methodological quality of available studies. Further, 
reported results are consistent with previous findings of mean-level changes in HRV 
across development, and suggest a positive association between HRV stability and 
advanced age.  
Heart rate. Developmentally, heart rate activity (the inverse of the mean NN 
interval) is typically highest during infancy, and decreases steadily with advancing age 
(Fleming et al., 2011; Lenard et al., 2004). Heart rate is largely influenced by activity of 
the sympathetic autonomic branch, whereas HRV is influenced by both sympathetic and 
parasympathetic autonomic branches. Significant negative associations between heart 
rate and HRV are typically reported among samples of adults (e.g., βrange = -0.17 – -0.38; 
Tsuji et al., 1996) and older adults (e.g., rrange = -0.39 – -0.55; Tsuji et al., 1994); 
however, results are more variable among children (e.g., βrange = -0.40 – 0.74; Jarrin et 
al., In press). As developmental declines in heart rate are typically observed between 
infancy and adolescence, and faster heart rate activity is typically associated with lower 
HRV, it is plausible that heart rate is an important consideration in examinations of HRV 
stability. A study by Henje Blom and colleagues (2009) measured HRV twice across 6 
months and reported higher stability after heart rate was included as a covariate: HF (r = 
0.54 vs. 0.66), LF (r = 0.62 vs. 0.65), SDNN (r = 0.64 vs. 0.66). Given the available 
evidence, researchers generally agree on the relevance of including heart rate as a 
covariate in HRV analyses, especially in the absence of specialized filtering algorithms 
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which account for differences/changes in heart rate, such as a moving polynomial filter. 
However, including heart rate as a statistical covariate in examinations of HRV stability 
is uncommon. As the association between heart rate and HRV may change across time, 
accounting for differences in heart rate across periods of child development may augment 
estimates of HRV stability.    
Blood pressure. Blood pressure becomes elevated as children develop into 
adolescents and adults (Chen, & Wang, 2008), which likely reflects compensatory 
cardiovascular mechanisms that augment blood flow to meet increasing bodily demands. 
Changes in systolic (SBP) and diastolic (SBP) blood pressure across development are 
likely related to similar changes in HRV. In a cross-sectional study, Tanaka and 
colleagues (2000) demonstrated that measures of SBP and DBP were negatively 
associated with HF and positively associated with LF:HF ratio among adolescents (Mage = 
13.5 years; HF βSBP = -0.51; βDBP = -0.49; LF:HF ratio βSBP = 0.52; βDBP = 0.33), but not 
among pre-adolescents (Mage = 9.0 years; HF βSBP = 0.19; βDBP = 0.06; LF:HF ratio βSBP = 
-0.13; βDBP = 0.01), after adjusting for age, weight, and height. Longitudinal studies 
examining the relation between blood pressure and HRV among children and adolescents 
are rare. Campbell and colleagues (2003) demonstrated that SBP measured at 14-years-
old was positively correlated with LF (r = 0.15) and LF:HF ratio (r = 0.09) measured at 
22-years-old, whereas DBP measured at 14-years-old was negatively correlated with LF 
measured at 22-years-old (r = -0.03); however, none of the correlations reached statistical 
significance, and thus must be interpreted with a degree of caution. It is likely that 
increasing sympathetic dominance across child development is associated with 
modulation of both BP and HRV. Baroreceptor reflex mechanisms, which detect 
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moment-to-moment increases or decreases in BP, trigger autonomic responses to 
modulate cardiac output. Further, decreased vagal tone (e.g., across older samples) results 
in vasodilation, which decreases BP and baroreceptor reflex control (Berntson et al., 
2007; Tanaka, Borres, Thulesius, Tamai, Ericson, & Lindblad, 2000). Thus, as BP and 
HRV are both controlled by autonomic modulation of cardiovascular activity, 
developmental changes in BP are likely associated with HRV stability.   
Pubertal development. Puberty is a critical developmental period when 
significant physical, biological, and psychological changes occur (Shirtcliff, Dahl, & 
Pollak, 2009). The timing of puberty is different between girls and boys, such that girls 
often begin puberty 2 to 3 years earlier (Patton & Vines, 2007; Shaffer, Wood & 
Willoughby, 2005). Puberty triggers the release of hormones from the pituitary gland 
(e.g., human growth hormone, estrogen, testosterone) that contribute to physical, 
biological, and sexual maturations. More data are available regarding the effects of 
estrogen, relative to testosterone, on autonomic functioning; however, literature reviews 
have been inconsistent about whether estrogen depresses (Kajantie & Phillips, 2006) or 
augments (Ordaz & Luna, 2012) sympathetic activity. Nevertheless, evidence suggests 
that sex hormones released during puberty impacts blood pressure and heart rate 
(McCabe, Porges, & Carter, 1981; Spear, 2000) and may also impact HRV. El-Sheikh 
(2005) demonstrated that parent-reported pubertal status was positively associated with 
cross-sectional measures of HF obtained from children at 9- (r = 0.22) and 11-years-old 
(r = 0.28); children in this study were mostly pre-pubertal at 9-years-old, whereas only 
girls were classified as early-pubertal at 11-years-old. Further, pre-pubertal children 
exhibit lower mean-level values of LF, SDNN, and SDANN, and higher HF, relative to 
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post-pubertal children (Chen et al., 2012; Kowalewsky, Alifier, Bochen, & Urban, 2007). 
Thus, a shift in sympathovagal balance (i.e., towards greater sympathetic dominance) 
appears to occur during puberty. Consistent with this, Jarrin and colleagues (In press) 
demonstrated that increased pubertal development (as measured by trained nurses using 
Tanner stages) was associated with decreased rMSSD (β = -0.08), pNN50 (β = -0.08), 
and HF (β = -0.06), and increased LF:HF ratio (β = 0.11). Taken together, pediatric 
studies demonstrate clear associations between pubertal development and HRV (although 
any sex-specific differences in the mechanisms and timing of this association remain to 
be examined). Thus, it is plausible that pubertal development is also associated with HRV 
stability.  
Growth and adiposity. As children grow, they naturally become taller and 
heavier (Adair, Martorell, & Stein, 2009; De Onis & World Health Organization, 2006; 
Shaffer, Wood, & Willoughby, 2005). Developmental changes in height and weight are 
normal occurrences, and both increase cardiovascular demand because the heart is 
required to maintain circulation throughout a larger frame; a possible explanation for this 
relates to the increased production of growth hormone during pubertal development. 
Although studies in children have not directly examined the relation between growth 
hormone and HRV, adults with growth hormone deficiencies have decreased sympathetic 
activity relative to normal controls (Leong, Mann, Wallymahmed, MacFarlane, & 
Wilding, 2000). Considering this, greater bioavailability of growth hormone may further 
contribute to a shift towards sympathetic dominance across child development. Seppälä 
and colleagues (2013) reported significant correlations between height and HRV (rrange = 
-0.15 – 0.14) in a large sample of children; however, they did not report which HRV 
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variables were more associated with height than others, which limits the ability to draw 
sound conclusions. A study by Rodriguez-Colon and colleagues (2011) with 9-year-old 
children demonstrated that height percentile was negatively associated with HF (β = -
0.11), LF (β = -0.07), SDNN (β = -3.20), and rMSSD (β = -4.88), and positively 
associated with LF:HF ratio (β = 0.07) and heart rate (β = 0.47; non-significant), based on 
a regression model including age, sex, race, sleep apnea, and sampling weight. Thus, it is 
plausible that height is also associated with HRV stability. Rodriguez-Colon and 
colleagues (2011) also demonstrated that weight percentile was negatively associated 
with HF (β = -0.15), LF (β = -0.11), SDNN (β = -4.50), and rMSSD (β = -5.71), and 
positively associated with LF:HF ratio (β = 0.05) and heart rate (β = 1.12); associations 
between waist circumference and HRV were similar to those between weight and HRV, 
but these analyses were not adjusted for similar covariates. Jarrin and colleagues (In 
press) also demonstrated that central adiposity (i.e., waist circumference) in children was 
positively associated with LF (β = 0.12) and LF:HF ratio (β = 0.18), even after adjusting 
for age, sex, puberty, heart rate, blood pressure, TV/computer screen time, physical 
activity, household income, and parental education. Longitudinal studies further support 
the relation between weight and HRV. Graziano and colleagues (2011) reported that 
reduced HF regulation in 5.5-year-olds was associated with being overweight 5 years 
later. Further, Campbell and colleagues (2003) reported that BMI at 14-years-old 
correlated negatively with HF (r = -0.10) and positively with LF:HF Ratio (r = 0.23) 
when participants were followed up at 22-years-old. Notedly, there is considerable intra-
individual variability in the timing and rate of growth among children across different 
periods of development. Considering this, although weight and other measures of 
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adiposity have been associated with HRV, it is plausible that the change in these 
measures across time is particularly relevant to examinations of HRV stability.  
Physical activity. Exercise promotes regularity and coordination among 
contractions of the heart’s ventricles and augments balance of autonomic cardiovascular 
control (Stein & Kleiger, 1999). Physical activity has been positively associated with 
parasympathetic dominance among adults (Sandercock, Bromley, & Brodie, 2005). 
However, studies in children often fail to show significant differences in HRV when 
measured before and after exercise (e.g., Gamelin et al., 2009; Winsley et al., 2003), 
suggesting that acute physical activity may not be associated with HRV stability in early 
development. However, there is evidence for an effect of overall physical fitness and 
HRV. Among adults, Gregoire and colleagues (1996) demonstrated that participants who 
engage in regular physical activity display higher parasympathetic and lower sympathetic 
activity at rest, compared to age- and sex-matched sedentary controls. Among children, 
Hutin and colleagues (2000) demonstrated that rMSSD measured from obese children 
steadily increased across a 4-month period of regular (4–5 days/week) exercise, but 
decreased across a subsequent 4-month period when training was halted. Among 
adolescents, Henje Blom and colleagues (2009) demonstrated that physical activity is 
negatively associated with heart rate (r = -0.44), and positively associated with LF (r = 
0.29), HF (r = 0.32), and SDNN (r = 0.37), based on partial correlations controlling for 
BMI, capillary glucose, and SBP; physical activity accounted for 13–17% of the variance 
among HF, LF, and SDNN in regression models. Sustained maintenance of physical 
activity may promote parasympathetic dominance, whereas sustained sedentary 
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behaviour may augment parasympathetic withdrawal. It is plausible that changes in 
physical fitness over time (e.g., joining team sport) could influence HRV stability.  
Summary   
Research from the adult (e.g., Tanaka et al., 2000; Tsuji et al., 1994, 1996) and 
pediatric literature (e.g., Henje Blom et al., 2009; Jarrin et al., In press; Rodriguez-Colon 
et al., 2011) has typically demonstrated that HRV is positively associated with more 
advanced age and greater physical fitness, and negatively associated with increased heart 
rate, blood pressure, pubertal status, and physical growth (e.g., increased weight). It is 
possible that these same factors influence the stability of pediatric HRV measures. Given 
that stability reflects consistency in a measure across development, it is plausible that 
accounting for individual developmental differences among measures of age, heart rate, 
blood pressure, pubertal status, growth, and physical activity across time would augment 
HRV stability. The psychometric stability of HRV can likely be improved if researchers 
account for developmental changes in factors associated with HRV by increasing 
methodological or statistical control. A poor understanding of developmental factors that 
affect the psychometrics of HRV may result in erroneous conclusions about the utility of 
predicting health outcomes using longitudinal HRV data.  
Current State of Knowledge 
HRV reliability. Available evidence from the adult and pediatric HRV literature 
suggested that HRV is a reliable measure of autonomic cardiovascular control. The 
majority of evidence for HRV reliability came from studies with adults. As such, 
evidence for HRV reliability among samples of infants, children, and adolescents was 
relatively less abundant. Most reviewed studies arrived at the same conclusion of 
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moderate HRV reliability. However, there was often considerable methodological 
variability across the adult and pediatric HRV literature (e.g., heterogeneous samples, 
distinct ECG recording protocols, different ECG recording durations [e.g., < 5-min, 10-
min, 24-hr recordings]). This methodological variability makes it challenging to draw 
meaningful comparisons about HRV reliability reported by different studies. Moreover, 
there was a paucity of research across both the adult and pediatric HRV literature that 
sufficiently conformed to published HRV measurement guidelines. Many of the reviewed 
studies failed to report pertinent study protocol (e.g., participant inclusion/exclusion 
criteria, time of ECG recording), sample characteristics (e.g., anthropometrics, ethnicity), 
and technical details (e.g., excluded NN-interval data, HRV derivation method). Minimal 
conformity to published guidelines reduces research standardization limits the 
interpretability of obtained results and yields greater potential for measurement error. 
Nevertheless, studies examining HRV reliability demonstrated that multiple 
methodological factors merit consideration when measuring HRV. Evidence suggested 
that methodological factors relevant to sample characteristics, study protocol, ECG signal 
acquisition and pre-processing methods, and HRV analysis techniques are relevant to 
producing reliable measures of HRV. In sum, while moderate HRV reliability was 
typically reported among studies with adults and children, poor reporting practices and 
limited research standardization were noteworthy concerns. As such, it is difficult to 
determine whether certain methodological features of a study made more of a 
contribution to HRV reliability than others.  
HRV stability. Available evidence from the pediatric HRV literature suggested 
that HRV reflects a moderately stable individual difference in children. HRV stability 
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was typically reported as weak-to-moderate among newborns and very young infants; 
moderate stability was observed by approximately 6-months-old, and was retained across 
childhood development into early adolescence. Most examinations of HRV stability have 
focused on HF; few studies have examined stability using other HRV measures. Further, 
a review of the extant pediatric HRV literature indicated that mean-level differences in 
HRV have been associated with developmentally-relevant, individual difference factors 
such as age, pubertal development, heart rate, blood pressure, height, weight, and 
physical fitness. However, given that only a few pediatric HRV researchers have 
examined stability while statistically controlling for such developmental factors, it 
remains to be tested empirically whether these same factors alter HRV stability. Studies 
that have included covariates in examinations of stability (El-Sheikh, 2005; Henje Blom 
et al., 2009) suggested that controlling for developmentally-relevant moderators would 
augment HRV stability. In sum, while moderate HRV stability is typically reported 
among children, studies were limited by a somewhat restricted focus on one measure of 
HRV, and a lack of statistical control of developmentally-relevant moderators, which 
have been previously associated with HRV. As such, it is difficult to determine whether 
these individual difference factors are also associated with HRV stability.  
Knowledge Gaps  
The current literature suggests that HRV is a reliable and stable measure of 
autonomic cardiovascular control among pediatric samples. However, three primary 
knowledge gaps regarding the psychometrics of HRV in the pediatric literature exist. 
First, studies examining HRV reliability have typically compared only limited 
methodological conditions (e.g., paced vs. spontaneous breathing; supine vs. standing 
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recording postures; rest vs. exercise). Mean-level differences in HRV (and heart rate) 
have been associated with methodological conditions such as whether or not participants 
were able to acclimate prior to data collection, the consistency of an ECG recording 
duration, and the application of editing and digital filtering techniques. It is intuitive that 
changing a study methodology across test-retest intervals (e.g., inconsistent ECG 
recording times, different ECG recording postures, unstandardized recording protocols) 
could compromise reliability. However, it remains to be empirically examined whether 
reliability of HRV is robust to methodological inconsistencies across time; this would 
help elucidate whether the consistency of some methodological factors are more salient to 
promoting reliability than others. Given that replication of initial study conditions is 
pertinent for ensuring reproducibility of results, it can be hypothesized that studies that 
maintain greater research standardization would yield more reliable measures of HRV 
compared to studies that use less consistent methodology. Further, the specific 
methodology used to derive HRV measures is relevant for deriving HRV measures that 
accurately reflect autonomic functioning. Using an appropriate ECG sampling rate, 
applying necessary editing and digital filtering to NN-interval data, and selecting 
appropriate frequency bandwidths are each pertinent methodological factors detailed by 
published HRV guidelines. Although it remains to be empirically examined whether or 
not a consideration of such methodological factors is relevant to improving the reliability 
of HRV measures, it can be hypothesized that studies that conform to published 
guidelines would yield more reliable measures of HRV.  
Second, studies examining HRV stability typically do not examine the influence 
of developmentally-relevant covariates. Multiple physiological and behavioural factors 
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have been associated with mean-level differences in HRV among children in cross-
sectional and longitudinal studies. However, few researchers control for age, heart rate, 
weight, or other developmentally-relevant covariates when examining HRV stability. 
Examining how such factors influence HRV stability is relevant to establishing whether 
HRV reflects a stable individual difference during childhood, and to understanding the 
strengths and limitations of using HRV as a predictor of future health outcomes. As such, 
it can be hypothesized that controlling for the influence of individual differences among 
factors such as age, heart rate, and weight, among others, could augment HRV stability 
by accounting for extraneous variance in longitudinal measures. Moreover, examinations 
of HRV stability chiefly focus on measures of HF relative to other time- and frequency-
domain measures. As such, evidence for stability of other HRV measures (e.g., LF, 
rMSSD) that provide additional information regarding autonomic cardiovascular control 
is lacking. Given that HF has been previously demonstrated as a stable measure among 
children, it can be hypothesized that other measures of HRV in children, particularly 
those reflecting parasympathetic modulation, would exhibit a similar degree of stability. 
Third, studies examining HRV stability typically use statistical methods that 
provide a somewhat restricted understanding of this psychometric property. Most studies 
that examine HRV stability use correlational techniques, which only account for rank 
order changes between individuals across test-retest intervals, not magnitude of mean 
changes. Exclusive use of these analytical methods may limit a thorough understanding 
of stability (i.e., stability as reflected only in the context of relative rank-order 
differences) because a consideration of mean-level changes is also pertinent. Statistical 
methods that account for mean-level changes and random error in longitudinal data (such 
43 
 
as the intra-class correlation) have utility in providing a more complete picture of HRV as 
a stable individual difference. However, examination of HRV stability using more 
advanced techniques is not common practice. Given the longitudinal associations 
observed between HRV and other biological processes (e.g., heart rate, puberty), 
examining whether simultaneous changes in measures of HRV and in developmentally-
relevant covariates across time may be pertinent to understanding HRV stability. As such, 
it can be hypothesized that accounting for developmental changes among specific within-
person factors would yield more meaningful information regarding stability of HRV in 
children. Taken together, a better understanding of the psychometric properties of HRV 
measured in infants, children, and adolescents requires an examination of methodological 
and intra-individual factors that could affect the reliability and stability of HRV, 
respectively.  
Study Aims  
The overarching aim of the present thesis was to conduct an empirical evaluation 
of the psychometric properties of time- and frequency-domain HRV measures in 
pediatric populations, from infancy through adolescence. The specific goals of this 
research were: (1) to synthesize available evidence for the test-retest reliability of time- 
and frequency-domain HRV measures from the extant literature, (2) to examine 
methodological factors that impact the reliability of HRV measures among samples of 
infants, children, and adolescents, and (3) to examine intra-individual and developmental 
factors that impact the temporal stability of time- and frequency-domain HRV measures 
among children. These aims were achieved through two complementary studies. The first 
study was a comprehensive meta-analysis of the existing pediatric literature to evaluate 
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the test-retest reliability of HRV. The goal of this study was to consider the impact of 
study methodology on the reliability of HRV measurement. The second study examined 
the 2-year stability of HRV measures obtained from children who had participated in a 
large, longitudinal cohort study within Quebec. The goal of this second study was to 
assess the impact of demographic (age, sex, pubertal status), cardiovascular (heart rate, 
blood pressure), anthropometric (height, weight, BMI, waist-circumference), and 
physical activity (self-reported weekly activity, time spent watching TV) variables on 
HRV measurement stability using time-varying covariates. This study evaluated HRV as 
a stable individual difference in youth. Taken together, these two studies provided timely 




Study 1: Method 
Literature Search Strategy 
First, a literature search was performed using PsycInfo and PubMed (MedLine) 
databases from January 1, 1970 to December 31, 2013, using the following keyword 
combinations: (“neonatal” OR “infant” OR “toddler” OR “child” OR “children” OR 
“adolescent” OR “adolescence” OR “teen” OR “youth” OR "young adult") AND (“heart 
period” OR “heart rate variability” OR “HRV” OR “R-R interval” OR “RR interval” OR 
“N-N interval” OR “NN interval” OR “heart interval” OR “respiratory sinus arrhythmia” 
OR “RSA” OR “vagal tone” OR “inter-beat interval” OR “IBI” OR “SDNN” OR 
“SDANN” OR “SDNNi” OR “rMSSD” OR “pNN50” OR “high frequency heart rate 
variability” OR “high frequency HRV” OR “low frequency heart rate variability” OR 
“low frequency HRV”) AND (“reliability” OR “reliable” OR “stable” OR “stability” OR 
“reproducible” OR “reproducibility” OR “psychometric” OR “intra-individual” OR “test-
retest” OR “repeatable” OR “repeatability” OR “longitudinal”). The following filters 
were also applied: Species: humans; Language: English; Age Range: birth to 18 years. 
This search yielded 975 non-redundant articles. 
Second, article titles were reviewed and abstracts were selected for follow-up if 
the title indicated that HRV was obtained from infants, children, or adolescents; 586 titles 
met this inclusion. Third, abstracts of the selected titles were reviewed and articles were 
selected for follow-up if the abstract suggested that HRV was measured from non-clinical 
samples of infants, children, or adolescents on more than one occasion; 82 articles met 
this criterion. Fourth, a descendancy approach was used to identify additional articles by 
reviewing the reference lists from selected articles; 328 non-redundant titles were 
identified. Following an abstract review of these references, 37 additional articles met 
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inclusion criteria. Fifth, an ascendancy approach was used to identify additional articles 
based on a forward citation search of the 82 initially selected articles using Web of 
Science; 191 non-redundant titles were identified. Following an abstract review of these 
references, 29 additional articles met inclusion criteria. Finally, letters of solicitation 
requesting additional or unpublished data were sent to authors who published two or 
more included articles; one additional article was obtained. A total of 143 non-redundant 
articles were identified for full review (see Figure 1). 
Article Inclusion and Exclusion 
Each of the 143 identified articles were read and fully reviewed for possible study 
inclusion. Articles were included in the meta-analysis if: (a) HRV was measured at least 
twice during separate, resting baseline conditions; (b) participants were non-clinical 
infants, children, or adolescents with a sample mean age of ≤ 18.0 years at the initial 
study assessment; and (c) sufficient baseline HRV data were presented for effect size 
computation (i.e., reporting only means was not sufficient for inclusion). Articles were 
excluded based on an a priori hierarchy: (a) not an empirical study (k = 1); (b) sample 
size less than 10 (k = 4); (c) sample consisted only of clinical (e.g., diabetes, anxiety) or 
special-population individuals (e.g., pre-term infants, athletes; k = 9); (d) second baseline 
ECG recording was obtained only on the same day as the first recording (k = 1); (e) 
second baseline ECG recording was not obtained (k = 51); (f) HRV data was obtained 
solely during periods of overnight sleep (k = 3); (g) HRV was derived from averaged 
heart rate (using beats per minute, BPM), rather than NN intervals (k = 4); (h) HRV data 
were averaged across rest and between task conditions (i.e., stress, exercise; k = 3); (i) 
data not reported for baseline HRV (k = 20); (j) data were redundant with another study 
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already included in the meta-analysis (k = 1; more complete article was included). Of the 
143 potentially relevant articles, 46 met inclusion criteria (see Figure 1).  
Reliability of Article Selection and Coding 
To evaluate article selection fidelity, inter- and intra-rater reliability were 
examined. A single rater (OW) initially coded all titles, abstracts, and articles. Next, a 
random sample of 10% of titles and abstracts was blindly coded a second time by OW 
after a four-month interval; a separate independent rater (JL) also coded titles and 
abstracts at this time. Excellent intra-rater (kappa = 1.0) and inter-rater (kappa = 1.0) 
agreement for title selection were obtained. Excellent intra-rater (kappa = 0.92) and 
adequate inter-rater agreement (kappa = 0.8) for abstract selection were obtained. 
Differences in abstract selection were resolved through discussion. For the included 
articles, excellent intra-rater reliability was obtained for categorical (kappa = 0.93) and 
continuous coding decisions (ICC = 1.0, 95% CI [1.0, 1.0]), and for selection of data used 
to calculate effect sizes (ICC = 1.0, 95% CI [1.0, 1.0]). Good inter-rater reliability was 
obtained for categorical (kappa = 0.83) and continuous coding decisions (ICC = 0.96, 
95% CI [0.927, 0.975]), and for selection of data used to calculate effect sizes (ICC = 1.0, 
95% CI [1.0, 1.0]). Each article required approximately 60 coding decisions. 
Article Coding and Data Extraction 
Study and sample characteristics. If demographic information (e.g., age, 
weight) was reported separately for males and females, a weighted average value was 
calculated. Mean participant age was coded in months. Sex was coded as percent male. 
Participant height (centimetres), weight (kilograms), BMI (kg/m
2
), systolic and diastolic 
blood pressure (mmHg), ethnicity (African American, European American, Hispanic, 
Asian, Mixed, Other, Unknown), and puberty status (Tanner stages) were coded. 
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Exclusion criteria for study participants as reported by each article were dichotomously 
coded (yes/no) within the following a priori categories: (a) prescription medication use; 
(b) abnormal pregnancy or birth (e.g., preterm birth, abnormal pediatric exam); (c) 
chronic medical illness (e.g., diabetes, cardiovascular pathology); (d) mental health 
diagnosis (e.g., cognitive, intellectual, psychological, behavioural disorder); (e) 
anthropometric characteristics (e.g., overweight, obese). Study follow-up length was 
coded in weeks. “Unmentioned” was coded when a study or sample characteristic of 
interest was not reported.   
Psychophysiological recording. Study location was coded (university/hospital 
lab; school; home/ambulatory; nursery). Time of day that the ECG recording occurred 
was coded (morning 06:00–11:59; afternoon 12:00 –17:59; evening 18:00–23:59). ECG 
sampling rate was dichotomously coded (≥ 500 Hz vs. < 500 Hz). Baseline ECG 
recording posture was coded (seated, supine, standing); “changed” was coded when 
children assumed different recording postures between study assessments. An a priori 
hierarchy was applied when more than one recording posture was reported ([1] seated, [2] 
supine, [3] standing). Studies with infants and toddlers were often recorded in a seated or 
supine posture; however, when no recording posture was identified infant/toddler studies 
were coded as supine. Inclusion of a pre-recording acclimatization period (i.e., time spent 
resting quietly prior to baseline ECG recording) was dichotomously coded (yes/no). Total 
ECG recording duration (baseline, task, recovery conditions combined) and baseline 
ECG recording duration were each coded in minutes. All studies were also 
dichotomously coded (yes/no) to indicate whether the location, recording time, recording 
posture, acclimatization period, total ECG recording duration, and baseline ECG 
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recording duration were identical across follow-up study assessments. Studies were 
dichotomously coded (yes/no) to indicate whether participants were awake for the entire 
duration of each ECG recording; several studies with infants had mixed sleep/wake 
recordings. “Unmentioned” was coded when a recording characteristic of interest was not 
reported.   
HRV pre-processing and analysis. Manual editing of ECG data and use of 
software-based filtering algorithms (e.g., Hanning/Hamming window, moving 
polynomial window) were both dichotomously coded (yes/no). The baseline ECG 
recording duration that was analyzed for HRV was coded in minutes; studies were 
dichotomously coded (yes/no) to indicate whether the baseline ECG recording duration 
analyzed for HRV was identical across all study follow-up assessments. The method of 
HRV signal processing (i.e., data reduction) was dichotomously coded (HRV processed 
using the mean of one, longer ECG recording epoch vs. HRV processed using the mean 
of multiple, shorter ECG recording epochs). “Unmentioned’ was coded when a pre-
processing or analysis characteristic of interest was not reported. 
Selection of baseline HRV measures. Baseline HRV was defined as any HRV 
measure obtained from ECG data recorded either independent of, or prior to, any 
experimental study condition (e.g., stress, tilt, exercise) across all study follow-up 
assessments. Time- and frequency-domain measures of baseline HRV were coded using a 
priori categories. Measures reported as heart period, mean NN-interval, or inter-beat 
interval were coded as NN in milliseconds (ms); SDNN and “heart period standard 
deviation” were coded as SDNN in ms; HF, respiratory sinus arrhythmia, and vagal tone 
were coded as HF in absolute (ms
2





) and normalized (n.u.) units. Frequency-domain HRV bandwidths were 
dichotomously coded (yes/no) to indicate whether a study selected an age-appropriate 
frequency band consistent with published HRV guidelines or recommendations (Bar-
Haim et al., 2000; Fox & Porges, 1985; Task Force, 1996); studies with infants and 
toddlers often used wider frequency bands relative to studies with children.  
Statistical Analysis 
 Effect size calculation. Effect sizes are scale-free measures of the strength of 
association between independent and dependent variables that can be represented in 
standardized (e.g., Hedges’ g, Fisher’s Z) or unstandardized (e.g., regression coefficient, 
mean difference) metrics (Rosenthal, 1994; Wilkinson & Task Force on Statistical 
Inference, 1999). Fisher’s Z was selected as the standardized common effect size for this 
meta-analysis. Fisher’s Z ranges from - to + and can be interpreted similar to a 
correlation; however, caution about bias is warranted when converting statistics derived 
from small samples (e.g., N < 30; Rosenberg et al., 2000; Rosenthal, 1994; Silver & 
Dunlap, 1987). Studies reporting effect sizes derived using different statistical methods 
were coded based on an a priori hierarchy ([1] Intra-class correlations, [2] partial 
correlation, [3] Pearson/zero-order correlation, [4] Spearman rank-order correlations, [5] 
unstandardized beta coefficients [6] F-ratios, [7] p-values). Intra-class correlations (ICC), 
as well as Pearson and Spearman correlations, were converted directly to Fisher’s Z 
(Rosenberg et al., 2000; Rosenthal, 1994). It has been suggested that ICCs are more 
comparable to r-type correlations following square-root transformation (e.g., Bornman, 
Mutz, & Daniel, 2010); however, preliminary analyses revealed no differences between 
Fisher’s Z values derived from untransformed and from square-root transformed ICCs. 
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As such, the untransformed (i.e., original) ICC value was converted to Fisher’s Z. Test 
statistics, including unstandardized beta coefficients and F-ratios, were converted to r and 
then to Fisher’s Z (Rosenthal, 1994; Rosenberg et al., 2000). When no other test statistic 
was available, exact p values were converted to the standard normal deviate (z-score), 
then to r, and then to Fisher’s Z (Rosenberg et al., 2000).  
Effect size management. Studies reporting effect sizes derived from two or more 
follow-up assessments were coded for both the entire study follow-up length and shorter 
follow-up intervals. Thus, multiple effect sizes for each reported HRV variable were 
extracted from each study if available; this allowed for both conservative (non-redundant; 
one effect size per study) and non-conservative (redundant; multiple effect sizes per 
study) analytical approaches. Non-redundant effect sizes were defined as those from the 
entire study follow-up length; multiple non-redundant effect sizes (i.e., from non-
overlapping study follow-up intervals; e.g., 2–4 weeks, 4–6 weeks) were also sample 
weight averaged to allow for one effect size per study. Redundant effect sizes were 
defined as those from multiple, overlapping, study follow-up intervals (e.g., 2–4 weeks, 
3–5 weeks).  
Analytic strategy. Because of noted methodological differences between HRV 
research conducted with infants and children, analyses were age-stratified (see Williams 
et al., 2012). Infant/toddler studies were defined as those with mean participant age less 
than 5 years (k = 31); child/adolescent studies were defined as those with mean 
participant age greater than 5 years but less than or equal to18 years (k = 15).   
To determine whether to conduct a fixed or random effects meta-analysis, we 
considered that the categorical variables coded are believed to capture all possible options 
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represented in the extant HRV literature (e.g., standardized vs. unstandardized ECG 
recording time; sitting vs. supine vs. standing posture; ≥ 500 Hz vs. < 500 Hz sampling 
rate); these coding options are not sampled from a larger population of possible options. 
Thus, a fixed-effects meta-analytic model, which assumes that variability in effect sizes 
are due only to sampling error (Rosenthal, 1994; Field & Gillett, 2010), was chosen for 
this study. A random-effects meta-analytic model, which assumes that variability in 
effect sizes is due to both random variance and sampling error, was not deemed 
appropriate given the data available (Rosenberg et al., 2000).  
All analyses were age-group stratified. A mean cumulative effect size was 
calculated overall and for each HRV variable separately. The heterogeneity (QT) test 
statistic was calculated as a measure of variation of the included effect sizes. A non-
significant QT indicates a homogeneous distribution, suggesting that variability of the 
effect sizes is less than that which would be expected from sampling error. A significant 
QT indicates a heterogeneous distribution, suggesting that additional moderator analyses 
may be warranted (Rosenberg et al., 2000). Moderator analyses were conducted using 
continuous and categorical variables coded from each study. Similar to regression, 
continuous analyses calculate a slope to test associations between an effect size and a 
continuous moderator (e.g., ECG recording duration). Similar to ANOVA, categorical 
analyses partition variance explained by the model (QM) and residual error variance (QE; 
Rosenberg et al., 2000). Bootstrap methods (1000 samples) were used to produce robust 
non-parametric estimates of confidence intervals around each effect size (Rosenberg et 
al., 2000). Finally, to address concerns of possible publication bias and the file-drawer 
problem, Orwin’s fail-safe numbers were used to determine the number of missing, 
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unpublished, or non-significant comparisons needed to make an overall effect size not 
different from 0.01. Analyses were performed using MetaWin 2 (Sinauer Associates, 
2000).  
The primary study hypothesis was that time- and frequency-domain HRV would 
exhibit moderate test-retest reliability among both infant/toddler and child/adolescent 
studies. Considering the recommendations outlined by published HRV guidelines and 
results from available methodological examinations of HRV (reviewed above), it was 
hypothesized that higher HRV reliability would be associated with studies that (a) 
considered factors relevant to study protocol and sample characteristics (i.e., shorter 
study follow-up length, greater sample homogeneity, smaller proportion of male 
participants); (b) maintained greater standardization of ECG recording conditions (i.e., 
consistent ECG recording time, included a pre-recording acclimatization period, 
consistent supine or seated ECG recording postures); and, (c) measured ECG and 
analyzed HRV in accordance with published guidelines and recommendations (i.e., 
sampling rate ≥ 500 Hz, edited and filtered ECG data prior to HRV analysis, analyzed 
longer [opposed to shorter] and consistent ECG recording durations, derived HRV using 
the multiple, shorter ECG epochs [opposed to a single, longer ECG epoch], selected a 
recommended frequency bandwidth [opposed to an alternative frequency bandwidth]). In 
addition, this meta-analysis examined whether test-retest reliability of HRV was 






Study 1: Results 
Study Participant and Recording Characteristics 
A total of 46 studies (N = 4790) were included in the present meta-analysis. 
Thirty-one studies of infants and toddlers (N = 3257) and 15 studies of children and 
adolescents (N = 1533) each had a mean of approximately 100 participants per study (See 
Tables 1 and 3). Approximately half of all participants were male for both age groups. 
Overall, few studies reported details about participant characteristics, presenting little 
information about height, weight, BMI, ethnicity, or study attrition. Data collection 
typically occurred at a university or hospital research lab for both infant/toddler (71%) 
and child/adolescent (67%) studies. The mean ECG recording duration analyzed for HRV 
was 4.54 min (SD = 4.32) in infant/toddler studies, and 3.22 min (SD = 0.96) in 
child/adolescent studies (See Table 2). The most commonly reported HRV measures 
were HF and NN in infant/toddler studies, and HF and LF in child/adolescent studies. A 
mean of 2.0 (SD = 1.03) and 2.5 (SD = 2.12) HRV variables were reported among 
infant/toddler and child/adolescent studies, respectively.  
Overall Summary Analyses  
Consistent with the main study hypothesis, HRV exhibited moderate test-retest 
reliability across both age groups. Further, reliability was significantly lower for 
infant/toddler studies compared to child/adolescent studies (Z = 0.42 vs. 0.64; QM = 
33.84, p < 0.001). Among infant/toddler studies, reliability of HF (Z = 0.42) and SDNN 
(Z = 0.43) were higher relative to NN (Z = 0.33). All infant/toddler analyses were 
heterogeneous, indicating further moderator analyses would be appropriate; HF reliability 
displayed the greatest relative heterogeneity among infant/toddler studies (QT = 71.61, p 
55 
 
< .001). Among child/adolescent studies, reliability of SDNN (Z = 0.85) was higher 
relative to HF (Z = 0.65), LF (Z = 0.61), and LF:HF ratio (Z = 0.52). All child/adolescent 
analyses were heterogeneous, except SDNN and LF:HF ratio; HF reliability displayed the 
greatest relative heterogeneity among child/adolescent studies (QT = 61.15, p < .001). 
(see Table 4). Further examination of each HRV variable was conducted using 
continuous and categorical moderator variables. Forest plots depicting HRV reliability 
effect sizes are presented in Figures 2 to 4.   
Moderator Analyses  
Continuous and categorical moderator analyses examined variables within the 
following four categories: study protocol (study follow-up length; consistency of study 
location; time of ECG recording; recording exclusively awake ECG data vs. not), sample 
characteristics (participant exclusion criteria; sample size, age, and weight; proportion of 
males), ECG signal acquisition and pre-processing (inclusion of a pre-recording 
acclimatization period, ECG recording posture, ECG sampling rate, editing and filtering 
techniques), and HRV analyses (ECG recording duration, consistency of ECG recording 
durations, HRV derivation method, HRV frequency bandwidth selection). Results from 
continuous moderator analyses are presented in Table 5; results from categorical 
moderator analyses are presented in Tables 6 and 7. Notedly, due to the paucity of studies 
available, most categorical analyses were limited to NN and HF among infant/toddler 
studies and HF and LF among child/adolescent studies. 
Study protocol. Longer study follow-up length was significantly associated with 
lower SDNN reliability (B = -0.01, p < 0.001), but was not associated with NN or HF 
reliability among infant/toddler studies. In contrast, longer study follow-up length was 
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significantly associated with lower HF reliability (B < -0.01, p = 0.012), but was not 
associated with SDNN reliability among child/adolescent studies. Further, longer study 
follow-up length was significantly associated with lower LF reliability (B = -0.01, p = 
0.015), but was not associated with LF:HF ratio reliability among child/adolescent 
studies. Results provided partial support for the hypothesis that longer study follow-up 
length is associated with reduced HRV reliability. However, significant heterogeneity 
remained for SDNN (QT = 14.92, p < .001) and HF (QT = 71.61, p < .001) among 
infant/toddler studies and for HF (QT = 61.15, p < .001) and LF (QT = 12.36, p < .05) 
among child/adolescent studies, indicating that further moderator analyses are required. 
No differences in reliability were observed between studies that maintained an 
identical study location across follow-up assessments and studies that changed study 
location at a subsequent follow-up assessment. 
No differences in reliability were observed between studies that limited ECG 
recording to the morning hours, or between studies that reported a consistent time of 
ECG recording across follow-up assessments (i.e., same vs. different ECG recording 
time) and HRV reliability across both age groups. Recording ECG exclusively while 
participants remained awake, compared to recording ECG without restricting participants 
from sleeping, yielded significantly higher HF reliability among infant/toddler studies (Z 
= 0.44 vs. 0.21; QM = 6.50, p = 0.011); all child/adolescent studies recorded ECG data 
while participants were awake. Results from infant/toddler studies that recorded ECG 
while participants remained awake, compared to studies that did not restrict participants 
from sleeping, provided partial support for the hypothesis that accounting for circadian 
factors is associated with higher HRV reliability. 
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Sample characteristics. Sample exclusions (yes/no) based on prescription 
medication use (Z = 0.61 vs. 0.23; QM = 14.06, p < 0.001), chronic medical illnesses (Z = 
0.47 vs. 0.26; QM = 5.26, p = 0.022), and low birth weight (e.g., < 2500 g; Z = 0.48 vs. 
0.27; QM = 4.71, p = 0.03) yielded significantly higher NN reliability among 
infant/toddler studies. Further, sample exclusion due to atypical neonatal characteristics 
(e.g., preterm birth, abnormal pediatric exam; Z = 0.34 vs. 0.45; QM = 8.34, p = 0.004) 
and low birth weight (Z = 0.23 vs. 0.44; QM = 6.31, p = 0.012) yielded significantly lower 
HF reliability among infant/toddler studies. NN reliability was most influenced by sample 
exclusions based on medication use; HF reliability was most influenced by sample 
exclusions based on birth weight among infant/toddler studies. Child/adolescent studies 
with sample exclusion criteria yielded no differences in HF reliability, suggesting HF 
reliability is more robust to sample heterogeneity among children and adolescents relative 
to infants and toddlers. Results from infant/toddler studies provided partial support for 
the hypothesis that increased sample heterogeneity is associated with higher HRV 
reliability. However, as significant heterogeneity was observed for NN and HF among 
infant/toddler studies and for HF among child/adolescent studies upon examination of 
participant exclusions, further moderator analyses are needed.  
Larger sample size was significantly associated with higher NN reliability (B < 
0.01, p = 0.027) and lower SDNN reliability (B = -0.01, p < 0.001) among infant/toddler 
studies, and lower LF reliability (B < -0.01, p = 0.049) among child/adolescent studies. 
Larger sample size was not associated with HF reliability in either age group, and was not 
associated with SDNN or LF:HF ratio reliability among child/adolescent studies.  
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Older sample age was significantly associated with higher NN (B = 0.01, p < 
0.001) and HF (B = 0.01, p = 0.002) reliability, but lower SDNN reliability (B = -0.53, p 
< 0.001) among infant/toddler studies. Conversely, older sample age was not associated 
with reliability of any HRV variables among child/adolescent studies. There were no 
associations between increased sample weight and HRV reliability across both age 
groups.  
Having a greater proportion of male participants was significantly associated with 
lower NN reliability (B = -0.02, p = 0.017) among infant/toddler studies; no relation was 
observed for HF. Conversely, having a greater proportion of male participants was 
significantly associated with lower HF (B = -0.01, p = 0.007) and LF (B = -0.01, p = 
0.008) reliability among child/adolescent studies; no relation was observed for LF:HF 
ratio. Results based on frequency-domain measures from child/adolescent studies 
provided partial support for the hypothesis that having a greater proportion of male 
participants is associated with lower HRV reliability. However, significant heterogeneity 
remained for NN (QT = 36.46, p < .001) among infant/toddler studies and for HF (QT = 
58.99, p < .001) and LF (QT = 12.36, p < .05) among child/adolescent studies that had a 
greater proportion of male participants, indicating that further moderator analyses are 
required. 
ECG signal acquisition and pre-processing. Including a pre-recording 
acclimatization period yielded significantly higher NN reliability (Z = 0.62 vs. 0.21; QM = 
18.31, p < 0.001) among infant/toddler studies, and higher HF (Z = 0.68 vs. 0.49; QM = 
4.85, p = 0.023) and LF reliability (Z = 0.77 vs. 0.39; QM = 9.03, p = 0.003) among 
child/adolescent studies; HF reliability among infant/toddler studies did not differ in the 
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presence or absence of an acclimatization period (Z = 0.43 vs. 0.42). Results largely 
supported the hypothesis that including a pre-recording acclimatization period is 
associated with higher HRV reliability, particularly for frequency-domain measures 
among child/adolescent studies. However, there remained significant heterogeneity for 
HF among child/adolescent studies that included a pre-recording acclimatization period 
(QT = 50.06, p < .001), indicating that further moderator analyses are required.  
ECG recording posture was significantly associated with NN (QM = 9.42, p = 
0.002) and HF (QM = 23.12, p < 0.001) reliability among infant/toddler studies; HF 
reliability was highest when ECG was recorded in the seated posture (Z = 0.50), and 
lowest when ECG was recorded in different postures across follow-up assessments (Z = 
0.19). HF and LF reliability did not differ between ECG recording postures among 
child/adolescent studies; however, effect sizes for HF and LF reliability were larger 
among studies that recorded ECG in a seated, relative to a supine posture. No 
child/adolescent studies reported a change in the ECG recording posture across study 
follow-up assessments. Results from infant/toddler studies provided partial support for 
the hypothesis that ECG recording postures associated with parasympathetic dominance 
yields higher reliability of measures reflecting parasympathetic modulation of heart rate. 
However, significant heterogeneity was observed for NN (QT = 31.55, p < .001) and HF 
(QT = 42.13, p < .001) among infant/toddler studies and for HF (QT = 33.85, p < .001) 
among child/adolescent studies that recorded ECG in a seated posture, indicating that 
further moderator analyses are required. 
Reporting an ECG sampling rate < 500 Hz versus no mention of ECG sampling 
rate was associated with significantly lower HF reliability (Z = 0.28 vs. 0.44; QM = 4.84, 
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p = 0.028) among infant/toddler studies. Reporting an ECG sampling rate ≥ 500 Hz 
versus no mention of ECG sampling rate was not associated with higher HF reliability 
among child/adolescent studies; this association approached significance for LF, such 
that studies reporting an ECG sampling rate ≥ 500 Hz yielded higher reliability relative to 
studies that did not report an ECG sampling rate (Z = 0.72 vs. 0.44; QM = 3.67, p = 
0.056). Minimal reporting of ECG sampling rate among included studies limited this 
analysis to comparisons between studies that did and did not report an ECG sampling 
rate; as such, this study could not adequately test the hypothesis that sampling rates ≥ 500 
Hz are associated with higher HRV reliability. 
Reporting manual editing of ECG data versus no mention of manual editing was 
significantly associated with higher NN reliability (Z = 0.38 vs. 0.14; QM = 4.99, p = 
0.025), while reporting a software-based filtering algorithm versus no mention of 
applying filtering algorithms was significantly associated with higher HF reliability (Z = 
0.45 vs. 0.35; QM = 4.85, p = 0.028) among infant/toddler studies. No differences in HF 
or LF reliability were observed among child/adolescent studies that reported or did not 
report manual editing or software-based filtering of ECG data. Results from 
infant/toddler studies provided partial support for the hypothesis editing and filtering of 
ECG data is associated with higher HRV reliability.  
HRV analyses. Longer ECG recording duration was significantly associated with 
lower NN reliability (B = -0.03, p = 0.026) among infant/toddler studies; however, results 
were no longer statistically significant after re-examining only those studies with ECG 
recording duration ≤ 5 min (excluded k = 2; B = 0.06, p = 0.083). No relation was 
observed between ECG recording duration and HF reliability among infant/toddler 
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studies. Conversely, longer ECG recording duration was significantly associated with 
higher HF (B = 0.14, p = 0.004), LF (B = 0.10, p = 0.040), and lower LF:HF ratio 
reliability (B = -0.35, p = 0.032) among child/adolescent studies; no relation was 
observed for SDNN. Results from child/adolescent studies provided partial support for 
the hypothesis that longer ECG recording durations are associated with higher HRV 
reliability. However, significant heterogeneity was observed for NN (QT = 45.82, p < 
.001) among infant/toddler studies and for HF (QT = 61.15, p < .001) and LF (QT = 12.36, 
p < .05) among child/adolescent studies that had longer ECG recording durations, 
indicating that further moderator analyses are required. 
Analyzing the same ECG recording duration across study follow-up assessments, 
compared to different recording durations, was associated with significantly higher NN 
(Z = 0.38 vs. 0.12; QM = 5.72, p = 0.017) and HF (Z = 0.45 vs. 0.33; QM = 5.13, p = 
0.024) reliability among infant/toddler studies. As well, infant/toddler studies that derived 
HF using the mean of two or more ECG analysis epochs (i.e., by segmenting a single 
ECG recording duration into shorter, sequential epochs) yielded significantly higher 
reliability compared to studies that derived HF using the mean of a single ECG epoch (Z 
= 0.46 vs. 0.25; QM = 5.41, p = 0.020). Results from infant/toddler studies provided 
partial support for the hypothesis that analyzing consistent ECG recording durations 
across follow-up assessments is associated with higher HRV reliability, and for the 
hypothesis that analyzing HRV from shorter ECG epochs is associated with higher HRV 
reliability. In the child/adolescent studies, all but one analyzed the same ECG recording 
duration across study follow-up assessments. As well, no difference in HF reliability was 
found between studies that analyzed two or more ECG epochs compared to studies that 
62 
 
analyzed a single epoch. Results from child/adolescent studies did not provide support for 
the hypothesis that analyzing consistent ECG recording durations across follow-up 
assessments is associated with higher HRV reliability, or for the hypothesis that 
analyzing HRV from shorter ECG epochs is associated with higher HRV reliability 
Selection of an HRV frequency bandwidth consistent with published guidelines 
and recommendations, compared to an alternative frequency bandwidth, yielded 
significantly higher HF reliability among child/adolescent studies (Z = 0.86 vs. 0.38; QM 
= 16.49, p < 0.001); no association with HF was observed among infant/toddler studies. 
LF reliability was not significantly associated with frequency bandwidth selection among 
child/adolescent studies; however, effect sizes for LF reliability were larger when studies 
selected a frequency bandwidth consistent with published guidelines and 
recommendations, relative to studies that selected an alternative frequency bandwidth (Z 
= 0.61 vs. 0.39). Results from infant/toddler studies did not support the hypothesis that 
selecting a frequency bandwidth consistent with published guidelines and 
recommendations is associated with higher HRV reliability, and instead suggested that 
HF reliability among infant/toddler studies was robust to frequency bandwidth selection. 
Results from child/adolescent studies provided partial support for the hypothesis that 
frequency bandwidth selection is associated with higher HRV (i.e., HF) reliability. 
Study Quality  
Ten dimensions of study quality were rated dichotomously and summed to yield a 
quality rating. Study quality variables associated with continuous data were dichotomized 
based on the median value of included studies. Study quality dimensions included: (1) 
explicit exclusion criteria for medical illness (28.3%); (2) explicit exclusion criteria for  
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prescription medication use (10.9%); (3) sample size of ≥ 50 participants (43.5%); (4) 
specified at least one pre-data collection participant instruction (e.g., overnight fast, no 
exercise 12 hr prior to data collection; 19.6%); (5) included pre-recording acclimatization 
period (32.6%); (6) resting/baseline ECG recording duration ≥ 3.5 min (52.2%); (7) ECG 
recording duration analyzed for HRV ≥ 3 min (50%); (8) identified both ECG recording 
hardware and HRV analysis software (80.4%); (9) explicitly reported both manual editing 
and digital filtering of ECG data (50%); and (10) used recommended, age-appropriate 
HRV frequency bandwidths (50%). Study quality was correlated with reliability effect 
sizes pertaining to the total study follow-up length. If reliability of two or more non-
redundant HRV variables were reported in a given study, Fisher’s Z values were averaged 
to yield one effect size per study. Study quality was not associated with effect sizes 
among infant/toddler studies (M = 3.94, SD = 2.06; r = -0.013, p = .945). Conversely, 
study quality was positively associated with effect sizes among child/adolescent studies 
(M = 4.67, SD = 1.76; r = 0.514, p = 0.050).  
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Study 1: Discussion 
The overarching aim of this meta-analysis was to examine the test-retest 
reliability of time- and frequency-domain HRV measures among pediatric studies. 
Consistent with the main study hypotheses, time- and frequency-domain HRV measures 
displayed moderate test-retest reliability across both age groups. Overall, HRV reliability 
among infant/toddler studies was significantly lower compared to child/adolescent 
studies. Among infant/toddler studies, all effect sizes were in the moderate range; SDNN 
and HF test-retest reliability were similar, while NN was relatively lower in comparison. 
Among child/adolescent studies, all effect sizes were also in the moderate range; HF and 
LF test-retest reliability were similar, while SDNN reliability was relatively higher and 
LF:HF ratio was relatively lower in comparison.  
Several moderating variables influenced HRV reliability. The paucity of study 
information reported by researchers precluded examination of several moderator 
variables of interest. Moderator analyses examined methodological factors relevant to 
study protocol (e.g., study follow-up length, time of ECG recording), sample 
characteristics (e.g., participant exclusion criteria, sample size, proportion of males), 
ECG signal acquisition and pre-processing (e.g., inclusion of a pre-recording 
acclimatization period, editing and filtering techniques), and HRV analyses (e.g., ECG 
recording duration, HRV frequency bandwidth selection).  
Study Protocol  
Longer study follow-up length was associated with decreased reliability for 
SDNN among infant/toddler studies, and decreased reliability of HF and LF among 
child/adolescent studies. Lower test-retest reliability with longer study follow-up lengths 
is not unexpected given basic psychometric principles (c.f., Cohen & Swerdlik, 2002). 
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The impact of age-related increases in HRV across childhood, which in part reflects 
physiological changes in the complexity of autonomic cardiovascular control, offers a 
plausible explanation for decreasing reliability with longer study follow-up lengths (i.e., 
longer test-retest intervals). For instance, Gentzler and colleagues (2012) obtained almost 
yearly measures of HF from children across 8 years and yielded one of the lowest effect 
sizes among child/adolescent studies, whereas effect sizes among studies that spanned 
from 1 week to 4 years were typically more homogeneous. One reason why study follow-
up length was not associated with HF reliability among infant/toddler studies could be 
related to study methodology in the derivation of HF. Infant/toddler studies typically 
derived HF using Porges’ (1985) moving polynomial filter, which can account for slow 
periodic processes and non-stationarity in the ECG data by excluding background sources 
of variance. Conversely, child/adolescent studies typically derived HF using spectral 
analysis techniques (e.g., fast Fourier transformation) or the peak-valley method (i.e., 
obtaining the difference in mean NN-intervals during inspiration and expiration between 
consecutive respiratory cycles; El-Sheikh, 2005). Given that these analytical methods do 
not inherently account for heart rate, this may explain why HF among child/adolescent 
studies was less reproducible across longer test-retest intervals. Application of a moving 
polynomial filter could contribute to more reproducible measures of HF by accounting 
for developmental changes in heart rate activity over longer test-retest intervals (e.g., 
among newborns followed-up after several months or years). Heart rate is one of many 
physiological changes that occur as children grow, decreasing from infancy. This change 
in heart rate likely contributes to the reproducibility of HRV, and should thus be 
considered when HRV is examined longitudinally in children. Given that longer study 
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follow-up length was associated with lower HF reliability among studies that typically 
did not account for heart rate, an examination of long-term HF reproducibility using 
measures derived with and without a moving polynomial filter as compared to HF 
derived with and without statistically controlling for heart rate may be warranted. 
Meta-analytic results indicated that limiting ECG recording to morning hours or 
using identical time-of-day of ECG recording for both study assessments was not 
associated with HF reliability, across either age group. However, based on limited data, 
reliability of SDNN and LF was higher among child/adolescent studies that used identical 
time-of-day of ECG recording for both study assessments relative to studies that did not. 
Circadian variation in HRV (i.e., greater sympathetic dominance in morning, 
parasympathetic dominance in evening/sleep) has been observed in infants 
(Hoppenbrouwers et al., 2012) and children (Massin et al., 2000; Rabbia et al., 2003). 
However, results provided only partial support for the hypothesis that controlling 
potential circadian confounds to HRV (i.e., maintaining an identical time of ECG 
recording for all participants across follow-up assessments) augments reliability. Other 
results from this meta-analysis indicated that among infant/toddler studies that recorded 
ECG during daytime hours, HF reliability was higher for those studies that exclusively 
contained awake ECG data compared to those that contained mixed awake/asleep 
recordings (i.e., studies that did not restrict participants from falling asleep during ECG 
recording). It is likely that infant/toddler studies that examined HF using combined 
awake/asleep data were unable to replicate the initial recording conditions at study 
follow-up, such that a different subset of participants may have fallen asleep at each 
study assessment. Long-term and overnight HRV recordings have been considered better 
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predictors of all-cause morbidity and mortality compared to short-term daytime measures 
(e.g., Ernst, 2014) that are less able to capture fluctuations in HRV between periods of 
wakefulness and sleep. The present meta-analysis could not thoroughly examine whether 
circadian factors affect HRV psychometrics. As such, future studies should consider 
examining repeated full day (i.e., 24-hr) and separate 12-hr (e.g., day-time vs. overnight) 
ECG recordings to better elucidate circadian factors, which may influence HRV 
reliability. Namely, considering the observed variations in autonomic activity throughout 
a 24-hr period (e.g., Guo & Stein, 2003; Huikruri et al., 1990), an examination of whether 
reliability changes based on the specific time of ECG recording could help determine 
whether some HRV variables (e.g., LF) are more reliable when consistently measured in 
the morning versus others (e.g., HF) that are measured in the evening.   
Sample Characteristics 
Sample exclusion criteria selected by researchers were another study protocol 
moderator that influenced HRV test-retest reliability. Increased sample homogeneity, 
attributable to the defined participant exclusion criteria, was typically associated with 
higher NN reliability and lower HF reliability among infant/toddler studies. HF reliability 
among child/adolescent studies with sample exclusion criteria did not differ from studies 
without exclusion criteria, suggesting that HF from children and adolescents, but not 
infants and toddlers, is more robust to reduced sample homogeneity. Infant/toddler 
studies that excluded participants based on prescription medication use, chronic illnesses, 
or low birth weight yielded higher NN reliability; exclusions based on medication use 
demonstrated the strongest effect on NN reliability (Zexclusion reported = 0.61 vs. Zunmentioned = 
0.23) relative to other exclusion criteria. Several medications and illnesses have been 
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associated with changes in sympathovagal balance (i.e., sympathetic hyperactivity and/or 
parasympathetic hypoactivity) among adults and children (e.g., Buchhorn et al., 2012; 
Earnst, 2014; Task Force, 1996). Given that NN is influenced by both sympathetic and 
parasympathetic autonomic branches, excluding participants who consume medications 
or have compromised health status from an otherwise healthy sample would help 
eliminate an additional source of variance in measures of heart rate and improve NN 
reliability. Conversely, studies that excluded participants based on prescription 
medication use had relatively lower HF reliability across both age groups; exclusion due 
to presence of a medical illness was not associated with HF reliability among 
child/adolescent studies. This result for medication exclusions and HF reliability among 
infant/toddler studies was paradoxical given results for NN; however, only two studies 
among both age groups reported this exclusion, and effect size confidence intervals were 
largely overlapping. As such, results provided only partial support for the hypothesis that 
increased sample homogeneity augments HRV reliability. It is recommended that future 
researchers examine the cross-sectional and longitudinal effects on HRV attributed to 
illnesses common to younger individuals and prescription medications typically 
prescribed to children. This would help determine if excluding participants based on 
certain illnesses or medications have a greater impact on HRV reliability compared to 
others.  
Sex was a significant moderator of HRV reliability across both age groups, albeit 
in different ways. Studies with a greater proportion of male participants yielded higher 
NN reliability among infant/toddler studies, yet lower HF and LF reliability among 
child/adolescent studies. These child/adolescent results are seemingly consistent with 
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adult findings of lower HRV reliability among males relative to females (e.g., Sookan & 
McKune, 2012). Current thinking is that sex differences in HRV result from greater 
sympathetic dominance among males relative to females. Indeed, females are commonly 
reported as having greater mean-level HF and yield greater HF reliability relative to 
males, although these findings are not consistent (e.g., El-Sheikh, 2005). Biologically, 
sex differences in HRV reliability may be associated with hormonal differences related to 
pubertal development (e.g., sympathetic alterations in response to increased concentration 
of estrogen; Kajantie & Phillips, 2006; Ordaz & Luna, 2012; Shirtcliff, Dahl, & Pollak, 
2009). As girls typically begin puberty approximately 2–3 years earlier than boys (Patton 
& Vines, 2007; Shaffer, Wood & Willoughby, 2005), sex differences in HRV reliability 
may become more pertinent as children achieve greater sexual maturation. For example, 
Silvetti and colleagues (2001) demonstrated that young boys have higher mean-level 
values of SDNN, rMSSD, and pNN50 relative to young girls, while adolescent boys have 
lower mean-level values of SDNN, rMSSD, and pNN50 relative to adolescent girls. 
However, Jarrin and colleagues (In press) demonstrated that pubertal onset (as indicated 
by measures of gonadarche and adrenarche) was negatively associated with rMSSD, 
pNN50, and HF, and positively associated with LF:HF ratio, suggesting that a more 
thorough examination of the associations between pubertal status, related hormone levels, 
and HRV reliability among youth may be warranted. As such, future studies should 
specifically examine sex differences in HRV reliability among children across different 
stages of puberty (e.g., pre-pubertal vs. mid-pubertal vs. post-pubertal) to better 
determine whether pubertal development can account for observed sex differences. 
Further, examining sex differences using 24-hr ECG data can help elucidate any possible 
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interactions between sex and circadian fluctuations in HRV. One simple recommendation 
to evaluate the role of sex on the psychometric properties of HRV measures would be for 
researchers to present sex-stratified analyses.  
ECG Signal Acquisition and Pre-Processing. 
Inclusion of a pre-recording acclimatization (i.e., habituation) period was a 
significant moderator of HRV reliability. Reporting an acclimatization period was 
associated with significantly higher NN reliability among infant/toddler studies and 
significantly higher HF and LF reliability among child/adolescent studies compared to 
studies that did not report this detail. As well, higher SDNN reliability across both age 
groups and higher LF:HF ratio reliability among child/adolescent studies was observed 
among those studies that included a pre-recording acclimatization period relative to 
studies that did not. Studies that reported an acclimatization period typically yielded the 
largest effect sizes and associated failsafe Ns relative to studies that did not, and relative 
to many of the other examined moderators. Further, while the QT statistic indicated that 
significant heterogeneity remained for HF among child/adolescent studies that reported 
an acclimatization period, the QT for LF among child/adolescent studies and for NN 
among infant/toddler studies indicated homogenous effect sizes. Results largely 
supported the hypothesis that allowing participants to habituate prior to data collection, as 
recommended by HRV measurement guidelines (e.g., Berntson et al., 1997), improves 
HRV reliability. Notably, given that the duration of the acclimatization periods reported 
by included studies was typically 5 min or less among infant/toddler studies and 10 min 
or less among child/adolescent studies, allowing even a brief habituation period prior to 
data collection may be sufficient to stabilize HRV and augment reliability. Obtaining 
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stable baseline HRV data is important for examining resting autonomic cardiovascular 
control and HRV reactivity to experimental stressors. Participants who are acclimated to 
experimental conditions prior to data collection would likely yield more reliable data 
because individual differences in physiological reactivity to experimental conditions are 
minimized (i.e., stress-related increases in sympathetic or respiratory activity; e.g., 
Ottaviani & Shapiro, 2011; Salomon, Matthews, & Allen, 2000; Traina, Cataldo, Galullo, 
& Russo, 2011). Conversely, participants who are not acclimated may yield less stable 
HRV measures, which in turn, would distort mean-level values and decrease test-retest 
reliability. Including a pre-recording acclimatization period may be especially pertinent 
for very young children, who may be more reactive to the unfamiliar relative to older 
children or adolescents. Thus, the results of this meta-analysis suggest pediatric 
researchers can improve HRV reliability by providing participants time to acclimate to 
their surroundings. Future researchers should consider examining HRV reliability among 
groups given different durations of time in which to acclimate prior to data collection. 
This would help determine if there is a minimum “acclimatization threshold” in children 
that could allow for the most reliable measures to be obtained; examining this between 
children of different ages would help to further elucidate whether the duration of optimal 
habituation changes across childhood development. 
The posture in which HRV was recorded influenced HRV reliability. Specifically, 
infant/toddler NN and HF reliability was higher for measures obtained in seated postures 
and lowest when posture changed between study recordings. Child/adolescent HF 
reliability was relatively higher among studies that recorded ECG in a seated, rather than 
a supine or an unmentioned posture. These observations are consistent with Young and 
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Leicht (2011), who demonstrated that adult HF reliability was higher in seated versus 
standing postures. Children who are asked to maintain a standing posture and remain still 
for a baseline ECG recording, even for a recording of only 3- to 5-min, may become 
more restless/fatigued compared to maintaining a seated posture; increased restlessness 
during the baseline recording could reduce the stationarity of heart rate signals, which 
could reduce reliability. Further, given that pharmacological blockade studies suggest that 
sympathetic dominance is augmented with increasing orthostatic load (e.g., standing vs, 
supine postures, Cacioppo et al., 1994), it may be that HF is more reliably measured in 
seated or supine, relative to standing, postures because it is in these postures that 
parasympathetic dominance is more readily observed. Relatedly, LF (which in part 
reflects sympathetic modulation) may be more reliably measured in a posture that reflects 
greater sympathetic, opposed to parasympathetic dominance; indeed, although it could 
not be tested statistically given the available data, LF reliability was higher when 
measured in a seated, relative to a supine position (see Table 7). Head-up-tilt paradigms 
are useful for determining the influence of posture on HRV, but are more commonly 
employed among the adult, compared to child HRV literature. Thus, future researchers 
should examine reliability of pediatric HRV using postural paradigms (e.g., head-up-tilt) 
to help improve the collective understanding of how HRV reliability among children is 
impacted by postural position. 
Very few studies reported ECG sampling rate, which precluded meaningful 
examination of whether sampling rate was associated HRV test-retest reliability. 
Infant/toddler HF reliability was higher among studies that did not report a sampling rate 
compared to studies that used a sampling rate < 500 Hz, while child/adolescent HF and 
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LF reliability was higher among studies that used a sampling rate ≥ 500 Hz relative to 
studies that did not report a sampling rate. Thus, conclusions about these results must be 
made with caution. Notedly, less than 20% (k = 5) of infant/toddler studies reporting HF 
explicitly detailed the ECG sampling rate. The minimal detailing of ECG sampling rate 
reflects an important gap in reporting practices among the pediatric, relative to the adult 
literature. HRV measurement guidelines (Berntson et al., 1997; Task Force, 1996) and 
findings described among the wider HRV methodology literature (e.g., Hejjel & Roth, 
2004; Merri et al., 1990; Riniolo & Porges, 1997; Singh et al., 2004), articulate the 
importance of using an "adequate" ECG sampling rate for both interpretive and study 
replication purposes. ECG sampling rate defines the minimal R-wave oscillation 
amplitude that can be detected within a heart rate recording, and is thus pertinent to 
accurate measurement of NN-interval data. It is possible that an “adequate” sampling rate 
may be age- or sample-specific (i.e., a different sampling rate may be required for infants 
who have faster heart rates compared to adults or to those with cardiovascular 
morbidities; Singh et al., 2004). Thus, there may be a threshold in R-wave detection 
across different age groups that can only be accommodated through application of an 
appropriate ECG sampling rate. As newer ECG hardware becomes available, many with 
different sampling rates (e.g., 128 Hz, 500 Hz, 1000 Hz), it will be important for future 
studies to examine the association between ECG sampling rate and HRV reliability.  
Editing of ECG data was associated with HRV reliability. Among infant/toddler 
studies, manual editing of ECG data was associated with higher NN reliability, while 
software-based filtering was associated with higher HF reliability. In contrast, 
child/adolescent studies that reported manual editing and software-based filtering did not 
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yield higher reliability compared to child/adolescent studies that did not report these 
details. The presence of artifacts and recording errors can significantly lengthen or 
shorten NN-intervals, distort variability, and vastly inflate measures of HRV (Bernston & 
Stowell, 1998; Mulder, 1992). Considering this, lower reliability of NN with unedited 
data is not unexpected. The higher reliability of HF associated with filtering ECG data 
among infant/toddler, but not child/adolescent studies could be attributed to differences in 
heart rate activity between the two groups. Given that infants and toddlers have faster 
heart rates compared to children and adolescents, ECG recordings from infants and 
toddlers may be more sensitive to aberrations in NN-interval data due to ectopic 
heartbeats or other artifacts (e.g., movement) that distort measures of HF and hinder 
reproducibility. As most infant/toddler studies applied a moving polynomial filter 
(Porges, 1985) to NN-interval data, extraneous variance heart rate measures attributed to 
artifacts (e.g., distortions in HF due to spectral leakage) or recording errors associated 
with poor data resolution (e.g., inadequate ECG sampling rates) may have been better 
accounted for among these studies compared to others that did not apply this filter. 
Editing and filtering of ECG data were not associated with HF reliability among 
child/adolescent studies, which suggests that HF reliability among children and 
adolescents is robust to unedited or unfiltered NN-interval data. It is possible that ECG 
recordings from children and adolescents exhibit greater inherent stationarity, which 
reduces the need for the same degree of data cleaning relative to ECG recordings from 
infants and toddlers. Thus, results from infant/toddler studies supported the hypothesis 
that carefully applied data cleaning procedures (i.e., editing/filtering) is associated with 
better HRV reliability. Notedly, given limited available data, nested analyses of reliability 
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(e.g., between studies that reported either manual/software or no editing at all; between 
studies that each reported different software-based filters) could not be performed. 
Studies that examine the effect of editing and filtering NN-interval data are available, 
however they are predominantly focused on either simulated or adult-derived ECG data. 
As such, it is recommended that future studies more thoroughly examine how different 
degrees of editing and filtering affects reliability of HRV measures obtained from NN-
interval data collected from pediatric samples. 
HRV Analysis  
Longer ECG recording duration was associated with lower NN reliability among 
infant/toddler studies, and higher HF and LF reliability among child/adolescent studies. 
Further, longer ECG recording duration was associated with lower LF:HF ratio reliability 
among child/adolescent studies, which is a paradoxical finding given the results for HF 
and LF. Infant/toddler studies typically used 2- to 5-min ECG recordings for HRV 
analysis, whereas child/adolescent studies typically used 3-min recordings. While these 
recording durations do not conform to the typical 5-min standard, results of this meta-
analysis suggest that HF can be reliably measured even when a recording of only 2 or 3 
min is obtained. The observed LF results are consistent with Marks and Lightfoot (1999), 
who demonstrated greater LF reliability when measures were derived from repeated 5-
min, compared to 2.5-min ECG recordings. Deriving reliable measures of LF requires 
longer ECG recordings than HF because low-frequency heart rate oscillations typically 
occur in intervals of 5-min or greater (Heathers, 2014; Kleiger et al., 2005). While longer 
ECG recordings can produce more reliable measures of HF and LF, the reduced 
reliability of LF:HF ratio with longer ECG recordings may reflect how the relative 
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contributions of HF and LF activity across a longer period of time (e.g., longer ECG 
recording) are less easily replicated upon study follow-up. However, results for LF:HF 
ratio must be interpreted with caution as only three studies contributed data for LF:HF 
ratio reliability; among these, the study with the longest ECG recording duration had the 
lowest effect size, and vice versa. Meta-analytic results also indicated that HF reliability 
among infant/toddler studies was higher when measures were derived using the mean of 
multiple ECG analysis epochs (relative to a single, longer ECG epoch or to studies that 
did not report a derivation method); similar results were not observed among 
child/adolescent studies. Among studies reporting this information, 30-sec epochs were 
typically used for both age groups. Results for studies that used multiple, shorter epochs 
were consistent with earlier findings from infant (Richards, 1995) and adult studies 
(McNames & Aboy, 2006). Shorter epochs are less contaminated by artifacts and 
recording errors that could distort measures and hinder reliability. As such, the use of 
multiple epochs for HF among infant/toddler studies may have better accounted for the 
presence of artifacts and recording errors, which increase variance in the measure. Given 
that HF reliability among infant/toddler studies was not associated with ECG recording 
duration, but was associated with the use of multiple epochs, it is possible that HRV 
reliability is influenced by an interaction between ECG recording duration and the HRV 
derivation method (e.g., better reliability among studies with both longer ECG recording 
durations and more ECG epochs). This could be tested using nested analyses; however, 
this was not possible in the present study due to limited available data. As such, it will be 
important for pediatric researchers to further examine how HRV reliability is impacted by 
deriving measures using multiple ECG recording durations (e.g., 5 min, 10 min, 15 min), 
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multiple data reduction techniques (e.g., mean of 2 epochs vs. mean of 10 epochs), and 
any interactions between the two. This will help inform decisions regarding optimal ECG 
recordings for pediatric HRV research, and extend available HRV guidelines.    
Selection of an HRV frequency bandwidth consistent with available guidelines 
and recommendations did not impact HF reliability among infant/toddler studies, but was 
associated with higher HF reliability among child/adolescent studies; effect sizes for LF 
reliability among child/adolescent studies were higher when a recommended frequency 
bandwidth was used relative to when an alternative bandwidth was selected. Spectral 
frequency bands determine the measurement boundaries of frequency-domain variables; 
if variability is above or below the frequency bandwidth cut-offs, results will provide less 
accurate estimates of autonomic cardiovascular control. Notably, published 
recommendations for HRV frequency bandwidths appropriate for pediatric studies only 
exist for HF among infants and toddlers up to 4-years-old (i.e., HF 0.24–1.04 Hz for 
children under 4-yrs; HF 0.20–1.20 Hz or 0.30–1.30 Hz for infants; Bar-Haim et al., 
2000; Fox & Porges, 1985); as such, most HRV studies with children and adolescents use 
adult frequency bandwidths (i.e., HF 0.15–0.40 Hz, LF 0.04–0.15 Hz; Berntson et al., 
1997; Task Force, 1996). Frequency bandwidth selection may not have affected 
reliability across infant/toddler studies because the wider bandwidths used among this 
age group accounted for heart period variance attributed to faster and more chaotic 
cardiovascular and respiratory patterns. Relatedly, the prominent use of a moving 
polynomial filter when deriving HF among infant/toddler studies, compared to 
child/adolescent studies that did not typically use this same filter, may have further 
influenced the present results. Among child/adolescent studies, those that used the HF 
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frequency bandwidth recommended for adults yielded higher HF reliability compared to 
studies that used a narrower bandwidth to account for paced breathing (e.g., 0.20–30 Hz; 
Mezzacappa et al., 1997) or a wider bandwidth to account for a broader sample age-range 
(e.g., 0.20–1.00 Hz; Gentzler et al., 2012). Although the influence of other 
methodological factors across included studies must be considered, this result suggested 
that the HF bandwidth recommended for adults may be suitable for deriving reliable 
measures of HRV among samples of children and adolescents. However, limited 
available data among child/adolescent studies precluded an examination of whether 
reliability would differ between studies that applied frequency bandwidths, which were 
wider or narrower than those recommended for adults. Examining such nuances in HRV 
measurement among pediatric studies can help maximize the psychometrics and 
interpretability of HRV data obtained from children and adolescents. Overall, results 
suggested that frequency bandwidth selection is pertinent to obtaining reliable measures 
of spectral HRV among children and adolescents. However, although this study 
demonstrated that use of adult HRV bandwidths (opposed to an alternative) was 
associated with higher reliability, this result does not imply that HRV measures derived 
using adult frequency bandwidths are necessarily valid. Given that frequency bandwidth 
recommendations are currently available only for adults and for infants/young children, 
the lack of frequency bandwidth recommendations for use among children and 
adolescents is a notable gap in the literature. It is recommended that future research 
examine cross-sectional and longitudinal HRV measures using a variety of frequency 
bandwidths to determine whether deriving reliable and valid HRV measures from 
children and adolescents requires a unique frequency bandwidth, or whether adult 
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bandwidths are equally appropriate among child and adolescent studies; this may help 
establish recommendations specific to HRV studies with pediatric samples. 
Limitations, Strengths, and Current State of the Literature 
There are four primary limitations of the present meta-analysis that merit 
consideration.  First, results must be interpreted in light of the coding decisions. Namely, 
although multiple variables were initially coded from each included study, the performed 
moderator analyses were restricted due to limited variability. One example is for the 
coding of the time of ECG recording. This moderator was intended to examine reliability 
between studies that recorded ECG in the morning (06:00–12:00), afternoon (12:00–
18:00), and evening (18:00–24:00). However, given that most studies failed to report this 
detail, analyses could only be performed after collapsing this moderator into a 
dichotomous variable (i.e., same vs. different time of ECG recording). Another example 
is for the coding of ECG sampling rate. This moderator was intended to examine 
reliability between studies that used slower (128 Hz, 250 Hz) relative to faster (500 Hz, 
1000 Hz) sampling rates. However, given that most studies also failed to report this 
detail, analyses could only be performed after collapsing this moderator into a 
dichotomous variable (< 500 Hz, ≥ 500 Hz). As such, several moderator variables were 
collapsed into categories that were more restricted than initially planned; this precluded a 
more comprehensive examination of how such factors influence test-retest reliability, and 
restricted testing of several specific hypotheses. Given that few included studies reported 
target methodological factors, the decision to collapse several moderators into 
dichotomous variables was warranted. Remaining coding decisions were developed in 
accordance with considerations for HRV measurement outlined by published guidelines 
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and recommendations (e.g., Bar-Haim et al., 2000; Berntson et al., 1997; Task Force, 
1996), common methodology among the pediatric HRV literature, and decisions of 
similar methodological reviews (Heathers, 2014). However, given that most published 
HRV guidelines are specific to adults, other moderator variables were coded to reflect 
available standards. For example, while selection of HRV frequency bandwidths is key to 
obtaining valid and reliable frequency-domain HRV variables, bandwidths specific to 
children and adolescents are not available. As such, reliability among child/adolescent 
studies in the context of frequency bandwidth selection could only be examined in 
relation to adult standards. Further, as many studies did not report this detail, frequency 
bandwidth could only be examined using a collapsed, dichotomized (appropriate vs. 
alternative frequency bandwidth) variable, instead of examining reliability between 
studies that used wider or narrower frequency bandwidths than recommended. Collapsing 
of moderators into smaller, more broad categories was a noted limitation of this meta-
analysis; however, doing so allowed for meaningful examinations of reliability 
moderators to be conducted. As such, future meta-analyses should attempt to replicate 
this coding strategy to examine whether the same moderator categories used here are 
similarly meaningful among a different sample of longitudinal HRV studies.  
Second, the focus on time- and frequency-domain measures precluded an 
examination of several moderator variables. Time- and frequency-domain measures are 
only two of several analytical methods for quantifying HRV. HRV measures derived 
from geometric (e.g., triangular index), wavelet-based (e.g., wavelet coefficient), and 
entropy-based (e.g., approximate entropy) analyses provide alternative perspectives of 
autonomic cardiovascular control, have different analytical assumptions, and have also 
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been associated with health outcomes (e.g., Kleiger et al., 2005). However, it remains to 
be determined whether these alternative HRV analytic methods yield data with greater 
predictive validity for future health outcomes relative to time- and frequency-domain 
measures. There are many more studies across the HRV literature that measure and 
discuss time- and frequency-domain HRV measures relative to available alternatives. 
Thus, the decision to examine only time- and frequency-domain HRV measures in this 
meta-analysis was made to accommodate an examination of HRV variables most 
commonly reported in the pediatric literature. However, future meta-analytic studies 
could perhaps avoid this limitation by examining reliability of alternative HRV measures 
beyond time- and frequency-domain indices. In addition to providing more data that can 
be used for moderator analyses in future meta-analytic studies, including a broader 
selection of HRV measures, other than time- and frequency-domain indices, would allow 
for a suitable way to compare psychometric properties of HRV derived from different 
techniques (e.g., frequency-domain vs. wavelet analysis). In turn, this would also allow 
for more comprehensive analyses of HRV reliability 
Third, examination of included studies using fixed-effects meta-analytic models 
may limit the generalizability of these results. A random-effects model assumes that 
variability in effect sizes is due to both random variance and sampling error, and also 
produces wider confidence intervals (Rosenberg et al., 2000). Thus, a random-effects 
model may have allowed for greater generalizability of these results to other time- and 
frequency-domain HRV studies. The present analyses used a fixed-effects model with 
non-redundant study effect sizes. Upon comparison of these results with those obtained 
using random-effects models, three overarching differences were observed between the 
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two sets of analyses (data not shown for parsimony). First, while moderate HRV 
reliability was still demonstrated, there were often slight differences in the mean effect 
size across many analyses; effect sizes from random-effects models were typically, but 
not consistently smaller than those produced using fixed-effects models. Second, 
heterogeneity statistics were typically not statistically significant among random-effects 
analyses, suggesting greater homogeneity of effect sizes across included studies. Finally, 
while some moderator analyses yielded significant results regardless of the meta-analytic 
model used (e.g., pre-recording acclimatization period for NN among infant/toddler 
studies, frequency bandwidth selection for HF among child/adolescent studies), several of 
the moderator analyses that were significant among fixed-effects models were no longer 
significant among random-effects models. However, methodological moderators that 
were not significant among fixed-effects models typically remained as such when 
examined using random-effects models. The differing sets of results between the two 
meta-analytic models suggest that caution regarding Type I error is warranted. Namely, 
while these results still indicated moderate test-retest reliability, results may only be 
applicable to the examined studies, and not a wider population of studies. However, this 
consideration does not necessarily nullify the observations and inferences made herein. 
For instance, it is possible that non-significant results observed across all analyses signify 
a robust lack of effect between certain moderators and HRV reliability. Given that the 
moderator variables chosen for this study reflect constructs that are conceptually 
meaningful for HRV research, it is almost equally relevant to understand which 
methodological factors are, and are not salient to producing reliable HRV data. The 
included moderators were coded to reflect a small number of methodological conditions 
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that were believed to capture all possible options represented in the extant HRV literature 
(e.g., specified vs. unspecified exclusion criteria; similar vs. dissimilar ECG recording 
durations). As such, a fixed-effects meta-analytic model was considered appropriate, 
given the nature of the data. Future meta-analyses of HRV reliability should consider 
replicating this comparative analytic strategy (i.e., fixed- vs. random-effects models) to 
determine whether these results are robust among a different sample of longitudinal HRV 
studies. 
Finally, as indicated above, the minimal reporting of pertinent methodological 
details among included studies restricted the number of moderator analyses that could be 
performed. This precluded an examination of several study hypotheses across one or both 
age groups, but also speaks to the current state of the wider pediatric HRV literature. 
Included studies failed to report essential study protocol (e.g., time of ECG recording), 
sample (e.g., participant ethnicity, anthropometrics, sample attrition), or technical details 
(e.g., ECG sampling rate, editing/filtering). Relatedly, the majority of included studies 
exclusively reported HF. It is generally established that HF is a strong predictor of health 
and development among pediatric and adult participants; as such, it is understandable 
(i.e., for comparative reasons) that HF is the most commonly reported HRV variable 
among pediatric studies. Increased reporting of other time- and frequency-domain 
variables (e.g., SDANN, rMSSD, VLF) and methodological details associated with their 
measurement among the pediatric literature can provide additional information about 
physiological (i.e., autonomic, circadian, hormonal) mechanisms that influence 
autonomic cardiovascular control in children. Importantly, the minimal reporting 
practices observed among included pediatric studies precluded an examination of nested 
84 
 
analyses (i.e., moderators of moderators). The present study examined test-retest 
reliability in the context of several moderator variables, some of which were pertinent to 
reliability among studies in both age groups. However, due to limited available data, 
moderator variables were examined in isolation of one another. Thus, because many 
studies reported such minimal methodological information, potentially important 
interactions between the examined moderators could not be examined. Such 
methodological interactions may also be pertinent to HRV reliability. The examination of 
nested analyses was warranted in this meta-analysis because significant heterogeneity 
remained evident following many of the included moderator analyses. This heterogeneity 
suggests that there was additional variability among effect sizes that had yet to be 
explained. Several nested analyses appeared particularly relevant and would help to 
elucidate whether one moderator had more of an impact on reliability than another. For 
example, the present meta-analysis was unable to examine whether studies that included 
a pre-recording acclimatization period (a key moderator of HRV reliability observed in 
this study) yielded higher reliability of HF among longer (e.g., ≥ 1 year) relative to 
shorter (e.g., ≤ 1 month) studies, or whether further differences existed between the two 
age groups. As another example, many of the factors associated with HRV reliability 
pertained to the control of variance attributed to heart rate activity; in many cases among 
infant/toddler studies, use of Porges’ (1985) moving polynomial filter was proposed as a 
methodological explanation for why HF reliability among infant/toddler studies was more 
robust to certain moderator variables (e.g., study follow-up length, use of software-based 
filters) relative to other HRV variables, or to HF among child/adolescent studies. As 
such, it would have been pertinent to conduct a nested analysis between studies that did 
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and did not apply this filter, and examine whether additional moderator analyses could 
account for remaining heterogeneity among effect sizes. In addition to the limitations 
posed for the present meta-analysis, minimal reporting of pertinent methodological 
details observed among included studies maintains previously noted gaps in the pediatric 
HRV literature. Taken together, observations from this research suggest that HRV studies 
among the pediatric literature would benefit from augmented reporting practices of key 
methodological and analytical details. More rigorous reporting of methodological and 
analytical details would increase the interpretability and replicability of published 
findings, and allow for more comprehensive and meaningful meta-analyses to be 
conducted in the future.  
There are five noted strengths in the present meta-analysis. First, to the best of our 
knowledge, this is the only available meta-analysis of HRV test-retest reliability among 
pediatric samples. Thus, the present study has potential to contribute important new 
knowledge to the field of HRV research. Primarily, the present study identified pertinent 
methodological considerations for obtaining reliable HRV measures among infants, 
children, and adolescents. Similar examinations do not appear available even in the adult 
HRV literature; while a quantitative review of HRV methodology was recently published 
(Heathers, 2014), it was not a meta-analysis, and the studies consisted only of adult HRV 
data specific to frequency-domain analyses. As such, pediatric HRV researchers can use 
the empirical data reported herein to guide the design of future studies in a way that helps 
produce more reliable and stable measures of HRV. Second, examined moderator 
variables largely reflected methodological factors that merit consideration by researchers 
before collected ECG data is analyzed for HRV. Namely, examined factors related to 
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study design (e.g., study follow-up length), participant recruitment (e.g., exclusion 
criteria), and ECG signal processing (e.g., editing and filtering, frequency bandwidth 
selection) are factors that are relevant to most HRV research contexts, regardless of the 
analytical method used to actually derive HRV (e.g., frequency-domain analysis, 
Poincare plot analysis). Thus, it is plausible that results from this study are generalizable 
to the wider HRV literature (e.g., adult studies), and may not necessarily be specific to 
reliability of pediatric measures of time- and frequency-domain HRV. Third, the 
identification and selection of studies for this meta-analysis, as well as relevant 
moderators, were determined from a comprehensive and systematic review of the extant 
(pediatric) HRV literature; as such, this meta-analysis included a broad selection of 
relevant pediatric studies and potential moderators of HRV reliability. Fourth, excellent 
coding fidelity of included studies was established following the blind re-coding of 
articles by an independent rater; thus, coding decisions were adequately objective and 
reproducible. Finally, reliability was examined using both non-redundant and redundant 
effect sizes, which yielded largely similar results across most analyses between the two.  
Conclusion 
Taken together, HRV is a reliable measure of autonomic cardiovascular control 
among pediatric samples. Several moderator variables were found to influence HRV 
reliability among both infant/toddler and child/adolescent studies. Notedly, this meta-
analysis demonstrated three key findings that appear most pertinent to pediatric HRV 
research. First, HRV reliability was higher and more robust to differences in study 
methodology among samples of children and adolescents relative to infants and toddlers. 
Second, methodological factors that control for extraneous variance attributed to heart 
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rate are pertinent to obtaining reproducible measures of HRV, particularly among 
samples of infants and toddlers who have faster and more chaotic heart rate activity 
relative to older children and adolescents. For instance, if participants are unable to 
habituate to experimental conditions or they are asked to maintain a posture that increases 
orthostatic stress during data collection, obtained ECG data would likely be contaminated 
by stress-related increases in heart rate, which in turn would distort mean-level estimates 
of HRV and limit reproducibility. Moreover, studies that do not properly edit or filter 
their ECG data for aberrations are likely to produce less reliable measures because the 
background influences of heart rate are not accounted for. Third, the pediatric HRV 
literature is notably restricted in its reporting of key methodological and technical details 
relative to the adult HRV literature; many of these details pertain to recommendations for 
improved inter-study consistency, as outlined by published HRV guidelines, and are 
important for interpretability and replicability of study findings. Further, as significant 
heterogeneity was observed across several analyses, including those wherein significant 
differences in reliability were identified between moderator variables (e.g., study follow-
up length, ECG recording posture, data editing/filtering), the minimal reporting of 
methodological details among examined studies precluded the ability to conduct nested 
analyses, which are important to elucidate whether interactions among the moderator 
variables could help explain remaining heterogeneity among effect sizes.  
As the current study has shown, carefully planned and maintained study 
methodology is an important consideration for obtaining reproducible measures of HRV 
from pediatric samples. However, given that HRV reflects a biological construct, 
methodological characteristics are likely not the only factors that influence the 
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psychometrics of pediatric HRV measures. HRV is mediated by multiple physiological, 
behavioural, and cognitive processes, which develop over time as children grow. 
Considering this it is plausible that internal, biological factors can also influence the 
reproducibility of HRV measures. Thus, in addition to the methodological considerations 
examined in this meta-analysis, it will be important for researchers to examine intra-
individual factors that further moderate reproducibility. In sum, HRV can be reliably 
measured among pediatric samples, but there are likely several additional factors not 
examined in the current study that could explain differences in reliability among HRV 
studies with infants, children, and adolescents. As such, future researchers should 
consider replicating these meta-analytic procedures to examine whether HRV reliability 
is robust among similar moderators, and whether additional heterogeneity among effect 






Study 2: Method 
Cohort Profile 
 Children and their families participated in the QUebec Adipose and Lifestyle 
InvesTigation in Youth (QUALITY) Cohort. The QUALITY Cohort (see Lambert et al., 
2011) included a large sample (N = 632) of children recruited from schools located within 
75 km of Montreal or Quebec City, Quebec, Canada. The overarching aim of the 
QUALITY study was to investigate the natural history of excess weight, including its 
genetic, biological, environmental, and psychosocial determinants, and its related 
cardiometabolic consequences (e.g., autonomic dysfunction, inflammation). Study 
inclusion criteria included having at least one overweight biological parent. Parents were 
defined as overweight with either a self-reported height and weight that yielded a BMI > 
30 kg/m
2
, or a waist circumference > 102 cm in men and > 88 cm in women. To account 
for genetic admixture, children included in QUALITY were limited to those of 
Caucasian, Western European decent. Further exclusion criteria for child participants 
included: (a) previous diagnosis of Type 1 or 2 diabetes; (b) medical or psychological 
condition that compromised ability to participate (i.e., hospitalized within the last month 
for a serious illness; hypertension, renal failure, inflammatory bowel disease); (c) 
restricted low-calorie diet (≤ 600 kcal/day); or (d) medication prescribed for hypertension 
(e.g., thiazides, β-blockers). Informed consent and assent were provided by parents and 
children, respectively. The QUALITY study was approved by the ethics review board of 
Direction Santé Québec, Institut de la Statistique du Québec, and CHU Sainte-Justine 
Hospital (#2040). The present study is based on analyses of QUALITY data; only 





Data for the present study are based on 632 children aged 8 to 10-years-old (M = 
9.60 yrs, SD = 0.92) who participated in the first clinic visit between 2005 and 2008. Of 
these children, 564 (89%) returned for a second clinic visit after 2 years (M = 2.08 yrs, 
SD = 0.16) when they were 10 to 12-years-old (M = 11.66 yrs, SD = 0.94). Attrition was 
due to (a) child refused to participate at second visit (n = 12); (b) families were 
unavailable or could not be located at second visit (n = 21); or, (c) families were no 
longer interested in participating at second visit/other (n = 35). Demographic, 
anthropometric, and cardiovascular measures obtained from QUALITY participants were 
obtained at the Centre hospitalier universitaire Sainte-Justine in Montreal or Hôspital 
Laval in Québec City, Canada. Approximately 81% of participating families resided in 
the greater Montreal area.  
Measures 
 Anthropometrics. Trained research nurses measured participant height, weight, 
and waist circumference. During these measurements, participants were dressed in light 
clothing with their shoes off. Height was measured using a stadiometer during maximal 
inspiration while participants stood against a wall. Weight was measured to the nearest 
0.2 kg using an electronic scale calibrated regularly using a set of standard weights. Waist 
circumference was measured at the end of normal expiration using measuring tape that 
was placed around the narrowest part of the body, midway between the lowest rib cage 
and the iliac crest. Height and waist circumference were each measured in duplicate to 
the nearest 0.1 cm and the mean was obtained; if values differed by more than 0.5 cm, a 
third measure was taken, and the mean of the two closest measurements was obtained. 
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BMI was calculated as weight in kg divided by height in m
2
. Age- and sex-adjusted 
height, weight, and BMI Z-score scores were also derived based on United States Center 
for Disease Control (2000) growth charts. A child was defined as overweight with a BMI 
≥ 85th to < 95th age- and sex-specific percentile, or as obese with a BMI ≥ 95th percentile.  
 Puberty. Trained research nurses measured children’s pubertal status using the 
Tanner puberty staging scale (Marshall & Tanner, 1969, 1970). The Tanner scale is a 5-
point categorical system that classifies physical development in children and adolescents 
using measureable primary and secondary sex characteristics. Criteria used to classify 
Tanner stages were as follows: Tanner 1 (no body hair growth for either sex, no breast 
growth for girls or genital growth for boys); Tanner 2 (indication of body hair growth for 
either sex, indication of breast budding for girls or slight genital growth for boys); Tanner 
3 (body hair is more abundant and more dispersed for either sex, indication of breast 
growth for girls or genital growth for boys); Tanner 4 (body hair has adult appearance but 
is not as abundant and does not extend to the inner thigh for either sex, further breast 
growth for girls or further genital growth for boys); Tanner 5 (complete body hair growth 
that extends to the inner thigh for either sex, adult-sized breasts for girls or adult-sized 
genitals for boys). Physician-rated measures of puberty are generally considered as a 
gold-standard method compared to self- and parent-reported measures (Lee, Valeria, 
Kochman, & Lenders, 2006; Netherton, Goodyer, Tamplin, & Herbert, 2004); given that 
puberty was examined by trained nurses, pubertal status of QUALITY participants was 
measured in accordance with a highly valid methodology.  
Blood pressure. Trained research nurses measured blood pressure (BP) using an 
appropriate-sized occlusion cuff (determined via arm circumference at the midpoint 
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between the acromion [i.e., shoulder blade] and elbow). The occlusion cuff was applied 
to the medial surface of the right arm over the brachial artery. Following a 5-min 
acclimatization period, measures of systolic (SBP) and diastolic (DBP) blood pressure 
were obtained in a seated posture using an oscillometric instrument (model CR9340; 
Dinamap XL, USA). Five consecutive blood pressure readings were obtained at 1-min 
intervals; the mean of the last three measures was used for analysis. Measurement of 
blood pressure was standardized for all participants at both clinic visits to maximize 
stationarity. Validity (Chiolero, Paradis, & Lambert, 2010; Park & Menard, 1998) and 
reliability (Skirton, Chamerlain, Lawson, Ryan, & Young, 2011) of this blood pressure 
instrument have been previously reported.  
Physical activity. As part of a larger questionnaire, children answered questions 
about physical activity. Children rated how much time they spent watching television (in 
hrs) during a typical weekday and a typical weekend. They also rated how frequently 
they engage in physical activity during a typical week using a Likert scale ranging from 1 
(no or very little physical activity) to 5 (frequent or almost daily physical activity). These 
questions were adapted from the International Physical Activity Questionnaire (IPAQ; 
Booth, 2000), an established self-report measure of physical activity with good test-retest 
reliability (r = 0.8) and moderate criterion validity against accelerometer data (r = 0.33; 
Craig et al., 2003). While objective measures of physical activity (e.g., accelerometry) are 
typically preferred over self-report, systematic reviews indicate that youth self-report of 
physical activity demonstrates adequate test-retest reliability (e.g., r > 0.7) and criterion 




Heart Rate Variability  
ECG signal acquisition. ECG was recorded using disposable, pre-gelled snap 
silver/silver-chloride electrodes arranged in a modified lead II configuration. To improve 
signal quality, electrode resistance was minimized (< 10 kO) by pre-cleaning the skin 
using a rubbing alcohol swap; this method is consistent with previous guidelines 
(Hermens, Freriks, Disselhorst-Klug, & Rau, 2000). The active electrode was placed on 
the right clavicle next to the sternum over the first rib between the two collarbones. A 
second electrode was placed on the left mid-clavicular line at the apex of the heart over 
the ninth rib. A ground electrode was placed near the lowest possible right rib on the 
abdomen. Additional impedance (dZ) electrodes were placed over the right fourth 
intercostal space at the sternal edge, the fifth intercostal space at the left axillary line, and 
on the sixth rib in the mid-clavicular line. ECG data were acquired in a seated posture 
using the 8500 Marquette MARS Holter Monitor (GE Marquette Medical Systems, 
Milwaukee, Wisconsin, USA) at a sampling rate of 128 Hz; data were stored on 
frequency-modulated cassettes for later processing.     
 ECG signal processing. ECG data were uploaded to the MARS Holter Analysis 
Workstation (GE Marquette Medical Systems, Milwaukee, Wisconsin, USA) for editing 
and analysis. Data were manually inspected for aberrant heart beats and recording 
artifacts. Beat-to-beat visual inspection of the shape, trend, and length of each QRS-
complex was performed using standard Marquette algorithms. ECG data were also 
verified for accuracy through visual inspection by a board-certified cardiologist. Artifact 
removal was based on a 20% change from the immediately preceding signal (Kleiger, 
Miller, Bigger, & Moss, 1987). A mean of 6.5% and 6.3% of ECG data was removed due 
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to artifacts and errors from recordings obtained at the first and second clinic visits, 
respectively. Artifacts or automatically excluded NN-intervals were corrected using cubic 
spline interpolation (via Marquette algorithms), which replaced missing data points based 
on a minimum of four acceptable surrounding R-peaks. Finally, ECG data were linearly 
detrended, mean-centered, and tapered for spectral leakage using a Hanning window.  
HRV analyses. Measures of HRV were derived for time- and frequency-domain 
variables based on all available ECG data. Time-domain variables included: NN, SDNN, 
rMSSD, and pNN50. Frequency-domain variables, derived using spectral analysis with 
Fast Fourier Transformation, included VLF (0.0033–0.04 Hz), LF (0.04–0.15 Hz), HF 
(0.15–0.40 Hz), and LF:HF Ratio. Heart rate was computed from NN using the following 
equation: 60,000 / NN (Berntson et al., 2007). 
Procedure 
 Parents and children arrived at the clinic at approximately 07:00; children were 
instructed to fast for 12 hrs and abstain from strenuous exercise for 48 hrs before 
participating. Parents and children were greeted by a research assistant, reviewed the 
study procedures, and provided their consent. First, parents completed questionnaires 
(e.g., demographics, socioeconomic status) and reported child medication use over the 
preceding 2 weeks (e.g., antibiotics, pain/fever, colds/allergies). Second, children’s 
height, weight, and waist circumference were measured, and pubertal status was 
determined using the Tanner staging system; height and weight were used to calculate 
measures of BMI. Third, research nurses prepared children for ECG measurement, which 
began at 08:00 and lasted ~3 hrs. Participants were seated and remained awake for the 
entire ECG recording duration. Fourth, the nurse removed the ECG recording equipment 
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and fitted the BP occlusion cuff to record blood pressure. Finally, children completed a 
questionnaire that inquired about physical activity and sedentary behaviour. The study 
protocol was identical across both clinic visits. Children underwent additional procedures 
as part of the larger QUALITY study, which are not relevant to the present analyses and 
are described elsewhere (Lambert et al., 2011). 
Data Screening  
Outliers and statistical assumptions. Data were screened to identify biologically 
implausible values and statistical extreme outliers (±6 standard deviations). From the first 
clinic visit, one participant had biologically implausible VLF, LF, and HF values, which 
were case-wise deleted; three additional values of LF and one value of weekday screen 
time were also deleted as extreme outliers. From the second clinic visit, one value for 
each of LF:HF ratio and weekday screen time were deleted as extreme outliers. Linearity 
and homoscedasticity were tested using bivariate scatter plots of each HRV and covariate 
pair from both clinic visits, and pairs of residuals. Visual inspection indicated most 
bivariate pairs exhibited linear relations and at least some homoscedasticity. The pattern 
of results was largely identical before and after the removal of additional potential 
outliers. Normality of each HRV and moderator variable from both clinic visits, and their 
residuals, were tested using visual inspection of histograms, PP-, and QQ-plots, and 
examination of skewness and kurtosis statistics (Kline, 2009; Tabachnick & Fidel, 2007). 
Normality was indicated for all variables and residuals at both clinic visits except weight, 
BMI, waist circumference, weekday and weekend screen time, SDNN, and frequency-
domain HRV variables, as indicated by QQ-plots. A natural log transformation of each 
variable corrected non-normality. As the pattern of the results was identical between 
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untransformed and transformed data, results using untransformed data are presented for 
parsimony.  
Missing data. Of the 632 participants who completed the first clinic visit, 72.5% 
had complete HRV data, and 87.3% had complete demographic (e.g., age, sex), 
cardiovascular (e.g., blood pressure), anthropometric (e.g., height, weight), and physical 
activity (e.g., self-reported weekly activity, weekday and weekend screen time) data at 
both visits. Prior to imputing missing values, independent samples t-tests and Chi-square 
analyses were conducted to examine whether HRV, demographic, cardiovascular, 
anthropometric, or physical activity measures obtained at the first clinic visit differed 
between return and non-return participants. For the HRV variables, independent samples 
t-tests yielded significant differences, such that those who did not return had lower NN 
(676.09 vs. 703.31 ms; t (573) = 2.75, p = 0.006), rMSSD (43.18 vs. 48.41 ms; t (573) = 
2.40, p = 0.017), pNN50 (25.89 vs. 21.17%; t (573) = 2.46, p = 0.014), LF (1098.96 vs. 
1302.38 ms
2
; t (80) = 2.35, p = 0.021), and HF (730.95 vs. 931.96 ms
2
; t (82) = 2.73, p = 
0.008), compared to return participants. For the moderator variables, independent 
samples t-tests yielded significant differences, such that those who did not return had 
higher SBP (95.96 vs. 93.54 mm/Hg; t (629) = -2.32, p = 0.021), DBP (50.30 vs. 48.35 
mm/Hg; t (629) = -2.96, p = 0.003), heart rate (89.72 vs. 86.17 bpm; t (573) = -3.55, p = 
0.004), and increased weekday screen time (2.69 vs. 2.21 hours; t (626) = -2.05, p = 
0.040), compared to return participants. There were no significant differences between 
return and non-return participants on measures of SDNN, VLF, LF:HF ratio, height, 
weight, waist circumference, BMI, or weekend screen time. Chi-square analyses 
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indicated no significant differences between return and non-return participants with 
regards to sex, pubertal status, or self-reported physical activity. 
Missing data analyses indicated that while 185 out of 632 cases (29.27%) had at 
least one missing value, and in total 7,470 out of 65,728 values (11.37%) were missing; 
missing values appeared non-monotone. Little’s tests indicated missing data for all HRV 
variables (χ2 [59] = 241.03, p < 0.001) and all moderator variables (χ2 [372] = 419.90, p = 
0.044) were not missing completely at random. This suggests that there may be a 
systematic relationship between missing and observed data (Little, 1988; McKnight, 
McKnight, Sidani, & Figueredo, 2007; Scheffer, 2002); this finding coincides with the 
examination of differences among measures obtained at the first clinic visit between the 
return and non-return participants. Missing data were imputed via multiple imputation 
with re-sampling techniques. All available demographic, cardiovascular, anthropometric, 
and HRV data were entered to inform the imputation model (Sterne et al., 2009). Five 
imputed datasets were created. Imputed data yielded an identical pattern of results 
compared to non-imputed data, although resulting imputed values were noticeably 
smaller relative to non-imputed data; only non-imputed results described for parsimony.  
Analytic Strategy 
Analyses were performed using SPSS v. 20 software (SPSS, INC., Chicago, IL). 
The overarching aim of the present study was to examine the 2-year stability of time- and 
frequency-domain HRV measures in a large sample of children. First, stability of NN, 
SDNN, rMSSD, pNN50, VLF, LF, HF, and LF:HF ratio was examined using Pearson (r) 
and Intra-class Correlations (ICCs). Average-measures ICCs, which range from 0 to 1, 
represent the ratio of between-subject to total variability (ICC = 2BS / [2BS + 2WS]), and 
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were calculated using a one-way random model. In contrast to Pearson correlations, 
which only account for rank-order differences between two variables, ICCs are 
advantageous in stability analyses as they account for rank order and mean-level 
differences between the two variables (Field, 2009; Weir, 2005). ICCs are categorized as 
poor (0–0.2), fair (0.3–0.4), moderate (0.5–0.6), strong (0.7–0.8), or excellent (0.9–1.0; 
Shrout & Fleiss, 1979).  
Second, partial correlations (rab.c) were calculated while controlling for a priori 
moderators specific to measures obtained at the first clinic visit, and time-varying 
covariates: age, heart rate, blood pressure, pubertal status, height, weight, BMI, waist 
circumference, weekday and weekend screen time, and weekly physical activity. 
Residualized change scores for the time-varying covariates were derived using linear 
regression analyses; data from the first clinic visit predicted data from the second, and the 
resulting coefficient was subtracted from its respective variable obtained at the second 
clinic visit (Field, 2009; Llabre, Spitzer, Saab, Ironson, & Schneiderman, 1991). Partial 
correlation analyses partialled out: (a) the variable measured at the first clinic visit, and 
(b) the time-varying covariate, which included both the residualized change score and its 
respective variable from the first clinic visit.   
The main study hypotheses were: (a) time- and frequency-domain HRV would 
exhibit moderate 2-year stability, as indicated using Pearson correlations and ICCs; (b) 
accounting for intra-individual differences in age, heart rate, blood pressure, pubertal 
status, height, weight (i.e., adiposity indices), and physical activity measured at the first 
clinic visit, and change among these variables across time would augment HRV stability, 
as indicated using partial correlations controlling for the variable measured at the first 
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clinic visit and for time-varying covariates; and (c) measures of heart rate, blood 
pressure, pubertal status, and weight would have the strongest moderating effects on 
HRV stability across both partial correlation analyses, particularly among HRV measures 
which predominantly reflect parasympathetic modulation (i.e., rMSSD, HF).  
Exploratory linear regression models were produced as a secondary analysis to 
examine individual associations between (a) covariates measured at the first clinic and (b) 
time-varying covariates (i.e., the residualized change score and its associated variable 
measured at the first clinic visit), and HRV measured at the second clinic visit. All 
models were adjusted for HRV measured at the first clinic visit. Both standardized and 




Study 2: Results 
At the first visit, 632 children and their parents participated; 564 children returned 
for a second visit. The majority of parents (Mage = 41.2, SD = 5.6 yrs) were overweight/ 
obese (78.7%, BMI ≥ 25 kg/m2), and had a post-secondary education (79.4%). All parent 
and child participants were Caucasian and of European descent (due to genetic inclusion 
criteria). At the first visit, 54.4% of children (Mage = 9.60, SD = 0.92 yrs) were male, and 
78.2% were classified in Tanner stage 1; children had ~6 hours per week of screen time 
(e.g., watching TV, playing computer games) and 16.1% reported no physical activity in 
a typical week. At the second visit, 49.5% of children (Mage = 11.66, SD = 0.94 yrs) were 
male, and 29.4% remained classified in the pre-pubertal stage; children had ~7.5 hours 
per week of screen time and 19.8% reported no physical activity in a typical week (See 
Table 8).  
Measures of height and heart rate from the QUALITY sample were comparable to 
population-based normative data from similarly aged children; measures of systolic and 
diastolic blood pressure were lower in comparison (Fleming et al., 2011; ELDEQ, Jarrin 
et al., In press; QCAHS, Lambert et al., 2011; Paradis et al., 2004). Not surprisingly, due 
to the objectives of the study, measures of weight and adiposity (BMI, waist 
circumference) from this sample were higher relative to population-based normative data 
(ELDEQ, Jarrin et al., In press; QCAHS, Lambert et al., 2011). Moreover, the QUALITY 
cohort were of higher SES, and were more likely to come from two-parent homes and 
reside in urban regions relative to a representative sample of similarly-aged Quebec 




ECG Data Integrity 
The methodological protocol for the clinic visits was standardized for all 
participants, such that ECG recordings began in the morning between 08:00 and 08:30. 
Across both visits, approximately 200 minutes of ECG data were recorded and only ~6% 
of data were excluded due to errors and artifacts (see Table 9). One participant from each 
clinic visit had less than 1 hour of ECG data available, and approximately 3% of 
participants at each clinic visit had ≥ 20% of ECG data removed due to errors and 
artifacts; results were similar before and after removal of this data (results not shown for 
parsimony). Time- and frequency-domain HRV measures were largely consistent with 
population-based normative data from similarly-aged children (Jarrin et al., In press), but 
were less consistent with normative data from studies with smaller samples (Acharya, 
Kannathal, Sing, Ping, & Chua, 2004; Martini et al., 2001; Rodriguez-Colon et al., 2011; 
Silvetti et al., 2001). 
HRV Stability 
Pearson correlations. To test the first hypothesis that time- and frequency-
domain HRV measures exhibit moderate 2-year stability, Pearson product-moment 
correlations were calculated for each HRV measure across both QUALITY visits (see 
Table 10). Results yielded statistically significant correlations for all time- and 
frequency-domain measures and indicated that HRV was moderately stable across 2 
years. Correlations among time-domain measures ranged from r = 0.67 to 0.72; NN was 
the relatively least stable measure, whereas SDNN was the relatively most stable. 
Correlations among frequency-domain measures ranged from r = 0.71 to 0.75; LF was 
the relatively least stable measure, whereas HF was the relatively most stable. These 
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results supported the first study hypothesis that HRV was moderately stable across 2 
years. 
Intra-class correlations. Stability of time- and frequency-domain HRV measures 
was also examined using intra-class correlations (ICCs; see Table 10). Results yielded 
statistically significant ICCs for all time- and frequency-domain measures and indicated 
that HRV exhibited strong stability across 2-years. ICCs for the time-domain measures 
ranged from ICC = 0.74 to 0.82; NN was the relatively least stable measure, while SDNN 
and rMSSD were the relatively most stable. ICCs for the frequency-domain measures 
similarly ranged from ICC = 0.79 to 0.85; VLF was the relatively least stable measure, 
while HF was the relatively most stable. ICCs suggest that within-subjects variance in 
HRV was low, that mean-level differences in HRV between the first and second clinic 
visit were minimal, and that participants’ relative rank-order of HRV was maintained 
across both QUALITY visits. These results further supported the first hypothesis that 
HRV is stable across 2 years.   
Partial correlations. To test the second hypothesis that controlling for 
developmentally-relevant moderators would augment HRV stability, partial correlations 
for each HRV variable were examined, adjusting for (a) individual covariates measured 
at the first clinic visit (age, heart rate, blood pressure, pubertal status, growth and 
adiposity, physical activity), and (b) time-varying developmental change in each 
covariate measured across both clinic visits (i.e., a residualized change score and the 
respective variable measured at the first clinic visit).  
Results of the partial correlation analysis yielded statistically significant 
correlations for all time- and frequency-domain measures, indicating that all HRV 
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variables were moderately stable across 2 years. Stability was robust to the effects of 
most examined moderators when analyzed using covariates from the first clinic visit (rtime 
range = 0.24–0.72; rfrequency range = 0.65–0.75; see Table 11) and time-varying covariates 
(rtime range = 0.55–0.75; rfrequency range = 0.71–0.80; see Table 12). Specific results for each 
of the moderators follows. 
Age. Controlling for age at the first clinic visit, and change in age across the study 
follow-up did not alter HRV stability (see Tables 11 and 12). This result could be 
explained by the minimal variability in participant age at both the first (SDage = 0.92 yrs) 
and second (SDage = 0.94 yrs) clinic visit. Results did not support the hypothesis that age 
augments HRV stability, and suggested that HRV stability is robust to differences in 
participant age at the first clinic visit and the change in age across a 2-year period.  
Heart rate. Controlling for heart rate measured at the first clinic visit yielded 
weak to moderate stability of time-domain measures (rrange = 0.24 to 0.61) relative to 
stability examined by Pearson correlations, while moderate stability of frequency-domain 
measures (rrange = 0.65 to 0.72) was retained; heart rate did not alter stability of LF:HF 
ratio. Conversely, controlling for time-varying change in heart rate across the study 
follow-up yielded moderate stability of all time-domain (rrange = 0.55 to 0.75) and 
frequency-domain measures (rrange = 0.72 to 0.80). Relative to other HRV variables, NN 
stability was weakest after controlling for heart rate among both analyses (see Tables 11 
and 12), which is not surprising considering that NN is the inverse of heart rate (Berntson 
et al., 2007). Moreover, stability of rMSSD (r = 0.75 vs. 0.69), pNN50 (r = 0.72 vs. 
0.68), and HF (r = 0.80 vs. 0.75), all of which reflect parasympathetic modulation, was 
augmented relative to stability examined by Pearson correlations after controlling for 
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time-varying change in heart rate. Given that reduced stability was observed after 
controlling for heart rate measured at the first clinic visit was not expected, results 
provided partial support for the hypothesis that controlling for heart rate augments HRV 
stability. 
  Blood pressure. Controlling for blood pressure measured at the first clinic visit, 
and change in blood pressure across the study follow-up did not alter HRV stability. 
Results from both analyses indicated that HRV remained moderately stable; values were 
largely consistent with stability examined by Pearson correlations after controlling for 
differences in blood pressure at the first clinic visit and time-varying change in blood 
pressure across the study follow-up (see Tables 11 and 12). Results were identical when 
blood pressure Z-scores were used (data not shown for parsimony). Results did not 
support the hypothesis that controlling for blood pressure augments HRV stability, and 
suggested that HRV stability is robust to blood pressure and change in blood pressure 
across a 2-year period.  
Puberty. Controlling for intra-individual differences in pubertal status measured 
at the first clinic visit and pubertal development across the study follow-up did not alter 
HRV stability (see Tables 11 and 12). This result could be explained by the minimal 
variability in pubertal status, and change in pubertal status across the study follow-up. 
Most QUALITY participants were classified as Tanner 1 (78.2%) at the first clinic visit, 
and most were classified as Tanner 2 or Tanner 3 (50%) at the second clinic visit. Results 
did not support the hypothesis that controlling for pubertal status augments HRV 
stability, and suggested that HRV stability is robust to pubertal status and pubertal 
development across a 2-year period.  
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Growth and adiposity. Controlling for measures of height, weight, BMI (CDC 
[2000] age- and sex-adjusted Z-score), or waist circumference obtained at the first clinic 
visit, and the change among these measures across the study follow-up did not alter HRV 
stability (see Tables 11 and 12). Results were identical when height and weight Z-scores 
(age- and sex-adjusted) were used (data not shown for parsimony). Controlling for BMI 
and waist circumference measured at the first clinic visit, and change among these 
measures across the study follow-up increased NN, SDNN, and LF stability relative to 
other HRV measures. Results did not support the hypothesis that controlling for measures 
of growth and adiposity augments HRV stability, and suggested that HRV stability is 
robust to measures of height, weight, BMI, and waist circumference, and change among 
these measures across a 2-year period. 
Physical activity. Controlling for self-reported measures of physical activity and 
screen time measured at the first clinic visit, and change among these measures across the 
study follow-up did not alter HRV stability (See Tables 11 and 12). Results did not 
support the hypothesis that controlling for measures of physical activity augments HRV 
stability, and suggested that HRV stability is robust to measures of physical activity and 
change in physical activity across a 2-year period. 
Secondary Post Hoc Analyses 
 To further test for relations between each proposed moderator and HRV, 
exploratory linear regression models examined the variance explained in each HRV 
variable measured at the second clinic visit by each covariate, after adjusting for HRV 
measured at the first clinic visit. Three models for each HRV measure were tested 
including (a) covariate measured at the first clinic visit, (b) residualized change scores 
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(variable at the first clinic visit predicting variable at the second), and (c) time-varying 
covariates, which included a residualized change score covariate and its respective 
covariate measured at the first clinic visit). The magnitude and direction of each 
regression coefficient was largely identical between analyses using time-varying 
covariates and analyses using only residualized change scores (i.e., change score not 
adjusted for the respective measure obtained at the first clinic visit). As such, specific 
results from regression models using only residualized change score covariates are not 
detailed for parsimony. Standardized and unstandardized coefficients for covariates 
measured at the first clinic visit are presented in Tables 13 and 14, respectively. 
Standardized and unstandardized coefficients for time-varying covariates are presented in 
Tables 15 and 16, respectively.  
Among covariates measured at the first clinic visit, significant positive 
associations were observed between age and NN (B = 0.85, β = .12, p < .001) and VLF (B 
= 8.52, β = .10, p < .001); puberty status and NN (B = 17.64, β = .11, p < .01); systolic 
blood pressure and NN (B = 0.71, β = .07, p < .05) and LF (B = 8.05, β = .07, p < .05); 
heart rate and NN (B = 4.54, β = .48, p < .05); all cardiovascular measures and LF (Brange 
= 8.05 to 12.58, βrange = .07 to .10, all p < .05); height and all HRV measures except HF 
and LF:HF ratio (Brange = 0.15 to 18.66, βrange = .08 to .17, all p < .05); all adiposity 
indices and all HRV measures except LF:HF ratio (Brange = 0.13 to 124.09, βrange = .08 to 
.16, all p < .05); and weekend screen time and VLF (B = 21.45, β = .07, p < .05). 
Standardized coefficients indicated that heart rate measured at the first clinic visit had the 
largest relative influence on HRV (i.e., NN) measured at the second clinic visit. The 
magnitude of the effect size between heart rate measured at the first clinic visit and NN is 
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consistent with results from the stability analysis (see above); however, the directionality 
of this association was opposite to that indicated by partial correlation results. 
Among time-varying covariates (i.e., both residualized change scores and the 
respective variable measured at the first clinic visit), significant positive associations 
were observed between all cardiovascular indices and LF:HF ratio (Brange = 0.03 to 0.07, 
βrange = .11 to .33, all p < .01); height and LF:HF ratio (B = 0.05, β = .57, p < .001); 
weight and LF:HF ratio (B = 0.02, β = .28, p < .05); weekly physical activity and all HRV 
variables except LF:HF ratio (Brange = 17.12 to 1322.14, βrange = .33 to .39, all p < .01); 
and weekday screen time and LF:HF ratio (B = 0.09, β = .13, p < .01). Significant 
negative associations were observed between pubertal status and NN (B = -53.41, β = -
.38, p < .01), VLF (B = -687.41, β = -.43, p < .01), and LF:HF ratio (B = -0.62, β = -.47, p 
< .001); age and rMSSD (B = -1.32, β = -.90, p < .05), pNN50 (B = -1.28, β = -1.01, p < 
.05), and HF (B = -51.62, β = -.87, p < .05); all cardiovascular indices and all HRV 
measures except LF:HF ratio (Brange = -0.34 to -69.37, βrange = -.09 to -.1.02, all p < .05); 
weight and all HRV measures except LF:HF ratio (Brange = -0.35 to -25.76, βrange = -.32 to 
-.43, all p < .05); waist circumference and all HRV measures except LF:HF ratio (Brange = 
-0.29 to -22.28, βrange = -.21 to -.41, all p < .05); and weekday screen time and NN (B = -
7.02, β = -.10, p < .05), rMSSD (B = -1.45, β = -.10, p < .05), pNN50 (B = -1.38, β = -.11, 
p < .05), and HF (B = -53.91, β = -.09, p < .05; see Table 14). Standardized coefficients 
indicated that time-varying measures of heart rate had the largest relative influence across 
all regression models and across all HRV variables. Results demonstrated that greater 
change in heart rate over time was associated with lower HRV at the second clinic visit; 
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this is consistent with results from partial correlation analyses, in that HRV stability was 
typically augmented after controlling for these time-varying changes.  
Regression analyses demonstrated that many of the examined covariates 
measured at the first clinic visit were positively associated with HRV, while many of the 
examined time-varying covariates were negatively associated with HRV. Overall, 
although HRV stability was robust to the influence of most selected covariates, and time-
varying change among these covariates, results from the secondary analysis suggested 
that consideration of such developmentally-relevant moderators (e.g., age, pubertal status, 
weekly physical activity) may be pertinent to a thorough understanding of factors that 





Study 2: Discussion 
The overarching aim of the second study was to examine the 2-year stability of 
time- and frequency-domain measures of HRV within a large sample of Quebec children. 
Overall, and consistent with the main study hypothesis, HRV exhibited moderate stability 
across 2 years. Further, frequency-domain measures exhibited greater stability relative to 
time-domain measures. These results replicate and extend previous findings among 
similarly-aged children (El-Sheikh, 2005; Hinnant & El-Sheikh, 2009; Hinnant et al., 
2011; Keller & El-Sheikh, 2009; Leicht & Allen, 2008), and among adolescents and 
young adults (Li et al., 2009).  
While previous cross-sectional and longitudinal pediatric studies observed 
negative associations between biological factors (e.g., heart rate, blood pressure, and 
weight) and mean-level differences in HRV, a comprehensive examination of whether 
such factors affected HRV stability had not been conducted. To address this gap, the 
present study examined HRV stability while controlling for a priori selection of 
developmentally-relevant, time-varying demographic, cardiovascular, anthropometric, 
and behavioural covariates. The second hypothesis tested whether accounting for 
differences in age, heart rate, blood pressure, pubertal status, growth and adiposity, and 
physical activity across 2 years would augment HRV stability.  
Developmentally-Relevant Covariates 
HRV stability was robust to changes in age. Age-related changes in HRV and 
HRV stability have been observed across infancy through adolescence. HRV increases 
between infancy and childhood, but subsequently decreases throughout adolescence and 
across adulthood (e.g., Finley et al., 1987; Goto et al., 1997; Longin et al., 2009; Seppala 
et al., 2013; Silvetti et al., 2001); this likely reflects developmental changes in autonomic 
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cardiovascular control across the lifespan. Associations between age and HRV have 
typically been examined in cross-sectional studies, many of which compare groups of 
small samples (N < 40) that included wide age ranges (e.g., 6–10 years, 5–11 years); 
however, cross-sectional methodology precludes consideration of the temporal relation 
between age and HRV. Results from previous longitudinal studies indicate that HRV 
stability is weak-to-moderate across infancy, and increases to moderate stability across 
early and middle childhood; this stability is maintained through adolescence (Bar-Haim 
et al., 2000; Bornstein & Suess, 2000; El-Sheikh, 2005; Henje Blom et al., 2009; Hinnant 
& El-Sheikh, 2009; Hinnant et al. 2011). Methodological features of the QUALITY 
study, namely, inclusion of 9-year-old children followed-up after 2 years, may have 
limited variability in participant age such that the change in age across 2 years was too 
narrow to observe the proposed effect. This restriction in age among QUALITY 
participants can explain why results did not support the hypothesis that controlling for 
age would augment HRV stability. To better examine whether controlling for age 
augments HRV stability, future studies should replicate these analyses using a sample of 
children with a wider age range. 
Controlling for heart rate influenced HRV stability. After controlling for heart rate 
measured at the first clinic visit, HRV stability was weak to moderate relative to results 
from Pearson correlations. However, after controlling for the change (i.e., decrease) in 
heart rate over 2 years (while also accounting for heart rate measured at the first clinic 
visit), HRV stability was moderate across all variables. Further, controlling for change in 
heart rate noticeably augmented stability of rMSSD, pNN50 and HF; given that these 
HRV measures all reflect parasympathetic modulation, it is not unexpected that there 
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would be higher stability after partialling out the change in heart rate (which is highly 
influenced by sympathetic mechanisms). The relatively higher (yet still moderate) HF 
stability after controlling for time-varying heart rate measures is consistent with results 
from a 6-month study with a smaller sample (N = 77) of healthy adolescents (Mage = 16.5 
years; Henje Blom et al., 2009); however, reduced stability of SDNN and LF found in 
this study is inconsistent with Henje Blom and colleagues (2009), who reported relatively 
higher SDNN and LF stability after controlling for continuous heart rate measures. 
Importantly, Henje Blom made no indication of whether analyses controlled for a single 
time-point heart rate measure from their first or second study visit, or if a change score 
was used; thus, methodological differences may account for these discrepancies. Results 
suggested that accounting for extraneous variance in HRV measures attributed to heart 
rate, and developmental changes in heart rate over time, is pertinent to longitudinal 
examinations of HRV among children; controlling for this variance can augment 
estimates of stability. While HRV is derived from heart rate, the two measures reflect 
different constructs with somewhat distinct implications; indeed, HRV measures are 
typically more sensitive to detecting improvements or declines in health relative to heart 
rate measures (Ernst, 2014). However, not considering the effect of heart rate on HRV 
measures may lead to erroneous conclusions about relations between HRV and health. 
The QUALITY study, along with many other studies with child and adolescent 
participants, did not apply a moving polynomial filter in the HRV data reduction phase; 
as the polynomial filter is designed to isolate variance in the HF band from extraneous 
background variability, application of this filter reduces the need to statistically control 
heart rate when studying HRV. As such, future researchers should examine whether 
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controlling for developmental changes in heart rate would result in similar augmentation 
of HRV stability after a moving polynomial filter is applied to the data 
HRV stability was robust to measures of systolic and diastolic blood pressure 
obtained at the first clinic visit, and changes in blood pressure across the 2-year follow-up 
after also controlling for blood pressure measured at the first clinic visit. Consistent with 
developmental patterns, QUALITY participants’ systolic and diastolic blood pressure 
increased across the study follow-up. Baroreflex receptors, located along the walls of 
major blood vessels (e.g., aortic arch, carotid sinuses), respond to increases and decreases 
in blood pressure by triggering autonomic mechanisms that decrease and increase heart 
rate, respectively, to maintain homeostasis. Thus, moment-to-moment changes in blood 
pressure can indirectly modulate heart rate, and thus influence HRV. Baroreflex 
sensitivity has been observed to decline across childhood and adolescence (e.g., Lenard et 
al., 2004); however, higher mean-level measures of HRV have been associated with 
higher blood pressure among previous cross-sectional studies (e.g., between pre-pubertal 
and post-pubertal children; Tanaka et al., 2000). Further, moderate associations between 
developmental increases in blood pressure and HRV have been observed among previous 
longitudinal studies (e.g., 14-year-olds followed-up after 8 years; Campbell et al., 2003). 
Given that QUALITY participants were about 9-years-old and followed-up after 2 years, 
it is possible that too little time had elapsed between clinic visits to detect an effect of 
blood pressure change on HRV stability in the present study. Considering this, future 
research could examine whether HRV stability is impacted by changes in blood pressure 
that occur over longer periods of time (e.g., 5+ years). Taken together, the present results 
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suggest that HRV stability is robust to intra-individual differences and 2-year change in 
blood pressure. 
Puberty status, measured using the Tanner staging system, did not alter HRV 
stability. Significant physical and biological (e.g., metabolic, hormonal) changes occur 
during puberty (Shirtcliff et al., 2009), and include developments in autonomic and 
cardiovascular functioning. Circulation of sex hormones (e.g., testosterone, estrogen) 
increases with more advanced pubertal development, and has been associated with sex-
specific alterations in parasympathetic functioning, heart rate, and blood pressure 
regulation (e.g., Spear, 2000). However, previous associations between pubertal status 
and HRV have been largely inconsistent. For example, lower mean-level measures of LF 
and SDNN, and higher HF have been observed in pre-pubertal, relative to post-pubertal 
children (Chen et al., 2012; Kowalewsky et al., 2007). Further, while El-Sheikh (2005) 
observed a positive association between pubertal status and HF, Jarrin and colleagues (In 
press) observed negative associations between pubertal status and rMSSD, pNN50 and 
HF. Inconsistent results between studies may relate to how puberty was measured (i.e., 
Tanner staging vs. measure of pubertal onset [i.e., gonadarche, menarche] vs. self-report). 
Most children in the QUALITY sample were classified in Tanner 1 at the first clinic visit, 
while approximately half of children were classified in Tanner 2 or 3 by the second clinic 
visit; only a minority of participants had reached a more advanced pubertal stage (i.e., 
Tanner 4, Tanner 5) by the 2-year follow-up. As such, limited variability among pubertal 
status and pubertal development in the QUALITY cohort may explain why there was no 
association with HRV stability. To address this shortcoming, and more comprehensively 
examine whether physiological changes associated with puberty influences HRV 
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stability, future researchers could obtain repeated measures of HRV from a youth 
followed-up across each Tanner stage. Further, an experimental study that involves 
administration of sex hormones to children and adolescents may allow for a controlled 
examination of how physiological changes associated with puberty affect HRV and HRV 
stability. Given the present findings, results did not support the hypothesis that pubertal 
status augments HRV stability, and suggested that HRV stability was robust to pubertal 
development across 2 years.  
Growth, measured by increases in height, weight, BMI, and waist circumference 
over time, did not alter HRV stability. Physical growth during child development can 
affect HRV because cardiovascular demand is increasing to maintain adequate circulation 
throughout the body. The present findings for HRV stability are inconsistent with 
previous cross-sectional (e.g., Rodriguez-Colon et al., 2011; Seppala et al., 2013) and 
longitudinal (e.g., Campbell et al., 2003; Graziano et al., 2011) studies which have 
reported negative associations between increased height, weight, BMI, and waist 
circumference and mean level measures of SDNN, HF, and LF, and positive associations 
with mean-level measures of LF:HF ratio and heart rate. Graziano and colleagues (2011) 
demonstrated that children with lower, compared to higher NN and HF activity at 5.5-
years-old demonstrated significantly greater BMI growth and were more likely to be 
overweight or at-risk for overweight at 10.5-years old. Campbell and colleagues (2003) 
demonstrated that BMI measured at 14-years-old was negatively associated with mean-
level measures of HF and positively associated with mean-level LF:HF ratio measured at 
22-years-old, after adjusting for systolic blood pressure measured at 14-years-old. While 
this study provides support for the longitudinal relation between HRV and BMI, 
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Campbell and colleagues (2003) did not examine time-varying associations using BMI 
change scores. Given the 2-year follow-up of QUALITY, change in anthropometric 
measures among QUALITY participants was not as large relative previous studies with 
longer test-retest intervals. Graziano and colleagues (2011) and Campbell and colleagues 
(2003) demonstrated significant negative associations between anthropometric and HRV 
measures across 5 and 8 years, respectively. Thus, it is possible that the extent of change 
in anthropometric measures between the first and second QUALITY visit (SDweight, first 
clinic visit = 11.47 kg; SD weight, second clinic visit = 14.84 kg) was not substantial enough to affect 
HRV stability relative to studies with longer test-retest intervals. Future pediatric studies 
with longer test-retest intervals (e.g., 5+ years) would allow for a more thorough 
examination of the association between anthropometric change and HRV stability. 
Considering the present findings, results suggested that HRV stability is robust to 
developmental increases in measures of growth and adiposity across 2 years.  
Measures of physical activity and weekday/weekend screen time did not affect 
HRV stability. Overall, relative to the first clinic visit, most QUALITY participants at the 
second visit reported less frequent regular physical activity, and watched more television 
on both weekdays and weekends. This suggests that participants may have become more 
sedentary across time. A meta-analysis of adult HRV studies (Sandercock, Bromley, & 
Brodie, 2005) demonstrated a positive moderate relation between physical activity 
training and parasympathetic dominance as measured by HRV (i.e., higher NN and HF); 
further, effect sizes for change in HF after physical activity training were higher among 
active, relative to sedentary, study participants. Associations between physical fitness and 
HRV among children are less consistent. Overall physical fitness has been associated 
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with higher parasympathetic dominance (e.g., Chen et al., 2012) and higher measures of 
LF, HF, and SDNN, even after controlling for BMI, systolic blood pressure, and blood 
glucose level (Henje Blom et al., 2009). Sedentary behaviour may augment 
sympathovagal imbalance across time, which could compromise HRV stability. 
Importantly, in the QUALITY study, only self-report measures of activity were available. 
Objective measurement of physical activity has potential to reduce response biases (e.g., 
recall errors), a psychometric concern which may affect child-reported data. As such, 
future longitudinal research should consider obtaining objective indices of physical 
activity (e.g., accelerometry, maximal oxygen consumption [VO2 max]), to examine 
whether time-varying change among these measures can provide a better understanding 
of how physical fitness influences HRV stability in children compared to self-report 
measures. Overall, results did not support the hypothesis that controlling for change in 
physical activity augments HRV stability; results indicated that HRV stability was robust 
to changes among self-reported physical activity measures across 2 years.   
Summary 
 The present study demonstrated that time- and frequency-domain HRV measures 
are moderately stable. Stability was reduced after controlling for heart rate measured at 
the first QUALITY visit, whereas stability of measures reflecting parasympathetic 
functioning (rMSSD, pNN50, HF) was augmented after controlling for the 2-year change 
in heart rate. However, HRV stability was robust to intra-individual differences in 
developmentally-relevant demographic (age, puberty), cardiovascular (blood pressure), 
growth and adiposity (height, weight, BMI, waist circumference) and self-reported 
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physical activity (weekday/weekend screen time, frequency of weekly physical activity) 
covariates.  
Limitations, Strengths, and Future Recommendations 
There are five primary limitations of the present study that warrant 
acknowledgement. First, QUALITY data were from a large, homogeneous sample of 
healthy children aged 9- to 11-years old. In turn, this sample homogeneity may pose a 
credible limitation in that variability among some examined covariates (e.g., age, pubertal 
status, height) was too limited to influence HRV stability. However, the 2-year follow-up 
improves upon shorter follow-up intervals used in the prior literature (e.g., 1 week, 2 
weeks); this longer follow-up permits better assessment of the contribution of 
development and growth on HRV stability. Future studies should examine HRV stability 
using a more diverse sample (e.g., racial diversity, wider age range, normally distributed 
weight) to determine the generalizability of these results.  
Second, the methodological protocol of the present study was highly controlled 
and standardized for all participants across both study assessments, which may influence 
the ecological validity of our stability findings. More specifically, the QUALITY study 
included detailed inclusion and exclusion criteria, ECG recordings lasted approximately 3 
hrs and started between 08:00 and 09:00, identical hardware was used for all participants, 
and identical editing and scoring procedures were used for all HRV data. Further, most 
covariates examined in this study were measured by trained staff under standardized 
conditions. Observing HRV stability that was robust to several developmentally-relevant 
covariates may be partly attributable to the methodological rigor of the QUALITY study; 
clinical or practical uses of HRV may yield lower stability estimates. In other words, 
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clinic-based HRV stability measures may be less ecologically valid compared to 
measures obtained under less controlled or standardized conditions. However, 
QUALITY’s examination of short-term (i.e., 3 hr) daytime time- and frequency-domain 
HRV measures obtained in a clinic setting is consistent with many other pediatric studies. 
Further, the moderate stability of HRV obtained in this study is consistent with results 
presented among other studies of similarly-aged children (e.g., Hinnant & El-Sheikh, 
2009; Keller & El-Sheikh, 2009). Future studies should replicate the present analyses 
using 24-hr ambulatory recordings to address potential concerns about the overall 
ecological validity of these findings, and examine relations between HRV stability and 
objective measures of physical activity (e.g., via accelerometers, pedometers, or 
concurrent measures of heart rate and oxygen consumption; VO
2
; Sirard & Pate, 2001) to 
address noted psychometric concerns. Moreover, other intra-individual factors not 
included in the present study that have been previously associated with HRV in children, 
such as ethnicity (e.g., Graziano et al., 2011; Li et al., 2009), socio-economic status (e.g., 
Campbell et al., 2013), and multiple sleep-related parameters (e.g., Burr, 2007; Jarrin et 
al., In press), should be examined in future studies.   
Third, missing data analysis indicated that ~11% of individual data points among 
the examined HRV variables and covariates were missing; this was primarily due to 
sample attrition. Analyses using imputed data revealed significantly reduced stability 
relative to analyses using the original data. Participants who did not return for a second 
assessment appeared more at-risk, as indicated by significantly higher SBP, DBP, heart 
rate, and weekday screen time, and significantly lower NN, rMSSD, pNN50, LF, and HF 
relative to participants who did return. The significant differences between return and 
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non-return participants on the above-mentioned measures suggest data were not missing 
at random (i.e., there may have been a systematic relationship between missing and 
observed data; Little, 1988; McKnight et al., 2007; Scheffer, 2002), and the reduction in 
HRV stability among imputed data may reflect this increased health risk. However, 
despite this missing data, analyses were based on a large sample of participants, allowing 
for sufficient statistical power. 
Fourth, only two assessments of HRV (and covariates) were obtained in this 
study. Although this typically allows for an adequate examination of stability, having 
only two measures of the included variables limits an adequate examination of growth 
over time (i.e., growth trajectory curves), and how such growth may impact HRV 
stability. Contrary to initial expectations, HRV stability was higher when measured using 
ICCs compared to Pearson correlations despite mean-level increases in HRV between the 
first and second study visit (Shrout & Fleiss, 1979). It is possible that mean-level 
differences (i.e., increases) in HRV among QUALITY participants across 2 years were 
too small to produce lower ICCs relative to Pearson correlations. Thus, using ICCs as a 
conservative measure of stability may be more meaningful when examining data 
collected over longer test-retest intervals to allow for more change in the measure to 
occur. Such an examination may require more advanced statistical techniques relative to 
the partial correlations employed in this study. The moderator variables examined in the 
present study were chosen based on findings from previous HRV research with adults 
and children. Most of the available research indicated that the selected moderators are 
associated with mean-level differences in HRV. However, the present study demonstrated 
that differences among moderator variables measured at the first clinic visit, and 
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developmental change in these measures across 2 years, did not alter HRV stability. 
Considering this, exploratory linear regression models were tested to examine the role of 
the covariates on HRV at the second clinic visit. Regression models indicated that several 
moderator variables measured at the first clinic visit had significant positive associations 
with HRV measures obtained at the second clinic visit; the magnitude of each association 
was generally weak, with the only exception being the association between heart rate and 
NN, which was moderate. In most cases, measures of growth and adiposity from the first 
clinic visit were positively associated with HRV, suggesting that greater initial mass was 
a significant predictor of greater HRV at the study follow-up. However, regression 
models with time-varying covariates (i.e., residualized change scores and the associated 
covariate from the first clinic visit) demonstrated the opposite effect. Namely, most 
significant time-varying predictors were negatively associated with HRV at the second 
clinic visit; the magnitude of each association was weak to moderate, with time-varying 
measures of age and heart rate typically revealing the largest associations. Among time-
varying regression models, the strongest associations were between change in age and 
pNN50, and change in heart rate and NN, suggesting that greater change (i.e., increase) in 
age, and change (i.e., decrease) in heart rate across 2 years was associated with greater 
reductions in pNN50 and NN at the second clinic visit, respectively. Another notable 
finding across regression models was that time-varying change (i.e., decrease) in regular 
physical activity across 2 years was significantly associated with HRV at the second 
clinic visit (whereas no associations were found among regression models with covariates 
measured at the first clinic visit, or among examinations of HRV stability). These results 
suggested that change (relative to initial differences) in the moderator variables 
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accounted for more variance in HRV measures obtained at the second clinic visit. 
Further, unstandardized coefficients revealed that time-varying change in the covariates 
(particularly heart rate, diastolic blood pressure, and weekly physical activity) had the 
strongest negative associations with VLF and LF. This suggests that change in these 
moderators across 2 years may have had a particularly salient effect on lower-frequency 
sources of autonomic cardiovascular control. Considering these findings in the larger 
context of this study, although the present results indicate that HRV stability was robust 
to many of the proposed moderator variables, these same moderators were significant 
predictors of HRV measured at the second clinic visit, particularly when the change in 
the moderator across 2 years was included in the model. Although it was beyond the 
scope of this thesis, taken together, regression analysis results suggested that more 
comprehensive statistical techniques may be required to better elucidate factors that 
influence stability or change in HRV measures across time. As such, it is plausible that a 
more comprehensive analytical technique could better examine relations between 
developmentally-relevant covariates and stability of HRV measures. Namely, 
generalizability theory, which can parse measurement variance into different 
components, or facets, may better explain key sources of variation in examinations of 
stability. By applying generalizability theory to the study of stability, a more statistically 
comprehensive examination can be performed. Similar to the proposed advantage of 
ICCs relative to Pearson correlations, “partial ICCs” can account for mean-level and 
rank-order change in HRV data across time, while partialling out additional variance 
attributed to a particular covariate. However, given that an analytical strategy such as this 
was beyond the scope of the present thesis, future studies of HRV stability should 
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consider applying generalizability theory to elucidate factors (or facets) that may be 
pertinent to a better understanding of moderators that influence HRV stability.  
Finally, some HRV measures used in the present study were not derived in 
accordance with recommendations outlined by established HRV guidelines (Berntson et 
al., 1997; Task Force, 1996). Namely, the sampling rate used during data collection (128 
Hz) may have influenced resulting HRV measures and the observed results in turn. The 
QUALITY study also did not apply a moving polynomial filter during the data reduction 
phase; not using this filter may have further impacted the fidelity of resulting HRV 
values. Further, the focus on time- and frequency-domain HRV measures in this study 
precluded an examination of stability among other HRV measures recommended by 
published guidelines, such as normalized frequency-domain indices, and measures 
derived from geometric (e.g., triangular index), Poincare plot (e.g., SD1, SD2), wavelet-
based (e.g., wavelet coefficient), or entropy-based (e.g., approximate entropy) analyses; 
these measures have also been associated with health outcomes (e.g., Kleiger et al., 
2005), but are less commonly reported among the pediatric HRV literature. However, (as 
previously noted) ECG recordings were of sufficient duration to examine the derived 
HRV measures, the methodological protocol was highly standardized for all study 
participants, validated hardware and software platforms were used, and ECG data were 
carefully screened and edited using established procedures. Thus, the time- and 
frequency-domain measures used in this study were obtained under largely ideal 
methodological conditions, and the specific variables examined herein are consistent with 




Conclusion   
Taken together, the present results demonstrated that autonomic cardiovascular 
control, as measured by time- and frequency-domain HRV, is moderately stable among 
children. Overall, the present study demonstrated three key findings that appear pertinent 
to pediatric HRV research. First, time- and frequency-domain measures reflect a stable 
individual difference in childhood.  Second, the moderate stability of HRV measures in 
children is robust to developmental changes and growth related to time-varying 
demographic, biological, and behavioural covariates. Third, results further demonstrated 
that HRV stability is influenced by variance attributed to changes in heart rate across 
time; this was indicated by reduced stability after controlling for heart rate measured at 
the first clinic visit, and augmented stability of HRV measures after controlling for 
change in heart rate across 2 years, particularly among measures reflecting 










HRV is an established measure of autonomic cardiovascular control in adults and 
children. While the psychometric properties of HRV have been extensively examined 
among adult samples, they are less well established among pediatric samples. 
Establishing test-retest reliability and temporal stability of HRV is an important requisite 
in determining whether the association between HRV and health is robust. If HRV cannot 
be reliably measured or does not reflect a stable individual difference, erroneous 
conclusions may be drawn about relations between autonomic cardiovascular control and 
long-term health outcomes. Among the extant pediatric literature there is a paucity of 
evidence for the reliability and stability of HRV measures among children. Existing 
studies are limited by small sample sizes, inconsistent methodological protocols, few 
methodological conditions considered, or scarce statistical controlling for covariates. 
Considering these gaps in the literature, the overarching goal of this thesis was to conduct 
a comprehensive examination of test-retest reliability and temporal stability of time- and 
frequency-domain HRV measures among pediatric samples. This goal was achieved 
using two complementary studies.  
The first study was a comprehensive meta-analytic review of HRV test-retest 
reliability among infants, children, and adolescents. Results indicated that HRV exhibited 
moderate test-retest reliability overall, while reliability among infants and toddlers was 
lower compared to reliability among children and adolescents. Moreover, there was less 
methodological consistency across infant/toddler studies relative to child/adolescent 
studies. Results indicated several methodological factors were pertinent to HRV 
reliability across both age groups. Namely, greater reliability of NN and HF among 
infant/toddler studies was associated with participant exclusion criteria based on 
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prescription medications, medical illnesses, or low birth weights; inclusion of a pre-
recording acclimatization period; recording ECG while participants were awake and 
seated; and, deriving HRV using the mean of several short recording epochs. Greater 
reliability of HF and LF among child/adolescent studies was associated with a lower 
proportion of male participants; longer ECG recording duration; inclusion of a pre-
recording acclimatization period; and, selection of HRV frequency bandwidths consistent 
with published guidelines and recommendations. Notedly, several moderator analyses 
were restricted as several studies across both age groups did not specify target 
methodological factors. Many of these methodological factors pertain to technical details 
that are relevant to data replication and interpretation, as outlined by established HRV 
guidelines. In other words, several factors that may be associated with HRV reliability 
(e.g., time of ECG recording, ECG sampling rate) could not be examined. Other 
discussed limitations of this meta-analysis included reduction of some categorical 
moderators to dichotomized variables, focus on short-term daytime HRV measures, and 
use of fixed- vs. random-effects models. Despite these shortcomings, the meta-analytic 
findings have important implications for the methodological design of future HRV 
studies with infants and youth.  
The second study was an examination of temporal stability of time- and 
frequency-domain HRV measures among children aged 9- to 11-years-old. Study results 
indicated that HRV exhibits moderate stability overall, and that stability was robust to 
developmental changes among measures of age, blood pressure, pubertal status, growth 
and adiposity, and self-reported physical activity across 2 years. Heart rate demonstrated 
notable influences on HRV stability across all variables except LF:HF ratio; controlling 
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for heart rate measured at the first clinic visit reduced HRV stability, while controlling 
for change in heart rate (i.e., decrease) augmented stability of rMSSD, pNN50, and HF, 
all of which reflect parasympathetic contributions to HRV. Taken together, this study 
demonstrated that HRV stability is robust to intra-individual differences across 2-year 
development of several physiological processes among children. To the best of our 
knowledge, this study was the first comprehensive examination of the relation between 
HRV stability and developmentally-relevant, time-varying covariates among children.  
This thesis provided strong evidence that time- and frequency-domain HRV 
measures can be reliably measured and are a stable individual difference among children. 
Reproducibility of pediatric HRV measures appears more sensitive to methodological 
differences during data collection and analysis across study assessments relative to intra-
individual differences within a sample across time. Standardizing the methodological 
protocol across study assessments, allowing participants to acclimate to experimental 
conditions prior to collection of baseline ECG data, and obtaining an ECG recording of 
adequate duration for the variable of interest are all methodological design issues which 
can improve test-retest reliability of HRV. Including a pre-recording acclimatization 
period and recording ECG in a seated posture were each substantial moderators of HRV 
reliability across both age groups. Attention to these methodological factors can minimize 
extraneous variance in HRV measures that contribute to poorer reproducibility.  
One consistent finding across both studies was the role of heart rate in moderating 
HRV psychometrics. The psychometric quality of pediatric HRV measures declined if 
extraneous variance attributed to the influence of heart rate was not accounted for across 
test-retest intervals. The meta-analysis demonstrated that HF reliability was reduced 
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among child/adolescent studies, but not infant/toddler studies, that had longer study 
follow-up length, did not include a pre-recording acclimatization period, and did not 
apply software-based filtering. The examination of stability indicated that HRV was more 
stable after controlling for change in heart rate across the 2-year study follow-up, 
particularly among measures reflecting parasympathetic modulation. Results of both 
studies indicate that the influence of heart rate contributes notable variance to 
longitudinal measures of HRV in children, and suggest that changes in heart rate activity 
over time is likely a key contributor to mean-level differences in HRV across test-retest 
intervals. Multiple factors contribute to heart rate, and would in turn affect HRV and its 
longitudinal psychometric properties. It has been demonstrated that a moving polynomial 
filter (Porges, 1985) extracts heart rate variance within a specified frequency band from 
slower periodic processes and background physiology, and can eliminate the need to 
include heart rate as a covariate. Application of a moving polynomial filter could help 
account for natural developmental changes and sudden aberrations in background heart 
rate activity better than alternative methods that do not account for heart rate changes. As 
discussed, young children may be especially sensitive to unfamiliar experimental 
conditions and stress-related increases in heart rate and respiration, which could distort 
estimates of HRV and limit the measure’s reproducibility. The lack of association 
between a pre-recording acclimatization period and HF reliability among infant/toddler 
studies in the meta-analysis might be explained by the more common use of a moving 
polynomial filter relative to child/adolescent studies. As such, although reliability was 
lower among infant/toddler, relative to child/adolescent studies, differences in heart rate 
activity among infants and toddlers across study assessments may have been accounted 
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for by the polynomial filter; this would explain why HF reliability among infant/toddler 
studies was not moderated by study follow-up length or inclusion of a pre-recording 
acclimatization period as it was among child/adolescent studies. Moreover, this suggests 
that use of a moving polynomial filter may be a methodological factor that is pertinent to 
improving pediatric HRV psychometrics. Considering this, although the QUALITY ECG 
data were linearly detrended, mean-centered, and tapered for spectral leakage using a 
Hanning window, a moving polynomial filter was not applied; thus, it remains to be 
determined whether including heart rate as a covariate would influence HRV stability in 
the same way had a moving polynomial filter been implemented. Taken together, results 
suggest that minimizing extraneous variance associated with intra-individual differences 
in heart rate activity, and the developmental change in heart rate across time, can produce 
more reliable and stable measures of HRV.  
Published guidelines (Berntson et al., 1997; Task Force, 1996) offer 
recommendations for improved HRV measurement quality and inter-study consistency, 
such as standardized data collection, analysis, and reporting practices. Current guidelines 
for HRV methodology, which are almost 2 decades old, are principally focused on adult 
HRV assessment. This thesis provides empirical support regarding the application of 
several guidelines recommended among adult HRV studies (e.g., inclusion of a pre-
recording acclimatization period, analyzing adequately-long and identical ECG recording 
durations, careful editing and filtering of NN-interval data, frequency bandwidth 
selection), which were pertinent for HRV reliability among children. This thesis also 
provides empirical support for how statistically controlling developmental changes in 
heart rate can augment estimates of HRV stability, particularly among measures 
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reflecting parasympathetic modulation. Moreover, exploratory regression analyses 
indicated that change over time across multiple developmentally-relevant moderators 
other than heart rate (pubertal development, blood pressure, growth and adiposity, 
physical activity) were significant predictors of HRV measured at the second QUALITY 
visit. As such, results of this thesis can help to inform future research into factors that are 
pertinent to HRV measurement among children. For instance, with the exception of 
studies with very young children (i.e., infants and toddlers), pediatric HRV measures in 
the frequency-domain are almost consistently derived using frequency bandwidths noted 
in adult measurement guidelines. An explicit examination of whether adult frequency 
bandwidths are actually appropriate for use among children and adolescents does not 
appear available. As such, an examination of the upper and lower limits of HF, LF, and 
VLF frequency bandwidths in children across various ages may help determine the point 
at which researchers should consider adjusting HRV frequency bandwidths to account for 
autonomic development throughout childhood. Relatedly, across the developmental 
period, children’s heart rate decreases, blood pressure increases, they naturally become 
taller and heavier, and they experience increasing hormonal, behavioural, and 
psychological changes with more advanced pubertal development; these changes have 
each been associated with shifts towards sympathetic dominance and should be 
considered when examining pediatric HRV. However, while age, heart rate, blood 
pressure, mass, and physical fitness appear pertinent to HRV studies with participants of 
any age, factors associated with pubertal development are a consideration that are unique 
to pediatric samples. Alterations to HRV associated with pubertal development have not 
been frequently examined (c.f., the number of studies in the meta-analysis that included 
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adolescent participants). Considering the results of this thesis, an extension of current 
HRV guidelines to include greater consideration of factors associated with HRV specific 
to children may be warranted.   
As previously described, the meta-analysis was restricted due to minimal 
reporting of target methodological factors intended for use in moderator analyses. Despite 
this drawback, moderator analyses indicated that reliability was generally robust across 
examined study and recording conditions. Several of these moderators pertain to 
important methodological considerations outlined by published guidelines for the 
interpretation and replication of HRV data. It is paramount that pediatric researchers 
adequately report pertinent methodological details, including participant characteristics 
(e.g., anthropometric data, sample ethnicity), ECG signal acquisition and pre-processing 
techniques (e.g., ECG sampling rate, editing and filtering procedures), and HRV analysis 
procedures (e.g., data reduction, presentation of absolute and normalized HRV units). 
The minimal methodological reporting practices among pediatric HRV studies contrasts 
with the more rigorous reporting practices often observed among adult HRV studies. 
More precise methodological reporting may help improve standardization across HRV 
studies, increase the interpretability and replication of findings, and allow for more 
comprehensive meta-analyses to be conducted in the future. 
General Limitations  
There are two common limitations across both studies in the present thesis that 
merit consideration. First, this thesis focused on short-term (i.e., < 5-hrs) daytime 
measures of time- and frequency-domain HRV. While these measures are frequently 
reported in the adult and pediatric HRV literature, other HRV measures derived from 
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longer recordings or alternative analytical techniques have also demonstrated clinically 
utility. Thus, as previously indicated, efforts to replicate these analyses using long-term 
HRV measures (i.e. ≥ 24-hr, 12-hr overnight) or measures derived using alternative 
analytical techniques (e.g., non-linear, geometrical) is warranted to determine the 
generalizability of these findings to alternative measures of HRV. Relatedly, HRV data 
from most studies included in the meta-analysis as well as data collected from the 
QUALITY cohort were obtained in a laboratory/clinic setting. While this methodology 
allows for increased standardization of ECG recordings, it potentially limits the 
ecological validity of these findings. Future examinations using ambulatory ECG data 
could help address this concern. However, short-term ECG measures obtained in 
laboratory or clinical settings are often more common among the HRV literature, due in 
part to the ease and reduced cost of collecting and analyzing shorter, relative to longer 
ambulatory HRV recordings. As such, considering the methodology commonly applied in 
contemporary research, the results of this thesis are largely applicable to many future 
HRV studies. 
Second, this thesis focused on HRV measures that were obtained during study 
conditions not associated with experimental stressors or manipulations. Although HRV 
measures obtained during passive (relative to task or challenge) conditions are 
prominently reported among adult and pediatric HRV studies, HRV reactivity is an 
important construct that was not examined here. Measures of reactivity are important for 
determining how the autonomic nervous system responds to cognitive (e.g., mental 
workload, attentional demands), emotional (e.g., negative affect, social stress), and 
physical (e.g., tilting, exercise) demands. As such, efforts to replicate these psychometric 
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analyses using data reflecting HRV reactivity, and more specifically, reactivity to 
different stressors, are warranted. This would help determine if the present findings 
generalize beyond the context of HRV measures obtained during states of passivity, and 
extend to measures of HRV reactivity.  
Conclusion 
Overall, the meta-analysis demonstrated that among infant/toddler studies, 
recording exclusively awake ECG data, careful editing and filtering of ECG data, and 
analyzing shorter ECG recording duration epochs were each associated with higher 
reliability; however, sample exclusions based on prescription medication use or the 
presence of a chronic illness were associated with higher NN, but lower HF reliability. 
Among child/adolescent studies, moderator variables pertaining to sample exclusions 
based on prescription medication use or the presence of a chronic illness, and to the 
explicit reporting of manual editing or digital filtering of ECG data prior to HRV 
analysis, were not associated with HRV reliability; however, higher reliability was 
yielded among studies that obtained longer (vs. shorter) ECG recording durations and 
used frequency-bandwidths consistent with published HRV guidelines and 
recommendations. Recording ECG in a seated posture and allowing participants an 
opportunity to acclimate to experimental conditions prior to data collection were both 
associated with higher reliability across both age groups. Analyses using data collected 
from the QUALITY cohort indicated that stability of time- and frequency-domain HRV 
was robust to developmental changes in measures of blood pressure, pubertal status, 
growth and adiposity, and physical activity, all variables which have been previously 
associated with pediatric HRV in cross-sectional and longitudinal studies. Further, 
stability of measures reflecting parasympathetic activity increased after controlling for 
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change in heart rate. Altogether, this research indicated that time- and frequency-domain 
HRV are moderately reliable measures of autonomic cardiovascular control, and reflect a 
moderately stable individual difference among children. In conclusion, this thesis 
provides comprehensive empirical evidence for the psychometric properties of pediatric 
HRV measures, and demonstrates that time- and frequency-domain HRV exhibit 
adequate and generally robust reproducibility over time. Evidence for the psychometric 
quality of pediatric HRV measures is particularly relevant for future studies that examine 
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 Continuous Study Descriptive Characteristics by Age Group 
 Infant/toddler (k = 31) Child/adolescent (k = 15) 
   k     N    M (SD)  k    N      M (SD) 
Study follow-up length (wk) 31 3257 64.27 (63.18) 15 1533 85.84 (111.04) 
Sample size (N)       
First study visit 31 3257 105.06 (89.48) 15 1533 102.2 (84.95) 
Final study visit 31 2202 71.03 (74.94) 15 1123 74.87 (90.93) 
Percent (%) of sample attrition       
First to second study visit 12 1865 21.67 (17.14) 7 1151 19.57 (7.70) 
Second to third study visit 3 794 9.33 (2.52) 1 251 16.00 (0.00) 
Sample mean age (mo)       
First study visit 31 3257 14.31 (17.87) 14 1261 122.43 (33.36) 
Final study visit 31 3257 31.77 (29.92) 13 1465 133.61 (34.48) 
Percent (%) of male participants       
First study visit 17 1337 45.47 (8.23) 12 1060 56.85 (21.66) 
Second study visit 16 1806 46.76 (6.48) 12 1383 57.45 (21.29) 
Height (cm)       
First study visit 2 108 52.30 (0.58) 2 38 147.35 (12.24) 
Second study visit 0     –      – 1 26 141.20 (0.00) 
Weight (kg)       
First study visit 10 499 3.61 (0.30) 4 264 83.93 (13.27) 
Second study visit 2 61 5.96 (0.01) 2 36 37.30 (0.85) 
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 Infant/toddler (k = 31) Child/adolescent (k = 15) 
     k     N    M (SD)  k    N      M (SD) 
Body mass index (BMI; kg/m
2
)       
First study visit 0     –      – 3 483 19.20 (1.15) 
Second study visit 0     –      – 1 77 22.30 (0.00) 
Effect sizes per study   31   3257 3.06 (4.70) 15 1533 2.60 (1.81) 
Note. ECG = electrocardiogram; wk = week; mo = month; cm = centimetre; kg = 
kilograms; kg/m
2



























ECG Recording Characteristics by Age Group 
 Infant/toddler (k = 31) Child/adolescent (k = 15) 





 5      500 3.46 (2.11) 10 1244 8.10 (8.79) 
ECG recording duration (min)
 a
        
Total recording duration 30    3230 24.98 (46.65) 14 1477 18.59 (20.77) 
Baseline recording duration 29    3196 4.76 (4.25) 15 1533 4.73 (3.63) 
Analyzed recording duration  29    3017 4.54 (4.32) 15 1533 3.22 (0.96) 




 18    2161 30.28 (13.32) 4 179 48.75 (48.02) 



















Categorical Study Descriptive Characteristics by Age Group 
     Infant/toddler (k = 31) Child/adolescent (k = 15) 
   k N  % 
a
  k.      N.    % 
a
 
Study recording location       
Identical study location 27 2750 87.1%. 14 1517. 93% 
Changed/multiple location(s) 4 507 12.9%. 1 16. 7% 
Sample exclusion criteria       
Prescription medications       
Exclusion reported 3 165 9.7%. 2 217. 13.3% 
Unmentioned 28 3092 90.3%. 13 1316. 86.7% 
Abnormal pregnancy/birth        
Exclusion reported 4 316 12.9%.  –  
Unmentioned 27 2941 87.1%. 15 1533 100% 
Single parent home/low SES       
Exclusion reported 3 114 9.7%. 4 599. 26.7% 
Unmentioned 28 3143 90.3%. 11 934. 73.3% 
Chronic medical illness       
Exclusion reported 6 376 19.4%. 7 951. 46.7% 
Unmentioned 25 2881 80.6%. 8 582. 53.3% 
Mental health condition       
Exclusion reported  –  6 874. 40% 
Unmentioned 31 3257 100%. 9 659. 60% 
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     Infant/toddler (k = 31) Child/adolescent (k = 15) 
   k N  % 
a
  k.        N.        % 
a
 
Weight characteristics       
Exclusion reported 2 202 6.5%. 1 201 6.7% 
Unmentioned 29 3055 93.5%. 14 1332 93.3% 
Time of ECG recording       
06:00-12:00 3 92 9.7%. 5 324 33.3% 
12:00-18:00 1 20 3.2%. 1 64 6.7% 
Unmentioned 27 3145 87.1%. 9 1145 60% 
Pre-recording acclimatization period duration (min)  
1–2  2 132 4%. 4 622 40.5% 
5–10  3 368 11%. 4 535 35% 
15–30   –  2 103 7% 
No acclimatization period 25 2631 80.6%. 5 289. 19% 
Daytime ECG recorded exclusively while awake     
Exclusively awake ECG data 25 2847 80.6%. 15 1533 100% 
Participant sleep unrestricted  6 410 19.4%.  –  
Additional measure of respiration      
Study measured respiration 8 757 25.8%. 6 1048 40% 
Not measured/unmentioned 23 2500 74.2%. 9 485 60% 
ECG recording posture       
Seated posture 19 2214 61.3%. 5 700 33.3% 
Supine posture 6 744 19.4%. 10 833 66.7% 
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     Infant/toddler (k = 31) Child/adolescent (k = 15) 
   k N  % 
a
  k  N.    % 
a
 
Changed recording posture 6 299 19.4%.  –  
ECG sampling rate       
> 500 Hz 3 85 9.7%. 9 1233 60% 
< 500 Hz 4 295 12.9%. 1 57 6.7% 
Unmentioned 24 2877 77.4%. 5 243 33.3% 
ECG recording duration (min)
  b
   
Total recording duration   
1–3  6 357 11%. 1 251 16.4% 
3.1–4.99  3 468 14.4%. 1 77 5% 
5–10  9 850 26.1%. 6 652 42.5% 
10.1–25  8 1207 37.1%. 4 286 18.7% 
50+  4 526 16%. 2 211 13.8% 
Baseline recording duration  
1–2  10 1067 32.8%. 1 16 1% 
2.1–4.99  6 662 20.3%. 10 1412 92% 
5–10  11 1348 41.4%. 3 95 6% 
10.1–25  2 119 4%. 1 10 1% 
Manual editing of ECG data       
Yes/reported 23 2638 74.2%. 13 1511 86.7% 
No/unmentioned 8 619 25.8%. 2 22 13.3% 
Software-based filter algorithm       
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     Infant/toddler (k = 31) Child/adolescent (k = 15) 
   k N  % 
a
  k.       N.    % 
a
 
Yes/reported 21 2091 67.7%. 8 433 53.3% 
No/unmentioned 10 1166 32.3%. 7 1100. 46.7% 
Analyzed ECG recording duration (min) 
b
    
0.5–1.9  4 369 11.3%.  –  
2–2.9 7 539 16.5%. 3 201 13.1% 
3–3.9  4 441 13.5%. 8 1160 75.7% 
4–4.9  3 229 7%. 2 103 6.2% 
5–10  9 1300 40%. 2 69 5% 
10.1–25  2 119 4.7%.  –  
HRV derivation method       
Mean of 1 ECG epoch  4 387 12.9%. 5 873 33.3% 
Mean of >2 ECG epochs 18 2161 58.1%. 4 179 26.7% 
Unmentioned 9 709 29%. 6 481 40% 
ECG recording epoch duration (sec) 
b
       
< 15 2 234 7.2%. 1 30 2% 
20 1 104 3.1%.  –  
30 13 1537 47.2%. 2 72 4.6% 
60 2 286 8.8%.  –  
120  –  1 77 5% 
Frequency bandwidth selection     
LF        
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     Infant/toddler (k = 31) Child/adolescent (k = 15) 
   k N  % 
a
  k       N.      % 
a
 
Recommended bandwidth 1 31 3.2%. 4 335 26.7% 
Alternative bandwidth  –  2 22 13.3% 
HF        
Recommended bandwidth 17 1968 54.8%. 6 216 40% 
Alternative bandwidth 7 539 22.6%. 3 243 20% 
Note. HRV = Heart Rate Variability; ECG = Electrocardiogram; LF = Low Frequency; 
HF = High Frequency; min = minutes; sec = seconds  
a
 Percent of total N.  
b














Overall Summary Analyses for HRV Reliability  
 k Z [95% CI]
a
 QT  p NFS 
Infant/toddler studies      
Averaged HRV indices
 b
  31 0.42 [0.35, 0.49] 80.86 <.001 1279 
NN 14 0.33 [0.15, 0.48] 45.82 <.001 443 
SDNN 3 0.43 [0.15, 0.91] 14.92 <.001 126 
HF 27 0.42 [0.35, 0.49] 71.61 <.001 1115 
Child/adolescent studies      
Averaged HRV indices
 b
 15 0.64 [0.51, 0.79] 59.86 <.001 949 
SDNN 4 0.85 [0.46, 1.04] 6.07 .108 334 
HF 15 0.65 [0.52, 0.82] 61.15 <.001 955 
LF 6 0.61 [0.41, 0.81] 12.36 .030 357 
LF:HF Ratio 3 0.52 [0.14, 1.19] 4.60 .101 151 
Note. k = Number of Studies; Z = Fisher’s Z; QT = Heterogeneity Statistic; NFS = 
Orwin’s Failsafe N; ES = effect size; HRV = Heart Rate Variability; HF = High 
Frequency; HP = Heart Period; SDNN = Standard Deviation of NN Intervals; LF = 
Low Frequency 
a
 Bootstrap 95% Confidence Interval. 
b
 Average of non-redundant effect sizes for 














HRV Reliability – Continuous Moderator Variables by Age Group 
 NN SDNN HF LF LF:HF Ratio 
 k    B (SE) QT k B (SE)    QT k B (SE)  QT k B (SE)  QT k B (SE)    QT 
Study follow-up length                
Infant/Toddler 14 .00(<.01) 45.82*** 3 -.01(<.01) *** 14.92*** 27 <.01(<.01) 71.61***  –   –  
Child/Adolescent  –  3 -.01(.01) .409 15 <-.01(<.01)** 61.15*** 6 -.01(>.01)*. 12.36* 3 .10(.06) 4.59 
Sample size (N)
a
                
Infant/Toddler 14 <.01(<.01) 45.82*** 3 -.01(<.01)*** 14.92*** 27 <.01(<.01) 71.61***  –   –  
Child/Adolescent       –  3 .01(<.01) 6.07 15 <-.01(<.01)* 61.15*** 6 <-.01(<.01) ** 12.36* 3 -.02(.03) 4.59 
Age (T0 mean; mo)                
Infant/Toddler 14 .01(<.01)*** 45.82*** 3 -.53(.14)*** 14.92*** 27 <.01(<.01)
**
 71.61***  –   –  
Child/Adolescent       –  3 <-.01(<.01) .685 14 <-.01(<.01) 58.99*** 6  <-.01(<.01)  12.36* 3 -.01(.01) 4.59 
Male (percent)                





 NN SDNN HF LF LF:HF Ratio 
    k    B (SE) QT k B (SE)    QT k B (SE) QT k B (SE) QT k B (SE)    QT 
Child/Adolescent       –  3 .01(.01) .421 14 -.01(<.01) ** 58.99*** 6 -.01(<.01) ** 12.36* 3 .05(.03) 4.59 
Weight (lbs)                
Infant/Toddler 5. .41(.43) 4.38      –  7.   .12(.26) 10.76       –     –  
Child/Adolescent       –          –  4.   <.01(.01) 3.45 3 -.01(.02) 3.89 3 -.02(.02) 4.59 
Analyzed ECG recording duration (min)
b
             
Infant/Toddler 14 -.03(.01)
*
 45.82***      –  27 -.01(.01) 71.61***       –     –  
Child/Adolescent       –  3 .24(.18) .181 15   .14(.05) ** 61.15*** 6 .10(.05)* 12.36* 3 -.35(.16)* 4.59 
Note. B = slope; SE = standard error; QT = total heterogeneity; HRV = heart rate variability; ECG = electrocardiogram; wk = week; 
mo = month; lbs = pounds; min = minutes; HP = heart period; SDNN = standard deviation of NN intervals; HF = high frequency; LF 
= low frequency 
a
 Sample size at first study visit. 
b
 Baseline recording duration submitted for HRV analysis 
*
 p < .05. 
**
 p < .01. 
***










Infant/Toddler HRV Reliability – Categorical Moderator Variables 
 
 NN  SDNN  HF 
 
k Z [95% CI] QT NFS k Z [95% CI] QT NFS      k Z [95% CI] QT NFS 
Sample exclusion criteria       
Prescription medications  QM = 14.06, p < .001  N/A  QM = 0.47, p = .491 
Exclusion reported 2 0.61 [.40, .65] 1.10 120 1 0.91 [-,-]     2 0.37 [.34, .50] 0.45 71 
Unmentioned 12 0.23 [.11, .39] 30.67*** 269 2 0.33 [.15, .76] 8.27** 63 25 0.43 [.33, .51] 70.68*** 1043 
Chronic medical illness  QM = 5.26, p = .022  N/A  QM = 2.97, p = .085 
Exclusion reported 3 0.47 [.04, .65] 11.74** 137 2 0.82 [.76, .91] 0.30 163     4 0.32 [.20, .40] 2.00 123 
Unmentioned 11 0.26 [.12, .44] 28.82*** 273 1 0.15 [-,-] 23 0.44 [.35, .52] 66.64*** 984 
Abnormal pregnancy/birth   QM = 1.07, p = .302  N/A  QM = 8.34, p = .004 
Exclusion reported 4 0.38 [.02, .61] 18.84*** 148  –    4 0.34 [-.01, .37] 6.88 91 
Unmentioned 10 0.29 [.15, .48] 25.92** 280 3 0.43 [.15, .91] 14.92*** 126 23 0.45 [.37, .52] 56.39*** 1004 






 NN  SDNN  HF 
 
k Z [95% CI] QT NFS k Z [95% CI] QT NFS     k Z [95% CI] QT NFS 
Exclusion reported 2 0.48 [.01, .65] 12.41*** 93  –     2 0.23 [-.07, .34] 5.09* 43 
Unmentioned 12 0.27 [.15, .45] 28.70** 309 3 0.43 [.15, .91] 14.92*** 126 25 0.44 [.36, .51] 60.20*** 1075 
Study recording location  N/A  N/A  QM = 0.06, p = .803 
Identical study location    13 0.35 [.18, .52] 41.29*** 446 3 0.43 [.15, .91] 14.92*** 126 23 0.42 [.33, .50] 58.09*** 944 
Changed/multiple locations  1 0.01 [-,-]  –     4 0.44 [.20, .55] 13.45** 170 
Time of ECG recording  N/A  N/A  QM = 0.37, p = .541 
Identical recording time  – 2 0.82 [.76, .91] 0.30 163     2 0.31 [.06, .33] 14.00 60 
Unmentioned 14 0.33 [-.-] 45.82*** 443 1 0.15 [-,-] 25 0.42 [.34, .49] 71.10** 1037 
Pre-ECG acclimatization period   QM = 18.31, p < .001  N/A  QM = 0.02, p = .880 
Yes/included  2 0.62 [0.55,0.65] 0.29 122 1 0.76 [-,-]     7 0.43 [.36, .49] 3.19 293 
No/unmentioned 12 0.21 [0.10,0.38] 27.22** 243 2 0.33 [0.15,0.91] 10.50*** 63 20 0.42 [.31, .51] 68.40*** 822 
ECG recorded while awake
a
   N/A  N/A  QM = 6.50, p = .011 






 NN  SDNN  HF 
 
k. Z [95% CI] QT NFS k Z [95% CI] QT NFS     k Z [95% CI] QT NFS 
No 1 0.01 [-,-] 2 0.82 [0.76,0.91] 0.30 163     3 0.21 [.03, .34] 4.79 60 
ECG recording posture
a
  QM = 9.42, p = .002  N/A  QM = 23.12, p < .001 
Sitting 10 0.39 [0.20,0.56] 31.55*** 384 1 0.15 [-,-] 18 0.50 [.41, .57] 42.13*** 883 
Supine/unmentioned 1 0.16 [-,-]  –     6 0.30 [.21, .34] 2.04 173 
Changed recording posture 3 0.01 [-0.21,0.59] 3.79 0 2 0.82 [0.76,0.91] 0.30 163     3 0.19 [-.07, .34] 4.32 53 
ECG sampling rate  N/A  N/A  QM = 4.84, p = .028 
> 500 Hz 1 0.40 [-,-] 2 0.82 [0.76,0.91] 0.30 163     1 0.50 [-,-] 
< 500 Hz 1 0.65 [-,-]  –     4 0.28 [.16, .34] 1.53 107 
Unmentioned 12 0.23 [.11, .40] 30.67*** 269 1 0.15 [-,-] 22 0.44 [.35, .51] 65.11*** 946 
Manual editing of ECG data  QM = 4.99, p = .025  N/A  QM = 1.92, p = .166 
Yes 12 0.38 [.16, .55] 40.80*** 439 1 0.91 [-,-] 21 0.44 [.36, .51] 63.64*** 894 
No/unmentioned 2 0.14 [.13, .16] 0.02 25 2 0.33 [.15, .76] 8.27** 63     6 0.34 [.23, .47] 6.04 200 






 NN  SDNN  HF 
 
k. Z [95% CI] QT NFS k Z [95% CI] QT NFS     k Z [95% CI] QT NFS 
Yes 11 0.36 [.14, .54] 41.87*** 382  – 21 0.45 [.34, .54] 61.05*** 888 
No/unmentioned 3 0.21 [.13, .59] 1.98 59 3 0.43 [.15, .91] 14.92*** 126 6 0.35 [.27, .45] 6.14 237 
Identical ECG recording duration
a
 QM = 5.75, p = .017  N/A  QM = 5.13, p = .024 
Yes 11 0.38 [.16, .56] 38.43*** 404 3 0.43 [.15, .85] 14.92*** 126 20 0.45 [.36, .53] 53.40*** 886 
No 3 0.12 [.01, .32] 1.67 31  – 7 0.33 [.21, .47] 13.07* 227 
HRV derivation method  QM = 2.14, p = .144  N/A  QM = 7.85, p = .020 
Mean of 1 ECG epoch  – 1 0.91 [-,-] 2 0.25 [.16, .34] 1.08 48 
Mean of >2 ECG epochs 9 0.37 [.12, .56] 35.34*** 326  – 18 0.46 [.38, .53] 47.97*** 811 
Unmentioned 5 0.24 [0.09,0.52] 8.34 115 2 0.33 [0.15,0.76] 8.27** 63 7 0.36 [.19, .54] 14.70
*
 242 
Age-appropriate frequency bands   N/A  N/A  QM = 4.45, p = .108 
Yes  –  – 17 0.43 [.33, .50] 36.24** 718 
No  –  – 8 0.48 [.32, .72] 30.84*** 372 
Note. k = number of studies; Z = Fisher’s Z; 95% CI = bootstrap 95% confidence interval; QM = between-groups heterogeneity; QT = 
total heterogeneity; NFS = failsafe N; SDNN = standard deviation of NN intervals; HF = high frequency; ECG = electrocardiogram 
a
 Specific to baseline recording condition. 
*
 p < .05. 
**
 p < .01. 
***






Child/Adolescent HRV Reliability – Categorical Moderator Variables 
  SDNN  HF  LF  LF:HF Ratio 
 k Z [95% CI]
 
 QT NFS k Z [95% CI] QT NFS   k. Z [95% CI] QT NFS k. Z [95% CI] QT NFS 
Sample exclusion criteria             
Prescription medications N/A  QM = 1.82, p = .178  N/A  N/A 
                 Exclusion reported – 2 0.55[.52, .87] 1.36 107  –  – 
Unmentioned  4 0.85[.46, 1.02] 6.07 334  13 0.66[.51,.84] 57.97*** 850 6 0.61[.41, .81] 12.36
*
 357 3. 0.52[.14, 1.19] 4.59 151 
Chronic medical illness N/A  QM = 2.25, p = .134  N/A  N/A 
Exclusion reported 1 0.79[-,-] 7 0.68[.50, .91] 38.68*** 469 1 0.78 [-,-]  – 
Unmentioned  3 0.89[.41, 1.07] 5.69 265 8 0.58[.43, .85] 20.22** 459 5 0.54[.39, .81] 9.58
*
 265 3. 0.52[.14, 1.19] 4.59 151 
Mental health condition N/A  QM = 0.73, p = .392  N/A  N/A 
                 Exclusion reported – 6 0.67[.48, .93] 37.80*** 395  –  – 
Unmentioned 4 0.85[.46, 1.02] 6.07 334 9 0.62[.46, .83] 22.62** 545 6 0.61[.41, .81] 12.36
*
 357 3. 0.52[.14,1.19] .4.59. 151 
Time of ECG recording  N/A  QM = 0.51, p =.474  QM = 1.80, p = .180  N/A 
Identical recording time 3 0.89[.44, 1.07] 5.69 265 7 0.68[.54, .94] 13.93
*





  SDNN  HF  LF  LF:HF Ratio 
 k Z [95% CI]
 
 QT NFS k Z [95% CI] QT NFS k Z [95% CI] QT NFS k. Z [95% CI] QT NFS 
Unmentioned 1 0.79[-,-] 8. 0.63[.46, .84] 46.71*** 499 2 0.55[.39, .78] 6.08
*
 107  – 
Pre-ECG acclimatization period  N/A  QM = 4.85, p = .028  QM = 9.03, p = .003  N/A 
Yes/included 3 0.87[.41, 1.07] 5.17 256 10 0.68[.54, .88] 50.06*** 666 4 0.77[.63, .92] 3.32 305 2. .0.69[.41, 1.19]  2.73 136 
No/unmentioned 1 0.54[-,-] 5. 0.49[.38, .79] 6.23 239 2 0.39[.39, .39] 0.00 76 1. 0.14[-,-] 
ECG recording posture
a
  N/A  QM = 5.78, p = .056  N/A  N/A 
Sitting 1 0.79[-,-] 5. 0.72[.49, .97] 33.85*** 354 1 0.78[-,-]  . – 
Supine 3 0.89[.41, 1.07] 5.69 265 5. 0.61[.40, 1.00] 16.67** 300 5 0.54[.39, .81] 9.58
*
 265 3 0.52[.14, 1.19]  4.59 151 
Unmentioned  – 5. 0.56[.50, .73] 4.56 274  –  – 
ECG sampling rate  N/A  QM = 1.33, p = .249  QM = 3.67, p = .056  N/A 
> 500 Hz 2 0.73[.41, .79] 1.52 144 9. 0.64[.49, .83] 43.32*** 570 2. 0.72[.41, .78] 1.44 142 1. 0.41[-,-] 
Unmentioned 1 0.54[-,-] 5. 0.54[.42, .92] 8.81 266 3. 0.44[0.39,1.26] 4.97 129 2..0.60[.14, 1.19] 4.34
*
 117 
Manual editing of ECG data  N/A  QM = 0.37, p = .544  QM = 0.46, p = .496  N/A 
Yes 3 0.87[.41, 1.07] 5.17 256 13. 0.65[.52, .81] 58.57*** 825 4. 0.59[.39, .78] 8.91
*
 233  1 0.41[-,-] 







  SDNN  HF  LF  LF:HF Ratio 
 k Z [95% CI]
 
 QT NFS k Z [95% CI] QT NFS k. Z [95% CI] QT NFS k. Z [95% CI] QT NFS 
Software-based filter algorithm N/A  QM = 0.25, p = .617  N/A  N/A 
Yes 3 0.89[.54, 1.07] 3.47 263 8 0.67[.46, .91] 21.12** 529 5 0.62[.41, .81]. 11.85
*
 302 2. 0.60[.14, 1.19] 4.34
*
 117 
No/unmentioned 1 0.41[-,-] 7 0.64[.48, .86] 39.78*** 439 1 0.41[-,-]  1. 0.41[-,-] 
Identical ECG recording duration
a
                
Yes 4 0.84[.46, 1.02] 6.07 334  14. 0.64[.51, .81] 60.55*** 888 6 0.61[.43, .81]. 12.36
*
 357  3. 0.52[.14, 1.19] 4.59 151 
No  – 1 0.87[-,-] – – 
HRV derivation method  N/A  QM = 3.22, p = .200  N/A  N/A 
Mean of 1 ECG epoch  – 5 0.67[.48, .93] 36.52*** 329 – – 
Mean of >2 ECG epochs 1 0.79[-,-] 4 0.74[.40, .83] 3.80 291 1 0.78[-,-]  – 
Unmentioned 3 0.89[.41, 1.07] 5.69 265 6 0.57[.42, .93] 17.62** 336 5 0.54[.39, .85]. 9.58
*
 265 3. 0.52[.14, 1.19] 4.59 151 
Age-appropriate frequency bands  N/A QM = 16.49, p < .001  N/A  N/A 
Yes  – 6 0.86[.70, .99] 5.18 508 5 0.61[.42, .85]. 11.92* 301  2. 0.69[.14, 1.19] .2.73 136 





Note. k = number of studies; Z = Fisher’s Z; 95% CI = bootstrap 95% confidence interval; QM = between-groups heterogeneity; QT = 
total heterogeneity; NFS = Failsafe N; SDNN = standard deviation of NN intervals; HF = high frequency; LF = low frequency; ECG = 
electrocardiogram; HRV = heart rate variability  
a
 Specific to baseline recording condition. 
*
 p < .05. 
**
 p < .01. 
***




Sample Demographic, Anthropometric, and Physical Activity Measures 
 Visit 1 (N = 632) Visit 2 (N  = 564) 
 M (SD)    Range M (SD) Range 
Age (months) 115.16 (11.07) 96.00–132.72 139.88 (11.23) 119.04–162.84 
Male Sex (n, %) 344 54.4% 313 49.5% 






Tanner 2 118 18.7% 181 28.6% 
Tanner 3 16 2.5% 135 21.4% 
Tanner 4 2 0.3% 48 7.6% 
Tanner 5 0 0.0% 10 1.6% 
Cardiovascular indices
a
    
Systolic BP (mm/Hg) 93.80 (8.11)
e
 70.33–123.33 97.39 (8.75) 73.33–128.67 
Diastolic BP (mm/Hg) 48.56 (5.12)
e
 32.33–67.33 50.40 (5.30) 35.00–69.00 
Heart rate (beats per minute) 86.51 (8.82) 61.73–121.95 82.39 (9.31) 54.3–116.73 
Growth and adiposity indices     
Height (meters) 138.86 (8.10) 116.50–162.10 151.43 (9.29) 124.50–179.60 
Weight (kilograms) 38.16 (11.47) 20.90–89.95 49.05 (14.84) 24.00–105.20 
BMI (Z-score)
b
 0.71 (1.08) -3.16–2.67 0.68 (1.09) -2.50–2.66 
Waist (centemeters) 67.46 (12.13) 49.00–114.00 72.42 (13.26) 50.95–121.00 
TV/computer screen time      
Weekday (hours) 2.26 (1.81)
f




Visit 1 (N = 632) Visit 2 (N  = 564) 
 
M (SD) Range M (SD) Range 
Weekend (hours) 3.95 (2.92)
h
 0.00–15.00 4.96 (3.25)i 0.00–21.00 
Weekly physical activity (n, %)    





Some (1 – 2 times) 206 32.6% 117 18.5% 
Often (3 – 4 times) 156 24.7% 236 37.3% 
Quite often (5 – 6 times) 84 13.3% 47 7.4% 
Very often (> 7 times) 83 13.1% 38 6.0% 
Note. BP = blood pressure; mm/Hg = millimeters of mercury; min = minute; BMI = body 
mass index  
a
 Recorded in a seated posture. 
b 
CDC (2000) age- and sex-normed Z-score (2000). c N = 





Descriptive Statistics for Electrocardiogram (ECG) and Heart Rate Variability (HRV)  
Measures 
 Visit 1 (N = 575) Visit 2 (N  = 503) 
 M (SD) Range M (SD) Range 
ECG recording      
Start time (hrs:min)  8:29 (0:20) 7:26–9:57 8:17 (0:20). 7:10–9:35 
Total duration (min) 200.62 (18.60) 50–245 198.63 (19.10). 58–227 
Artifacts (% removed) 6.51 (5.79)% 1–49% 6.27 (5.79)%. 1–60% 
Time-domain HRV     
NN (ms) 700.66 (70.89) 492–972 737.47 (83.35). 514–1105 
SDNN (ms) 85.07 (23.32) 39–183 91.09 (25.44). 42–195 
rMSSD (ms) 47.90 (15.56) 15–102 50.24 (16.58). 15–100 
pNN50 (%) 25.43 (13.70) 0.60–68.90 27.25 (14.27). 0.90–63.70 















 63.03–4989.17 920.75 (675.50) 69.25–4307.29 
LF:HF Ratio 1.70 (0.70) 0.54–4.70 1.83 (0.80)c 0.54–6.07 
Note. VLF = very low frequency; LF = low frequency; HF = high frequency; NN = mean 
NN interval; SDNN = standard deviation of NN intervals; rMSSD = root mean square of 
successive differences of NN intervals; pNN50 = proportion of successive NN intervals 
differing by >50 ms; ms = millisecond; ms
2
 = millisecond squared 
 
a 
n = 574. 
b
 n = 571. 
c





HRV Stability: Intra-class (ICC) and Pearson Correlations (r)  
 Intra-class Correlation Pearson Correlation 
 ICC [95% CI] r [95% CI] 
Time-domain HRV   
NN (ms) 0.74 [0.68, 0.78] 0.67 [0.62, 0.72] 
SDNN (ms) 0.82 [0.78, 0.85] 0.72 [0.68, 0.76] 
rMSSD (ms) 0.82 [0.78, 0.85] 0.69 [0.64, 0.74] 
pNN50 (%) 0.80 [0.76, 0.84] 0.68 [0.63, 0.73] 
Frequency-domain HRV   
VLF (ms
2
) 0.79 [0.74, 0.82] 0.73 [0.69, 0.77] 
LF (ms
2
) 0.82 [0.79, 0.85] 0.71 [0.66, 0.75] 
HF (ms
2
) 0.85 [0.83, 0.88] 0.75 [0.71, 0.79] 
LF:HF ratio 0.83 [0.80, 0.86] 0.73 [0.69, 0.77].. 
Note. All p < 0.001. VLF = very low frequency; LF = low frequency; HF = high 
frequency; NN = mean NN interval; SDNN = standard deviation of NN intervals;    
rMSSD = root mean square of successive differences of NN intervals; pNN50 = 












HRV Stability: Partial Correlations (rab.c), Visit 1 Covariates Only 
 Time-domain  Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50   VLF LF HF LF:HF 
Age (months) 0.67 0.71 0.69 0.68 0.73 0.71 0.75 0.73 
Puberty status (Tanner) 0.68 0.72 0.69 0.68 0.73 0.71 0.75 0.73 
Cardiovascular indices
a
         
Systolic BP (mm/Hg) 0.68 0.72 0.69 0.67 0.73 0.71 0.75 0.72 
Diastolic BP (mm/Hg) 0.65 0.71 0.68 0.66 0.73 0.71 0.75 0.73 
Heart rate (beats per minute) 0.24 0.61 0.52 0.48 0.66 0.65 0.69 0.72 
Growth and adiposity indices         
Height (meters) 0.67 0.71 0.70 0.68 0.73 0.71 0.75 0.72 
Weight (kilograms) 0.69 0.72 0.70 0.69 0.73 0.72 0.75 0.72 
BMI (Z-score)
b
 0.69 0.72 0.70 0.68 0.73 0.72 0.75 0.72 
Waist (centemeters) 0.69 0.72 0.70 0.68 0.73 0.72 0.75 0.72 
Physical activity indices         
Weekly physical activity 0.67 0.71 0.69 0.67 0.73 0.71 0.75 0.73 
Weekday screen time (hrs) 0.67 0.72 0.69 0.67 0.73 0.71 0.75 0.72 
Weekend screen time (hrs) 0.67 0.72 0.69 0.67 0.74 0.71 0.75 0.72 
Note. All p < 0.001; BP = blood pressure; mm/Hg = millimeters of mercury; BMI = body 
mass index; VLF = very low frequency (ms
2
); LF = low frequency (ms
2
); HF = high 
frequency (ms
2
); NN = mean NN interval (ms); SDNN = standard deviation of NN 
intervals (ms); rMSSD = root mean square of successive differences of NN intervals 
(ms); pNN50 = proportion of successive NN intervals differing by >50 ms (%); ms = 
millisecond; ms
2
 = millisecond squared 
a
 = Recorded in a seated posture. 
b 




HRV Stability: Partial Correlations (rab.c), Time-Varying Covariates  
 Time-domain Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50 VLF LF HF LF:HF 
Age (months) 0.67 0.72 0.70 0.68 0.73 0.71 0.75 0.73 
Puberty status (Tanner) 0.68 0.72 0.70 0.68 0.74 0.71 0.75 0.73 
Cardiovascular indices
a
         
Systolic BP (mm/Hg) 0.68 0.72 0.70 0.68 0.74 0.72 0.75 0.72 
Diastolic BP (mm/Hg) 0.65 0.72 0.68 0.65 0.74 0.71 0.75 0.73 
Heart rate (beats per minute) 0.55 0.68 0.75 0.72 0.73 0.72 0.80 0.75 
Growth and adiposity indices         
Height (meters) 0.67 0.71 0.70 0.68 0.73 0.71 0.75 0.72 
Weight (kilograms) 0.69 0.72 0.70 0.68 0.73 0.72 0.76 0.72 
BMI (Z-score)
b
 0.69 0.72 0.70 0.68 0.73 0.72 0.75 0.72 
Waist (centemeters) 0.69 0.72 0.71 0.69 0.74 0.72 0.76 0.72 
Physical activity indices         
Weekly physical activity 0.68 0.72 0.70 0.68 0.74 0.71 0.75 0.73 
Weekday screen time (hrs) 0.67 0.72 0.70 0.67 0.74 0.72 0.75 0.73 
Weekend screen time (hrs) 0.67 0.72 0.69 0.67 0.74 0.71 0.75 0.73 
Note. Time-varying covariates = visit 1 covariate and residualized change score; All p < 
0.001; BP = blood pressure; mm/Hg = millimeters of mercury; BMI = body mass index; 
VLF = very low frequency (ms
2
); LF = low frequency (ms
2
); HF = high frequency (ms
2
); 
NN = mean NN interval (ms); SDNN = standard deviation of NN intervals (ms); rMSSD 
= root mean square of successive differences of NN intervals (ms); pNN50 = proportion 
of successive NN intervals differing by >50 ms (%); ms = millisecond; ms
2
 = millisecond 
squared 
a
 = Recorded in a seated posture. 
b 




HRV Regression: Standardized Beta Coefficients, Visit 1 Covariates Only 
 Time-domain  Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50 VLF LF HF LF:HF 
Age (months) .12
***
 .03 .05 .05 .10
***
 .03 .00 .05 
Puberty status (Tanner) .11
**
 .03 .03 .03 .05 .02 .01 -.04 
Cardiovascular indices
a
         
Systolic BP (mm/Hg) .07
*





Diastolic BP (mm/Hg) .02 .01 .00 -.02 .04 .07
*
 .02 .06 
Heart rate (beats per minute) .48
*
 .03 .06 -.01 .04 .10
*
 .07 -.04 





























































Physical activity indices         
Weekly physical activity .03 .02 .01 .00 .02 .00 .00 -.02 
Weekday screen time (hrs) .00 .00 .01 .05 .00 .00 .00 -.04 
Weekend screen time (hrs) .01 .02 .02 .02 .07
*
 .02 .01 -.03 
Note. BP = blood pressure; mm/Hg = millimeters of mercury; BMI = body mass index; 
VLF = very low frequency (ms
2
); LF = low frequency (ms
2
); HF = high frequency (ms
2
); 
NN = mean NN interval (ms); SDNN = standard deviation of NN intervals (ms); rMSSD 
= root mean square of successive differences of NN intervals (ms); pNN50 = proportion 
of successive NN intervals differing by >50 ms (%); ms = millisecond; ms
2
 = millisecond 
squared 
a
 = Recorded in a seated posture. 
b 
= CDC (2000) age- and sex-normed Z-score (2000) 
*
 p < .05. 
**
 p < .01. 
***




HRV Regression: Unstandardized Beta Coefficients, Visit 1 Covariates Only 
 Time-domain  Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50 VLF LF HF LF:HF 
Age (months) 0.85 0.07 0.07 0.07 8.52 2.06 0.14 0.00 
Puberty status (Tanner) 17.64 1.29 1.08 0.95 92.92 34.74 10.98 -0.06 
Cardiovascular indices
a
         
Systolic BP (mm/Hg) 0.71 0.12 0.06 0.03 7.29 8.05 1.05 0.01 
Diastolic BP (mm/Hg) 0.30 0.03 -0.01 -0.05 8.24 12.58 3.21 0.01 
Heart rate (beats per minute) 4.54 0.08 0.11 -0.01 4.90 10.47 5.36 0.00 
Growth and adiposity indices         
Height (meters) 1.77 0.25 0.17 0.15 18.66 10.03 2.84 0.01 
Weight (kilograms) 1.39 0.23 0.19 0.15 13.91 12.16 5.26 0.00 
BMI (Z-score)
b
 11.06 2.09 1.76 1.39 94.02 124.09 65.51 0.01 
Waist (centemeters) 1.06 0.18 0.16 0.13 9.90 11.47 5.24 0.00 
Physical activity indices         
Weekly physical activity 2.17 0.37 0.09 0.06 12.02 3.02 1.59 -0.01 
Weekday screen time (hrs) 0.16 -0.04 0.11 0.01 26.79 -0.59 0.70 -0.02 
Weekend screen time (hrs) 0.31 0.15 0.11 0.08 21.45 4.32 2.23 --0.01 
Note. BP = blood pressure; mm/Hg = millimeters of mercury; BMI = body mass index; 
VLF = very low frequency (ms
2
); LF = low frequency (ms
2
); HF = high frequency (ms
2
); 
NN = mean NN interval (ms); SDNN = standard deviation of NN intervals (ms); rMSSD 
= root mean square of successive differences of NN intervals (ms); pNN50 = proportion 
of successive NN intervals differing by >50 ms (%); ms = millisecond; ms
2
 = millisecond 
squared 
a
 = Recorded in a seated posture. 
b 





HRV Regression: Standardized Beta Coefficients, Time-Varying Covariates 
 Time-domain  Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50 VLF LF HF LF:HF 




 -.23 .-.46 -.87
*
 .72 
Puberty status (Tanner) -.38
**
 -.06 .05 -.09 -.43
**





         



















































Growth and adiposity indices         










































Physical activity indices         


























Weekend screen time (hrs) -.06 -.02 -.04 -.06 .01 .01 -.01 .06 
Note. Time-varying covariates = visit 1 covariate and residualized change score; BP = 
blood pressure; mm/Hg = millimeters of mercury; BMI = body mass index; VLF = very 
low frequency (ms2); LF = low frequency (ms2); HF = high frequency (ms2); NN =  mean 
NN interval (ms); SDNN = standard deviation of NN intervals (ms); rMSSD = root mean 
square of successive differences of NN intervals (ms); pNN50 = proportion of successive 
NN intervals differing by >50 ms (%); ms = millisecond; ms
2
 = millisecond squared 
a
 = Recorded in a seated posture. 
b 
= CDC (2000) age- and sex-normed Z-score (2000) 
*
 p < .05. 
**
 p < .01. 
***




HRV Regression: Unstandardized Beta Coefficients, Time-Varying Covariates 
 Time-domain  Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50 VLF LF HF LF:HF 
Age (months) -2.56 -1.40 -1.32 -1.28 -23.81 -38.28 -51.62 0.05 
Puberty status (Tanner) -53.41 -2.71 -1.27 0.31 -687.41 88.96 122.38 -.62 
Cardiovascular indices
a
         
Systolic BP (mm/Hg) -1.52 -0.46 -0.38 -0.34 -10.74 -12.38 -11.79 0.07 
Diastolic BP (mm/Hg) -5.61 -1.30 -1.08 -0.96 -38.72 -38.96 -30.58 0.03 
Heart rate (beats per minute) -9.80 -1.89 -1.61 -1.41 -69.37 -64.85 -47.86 0.03 
Growth and adiposity indices         
Height (meters) 0.45 -0.41 -0.46 -0.34 17.37 -26.56 -31.61 0.05 
Weight (kilograms) -2.31 -0.74 -0.42 -0.35 -21.00 -25.76 -19.18 0.02 
BMI (Z-score)
b
 10.38 2.46 0.89 0.77 63.45 92.05 54.72 0.01 
Waist (centemeters) -2.60 -0.43 -0.29 -0.29 -22.28 -18.60 -10.77 0.01 
Physical activity indices         
Weekly physical activity .111.42. 35.05. 22.27 17.12 1322.14 1236.91 782.05. -0.24 
Weekday screen time (hrs) -7.02 -1.44 -1.45 -1.38 -20.32 -52.29 -53.91 0.09 
Weekend screen time (hrs). -2.02 -0.16 -0.29 -0.39 5.67 2.62 -3.01 0.02 
Note. Time-varying covariates = visit 1 covariate and residualized change score; BP = 
blood pressure; mm/Hg = millimeters of mercury; BMI = body mass index; VLF = very 
low frequency (ms2); LF = low frequency (ms2); HF = high frequency (ms2); NN =  mean 
NN interval (ms); SDNN = standard deviation of NN intervals (ms); rMSSD = root mean 
square of successive differences of NN intervals (ms); pNN50 = proportion of successive 
NN intervals differing by >50 ms (%); ms = millisecond; ms
2
 = millisecond squared 
a
 = Recorded in a seated posture. 
b 





HRV Stability: Intra-class (ICC) and Pearson Correlations (r) with Imputed Data  
 ICC [95% CI] r [95% CI] 
Time-domain HRV   
NN (ms) 0.59 [0.52, 0.65] 0.54 [0.48, 0.59] 
SDNN (ms) 0.78 [0.74, 0.81] 0.64 [0.59, 0.69] 
rMSSD (ms) 0.72 [0.68, 0.76] 0.59 [0.54, 0.64] 
pNN50 (%) 0.72 [0.68, 0.76] 0.58 [0.52, 0.63] 
Frequency-domain HRV   
VLF (ms2) 0.76 [0.72, 0.79] 0.67 [0.62, 0.71] 
LF (ms2) 0.82 [0.79, 0.85] 0.68 [0.64, 0.72] 
HF (ms2) 0.82 [0.79, 0.85] 0.68 [0.64, 0.72] 
LF:HF ratio 0.80 [0.76, 0.83] 0.62 [0.57, 0.67] 
Note. All p < 0.001. VLF = very low frequency; LF = low frequency; HF = high 
frequency; NN = mean NN interval; SDNN = standard deviation of NN intervals;    
rMSSD = root mean square of successive differences of NN intervals; pNN50 = 













HRV Stability: Partial Correlations (rab.c), Visit 1 Covariates Only with Imputed Data 
 Time-domain  Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50 VLF LF HF LF:HF 
Age (months) 0.52 0.64 0.59 0.58 0.66 0.68 0.68 0.61 
Puberty status (Tanner) 0.54 0.64 0.59 0.58 0.67 0.68 0.67 0.62 
Cardiovascular indices
a
         
Systolic BP (mm/Hg) 0.54 0.64 0.59 0.57 0.67 0.68 0.67 0.60 
Diastolic BP (mm/Hg) 0.51 0.64 0.58 0.56 0.67 0.68 0.67 0.61 
Heart rate (beats per minute) 0.14 0.56 0.44 0.41 0.62 0.64 0.63 0.61 
Growth and adiposity indices         
Height (meters) 0.52 0.63 0.59 0.58 0.66 0.68 0.67 0.61 
Weight (kilograms) 0.54 0.64 0.60 0.58 0.66 0.68 0.68 0.60 
BMI (Z-score)
b
 0.54 0.64 0.60 0.58 0.66 0.68 0.68 0.61 
Waist (centemeters) 0.54 0.64 0.60 0.58 0.66 0.68 0.68 0.60 
Physical activity indices         
Weekly physical activity 0.53 0.64 0.59 0.58 0.66 0.67 0.67 0.62 
Weekday screen time (hrs) 0.54 0.64 0.59 0.58 0.67 0.68 0.67 0.62 
Weekend screen time (hrs) 0.54 0.64 0.59 0.58 0.67 0.68 0.67 0.62 
Note. All p < 0.001; BP = blood pressure; mm/Hg = millimeters of mercury; BMI = body 
mass index; VLF = very low frequency (ms
2
); LF = low frequency (ms
2
); HF = high 
frequency (ms
2
); NN = mean NN interval (ms); SDNN = standard deviation of NN 
intervals (ms); rMSSD = root mean square of successive differences of NN intervals 
(ms); pNN50 = proportion of successive NN intervals differing by >50 ms (%); ms = 
millisecond; ms
2
 = millisecond squared 
a
 = Recorded in a seated posture. 
b 




HRV Stability: Partial Correlations (rab.c), Time-Varying Covariates with Imputed Data 
 Time-domain  Frequency-domain 
Time-varying covariates NN SDNN rMSSD pNN50 VLF LF HF LF:HF 
Age (months) 0.52 0.64 0.59 0.58 0.66 0.68 0.68 0.61 
Puberty status (Tanner) 0.61 0.68 0.63 0.61 0.72 0.72 0.71 0.70 
Cardiovascular indices
a
         
Systolic BP (mm/Hg) 0.55 0.64 0.59 0.58 0.67 0.68 0.68 0.61 
Diastolic BP (mm/Hg) 0.50 0.64 0.57 0.55 0.67 0.68 0.67 0.61 
Heart rate (beats per minute) 0.21 0.61 0.63 0.60 0.65 0.69 0.72 0.63 
Growth and adiposity indices         
Height (meters) 0.52 0.63 0.59 0.58 0.66 0.68 0.68 0.61 
Weight (kilograms) 0.54 0.64 0.60 0.58 0.66 0.68 0.68 0.61 
BMI (Z-score)
b
 0.54 0.64 0.60 0.58 0.66 0.68 0.68 0.61 
Waist (centemeters) 0.54 0.64 0.60 0.58 0.67 0.68 0.68 0.60 
Physical activity indices         
Weekly physical activity 0.60 0.68 0.63 0.61 0.72 0.72 0.71 0.70 
Weekday screen time (hrs) 0.53 0.64 0.59 0.58 0.67 0.68 0.68 0.62 
Weekend screen time (hrs) 0.54 0.64 0.59 0.58 0.67 0.68 0.67 0.62 
Note. Time-varying covariates = visit 1 covariate and residualized change score; All p < 
0.001; BP = blood pressure; mm/Hg = millimeters of mercury; BMI = body mass index; 
VLF = very low frequency (ms
2
); LF = low frequency (ms
2
); HF = high frequency (ms
2
); 
NN = mean NN interval (ms); SDNN = standard deviation of NN intervals (ms); rMSSD 
= root mean square of successive differences of NN intervals (ms); pNN50 = proportion 
of successive NN intervals differing by >50 ms (%); ms = millisecond; ms
2
 = millisecond 
squared 
a
 = Recorded in a seated posture. 
b 




Figure 1: Flow Chart for Article Identification and Inclusion in Meta-Analysis 
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To determine whether a physiological variable is being accurately measured and 
interpreted, evidence must exist to support its validity (i.e., the accuracy with which a 
variable is measured), reliability (i.e., the repeatability of data within and between study 
contexts), and stability (i.e., the within-person consistency of a characteristic or attribute 
across time).   
Validity  
Validity represents both the extent to which a variable (e.g., heart rate) accurately 
quantifies what it intends to quantify (e.g., ventricular contractions), and the agreement 
between independent methodological procedures (e.g., stethoscope, ambulatory monitor; 
Campbell & Fisk, 1959; Campbell, 1960; Cohen & Swerdlik, 2010). Greater 
measurement validity in specific, controlled contexts (e.g., standardized protocols, 
homogenous samples) permits the researcher to make assertions and inferences related to 
the comparability and generalizability to other contexts (e.g., uncontrolled settings, 
heterogeneous samples). Evidence for validity is obtained when data (a) represent an 
adequate sample of the specific variable of interest (i.e., content validity); (b) correlate 
positively with data obtained concurrently using measures of an equivalent or related 
variable, or with data obtained in the future postulated as predictable from the initially-
obtained data (i.e., criterion-related validity); and (c) behave in a way consistent with 
theory (i.e., correlates positively, or converges with established/theoretically related 
measures, and correlates negatively, or can be discriminated from 
established/theoretically unrelated measures). A single psychological process (e.g., 
anxiety) can affect several physiological variables (e.g., heart rate, respiration, blood 
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pressure; Tomarken, 1995); thus, specificity of a variable is paramount for content 
validity. Further, evidence for the appropriateness of conclusions about physiological 
data related to an underlying construct is an ongoing and iterative process (i.e., construct 
validity; Cronbach & Meehl, 1955; Smith, 2005). Evidence for construct validity is 
especially important in psychophysiological research given the oftentimes unavailability 
of suitable criterion measures with which a variable used to represent a construct can be 
compared (Cohen & Swerdlik, 2010). A useful way to demonstrate which variable is the 
most valid representation of an underlying construct is by comparing theory-driven 
expectations about the strength and direction of associations across both related and 
unrelated variables using a multitrait-multimethod matrix (Campbell & Fisk, 1959; 
Smith, 2005). Together, this evidence allows one to infer that a measurement is valid.  
Reliability 
Reliability describes the extent to which data can be measured and interpreted 
consistently across time and methodological contexts (Campbell & Fisk, 1959; Campbell, 
1960; Cohen & Swerdlik, 2010; Kaplan & Saccuzzo, 1997). Classical test theory states 
that data are comprised of a “true score” and “measurement error”, with greater 
measurement error reflecting poorer reliability (Nunnally & Bernstein, 1994). Multiple 
sources of measurement error can reduce a variable’s reliability. It is pertinent to 
distinguish true score variance from random or transient fluctuations, both within- and 
between-assessments, by examining how different sources of error variance affect a 
variable’s reliability (Polit, 2014; Tomarken, 1995). Evidence for reliability is obtained 
when data a) demonstrate minimal variation across content within a given assessment 
(i.e., internal consistency); b) can be replicated across time and methodologically-
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equivalent contexts (i.e., test-retest reliability); c) are consistent when measured using 
two or more equivalent procedures (i.e., parallel-forms reliability); and, d) are measured 
and interpreted consistently by different individuals, such that error variance due to 
researcher subjectivity is minimized (i.e., inter-rater reliability; Nunnally & Bernstein, 
1994; Tomarken, 1995). Generalizability theory is one analytical tool to statistically 
determine which source of error variance has the biggest impact on a variable’s reliability 
when considered separately or in comparison to other sources of error (e.g., Di Nocera, 
Ferlazzo, & Borghi, 2001). Together, this evidence allows one to infer that the 
measurement of a variable is reliable.  
Stability 
Stability refers to the consistency of a variable, and is directly concerned with 
individual differences and within-person factors that contribute to observed changes in a 
characteristic or attribute across time (Tomarken, 1995). Stability reflects the extent of 
“true variation” in a variable or underlying construct across time. Once reliability has 
been established, observed changes in a variable obtained between test-retest intervals 
can be best interpreted in the context of stability (Polit, 2014; Tomarken, 1995). Evidence 
for stability is obtained when data a) demonstrate consistency in the absolute quantitative 
value of a variable measured on multiple occasions, and b) allow for inferences regarding 
the developmental trajectory of an underlying construct, as represented by a measured 
variable. It is pertinent to consider both time-invariant (i.e., static, stable; sex, ethnicity) 
and time-variant (i.e., dynamic, temporal; mood, growth) within-person factors when 
examining stability (Anastasi, 1953, Fracasso, Porges, Lamb, & Rosenberg, 1994). 




Anastasi, A. (1953). Individual differences. Annual Review of Psychology, 4, 137-156. 
Cohen, R. J. & Swerdlik M. E. (2010) Psychological Testing and Assessment: An 
Introduction to Tests and Measurements (7
th
 ed.). New York, NY: McGraw-Hill. 
Cronbach, L.J., & Meehl, P. E. (1955). Construct validity in psychological tests. 
Psychological Bulletin, 52, 281-302. 
Campbell, D.T., & Fiske, D. W. (1959).Convergent and discriminant validation by the 
multitrait-multimethod matrix. Psychological Bulletin, 56, 81-105. 
Campbell, D. T. (1960). Recommendations for APA test standards regarding construct, 
trait, or disciminant validity. American Psychologist, 15, 546-553. 
Fracasso, M. P., Porges, S. W., Lamb, M. E., & Rosenberg, A. A. (1994). Cardiac 
activity in infancy: Reliability and stability of individual differences. Infant 
Behaviour and Development, 17, 277-284. 
Kaplan, R. M. & Saccuzzo, D. P. (1997) Psychological Testing: Principles, Applications, 
and issues (4
th
 ed.). California: Brooks/Cole Publishing Co. 
Nunnally, J. C. & Bernstein, I. H. (1994). Psychometric Theory (3
rd
 ed.). New York: 
McGraw Hill, Inc.  
Polit, D. F. (2014). Getting serious about test-retest reliability: A critique of retest 
research and some recommendations. Quality of Life Research, 23, 1713-1720. 
Smith, G. T. (2005). On construct validity: Issues of method and measurement. 
Psychological Assessment, 17(4), 396-408. 
Tomarken, A. J. (1995). A psychometric perspective on psychophysiological measures. 
Psychological Assessment, 7(3), 387-395. 
 
